DGE	Genes	Process~name	num_of_Genes	gene_group	percentage%	P-value	Benjamini and Hochberg (FDR)	 Hommel singlewise process	Bonferroni single-step process	Hommel singlewise process	Hochberg step-up process	Benjamini and Yekutieli
down	AKR1B15; PIR; SCD; PRODH; HR; AKR1B10; UGDH; ALOX12B; BBOX1; TM7SF2; CYP11A1; CYP2E1; GSTA1; SOD3; TXN; MGST1; CYP2C9; IMPDH2; BMP2; CYP4B1; NQO1; CBR1; AOC1; MAOA; FDXR; ALDH3A1; RRM2; UQCRC1; PRDX2; CYP2C19; SPR; ADH7; ALDH3B2; ALDH9A1; AKR1C2; AKR1C1; PRDX1; PRDX4; SQLE; PTGR1; DHCR24; NSDHL; MSMO1; RPE65; PHYHD1; CYB5R2; RETSAT; DEGS2; MOXD1; DHRS11; FA2H; P3H2; CYP4X1; CYP4Z2P; SDR16C5; HSD17B8; RDH12; HSD17B10; TXN2; TXNDC17; DOHH; ALOXE3; CYP4F11; CYP4F12; PNPO; CYP39A1; STEAP1; CYB5R1; HIGD1A; CYP2J2; CYP2F1; CYP2C18; STEAP3;	GO:0055114~oxidation-reduction process	73	526	13.8783269961977	0	0	0	0	0	0	0
down	ANG; ME1; DHCR24; TXN2; PIAS3; TIMP4; TIMP3;	GO:0009725~response to hormone	7	42	16.6666666666667	0.00010763569573968	0.00315969508356173	0.377047842176109	0.390179397056351	0.276085559572287	0.377047842176109	0.0277198885550718
down	MAOA; COMT; MAOB; PRIMA1;	GO:0042135~neurotransmitter catabolic process	4	8	50	0.00010895500288143	0.00315969508356173	0.381560420090799	0.394961885445216	0.278162122356314	0.381451465087918	0.0277198885550718
down	MAOA; COMT; MAOB; MOXD1;	GO:0042420~dopamine catabolic process	4	8	50	0.00010895500288143	0.00315969508356173	0.381560420090799	0.394961885445216	0.278162122356314	0.381451465087918	0.0277198885550718
up	QSOX1; WDR1; CFD; SERPINA1; EGF; FN1; PPBP; PF4; APP; ITGB3; SERPINE1; PSAP; LYN; ITGA2B; PLEK; SRGN; F5; ACTN1; SELP; PECAM1; CD36; VCL; ORM2; ACTN2; CTSW; TMSB4X; ITIH3; STXBP2; ECM1; FERMT3; SCG3; FAM49B; TLN1;	GO:0002576~platelet degranulation	33	124	26.6129032258064	0.00010961703173373	0.0107680464173104	0.639615380166332	0.646082785038623	0.618678527105189	0.639615380166332	0.0997012411809878
down	NKX2-8; HRAS; SRD5A1; UGT1A1; MPST; CEBPA; WNT4; HMGCS1; PCSK9;	GO:0001889~liver development	9	75	12	0.00011610146558616	0.00331391978543174	0.406239028085975	0.420867812749831	0.289324852240711	0.406239028085975	0.0290728961824586
down	FOXN1; SOX15; PTTG1; EGFR; ANXA4; CKS2; ID4; MAZ; IRX6; IRX4; IRX3; GLO1; MESP2; TEF; TFAP2C; SOX7; STOX2; GTF2IRD1; POU2F3; SOX21; RUVBL2; NR2F6; SPDEF; PIAS3; ZIC2; FOXA1; GRHL3; FOXI2; KLF5; TFAP2B; HOPX; DLX3; GRHL2; DLX5; BARX2;	GO:0006357~regulation of transcription by RNA polymerase II	35	747	4.68540829986613	0.00011839398122104	0.00333172840164266	0.414142146311209	0.429178181926282	0.29215393393731	0.414142146311209	0.0292291305163521
down	BMP7; ITGA8; IRX3; APH1A; EYA1; SOX17;	GO:0001656~metanephros development	6	29	20.6896551724138	0.00011856357622397	0.00333172840164266	0.414616826055235	0.429792963811904	0.292377778968318	0.414616826055235	0.0292291305163521
down	ALDOA; TK1; SHMT1; SHMT2; ALDH9A1; AQP5; TRPM4; HSD17B10;	GO:0051289~protein homotetramerization	8	59	13.5593220338983	0.00012876619110635	0.00356318658595831	0.450037837916712	0.466777442760538	0.304840860953891	0.450037837916712	0.0312597046397123
up	DOK2; CD4; CD8A; CSF1R; CD3E; LYN; CD7; RAPGEF1; TRAT1; IL31RA; RASGRP4; DOK1; NRTN; PILRB; FRK; SLA; EPHA10; NEDD9; FGR; SHC2; FES; HCK; MERTK; EPHB1; BLK; CASS4; EPHA2; FLT3; LCK; SHC4; LMTK2; SHC3;	GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway	32	120	26.6666666666667	0.00013379785719047	0.012719428552914	0.780442900992048	0.788604570280667	0.685314565220973	0.780442900992048	0.117769070144404
down	CES2; GSTA1; AKR1C2; PTGR1; AKR1C1;	GO:0006693~prostaglandin metabolic process	5	18	27.7777777777778	0.00013685740980706	0.00370229933246731	0.478179789865893	0.496108110550619	0.314772042556255	0.477906075046279	0.0324801356394886
down	TUBB; TUBB4B; PRDX1; RAET1G; RAET1E;	GO:0042267~natural killer cell mediated cytotoxicity	5	18	27.7777777777778	0.00013685740980706	0.00370229933246731	0.478179789865893	0.496108110550619	0.314772042556255	0.477906075046279	0.0324801356394886
down	DSP; KRT9; KRT20; KRT17; TCHH;	GO:0045109~intermediate filament organization	5	18	27.7777777777778	0.00013685740980706	0.00370229933246731	0.478179789865893	0.496108110550619	0.314772042556255	0.477906075046279	0.0324801356394886
down	CAPN8; PIR; PRSS3; AKR1C2; AKR1C1; CYP39A1;	GO:0007586~digestion	6	30	20	0.00013957924902041	0.00372040277719859	0.487271158330273	0.505974777699009	0.318101108517528	0.487131579081252	0.0326389564931288
down	OIP5; CENPA; CENPW; CENPU; CENPI; CENPH;	GO:0034080~CENP-A containing nucleosome assembly	6	30	20	0.00013957924902041	0.00372040277719859	0.487271158330273	0.505974777699009	0.318101108517528	0.487131579081252	0.0326389564931288
down	EGFR; HRAS; FGF1; ADRA2A; EDN3; MIF; MST1R; TPD52L1;	GO:0043406~positive regulation of MAP kinase activity	8	60	13.3333333333333	0.00014308060415135	0.00378589189816549	0.499208227884087	0.518667190048672	0.322360601153009	0.499208227884087	0.0332134901385481
up	LILRA5; CCL24; TLR4; TLR2; JAK2; TNF; IFNG; SERPINE1; OSM; ITGA2; TNFSF4; PTGER4; SNCA; CCR2; STAT5B; NLRP12; IL2; S100A12; IL16; TLR10; NFKBIZ; IL21; TLR7; GPSM3;	GO:0050729~positive regulation of inflammatory response	24	78	30.7692307692308	0.00015209469730503	0.0135825173623621	0.88655999059107	0.896446145915897	0.72235546425827	0.88655999059107	0.125760401367964
down	AKR7A3; AKR1A1; ALDH3A1; ALDH9A1;	GO:0006081~cellular aldehyde metabolic process	4	9	44.4444444444444	0.00015457420719755	0.00394599648655731	0.539000260497875	0.560331501091138	0.335415573515705	0.538536537876283	0.0346180817937575
down	AKR1B10; AKR1A1; AKR1C2; AKR1C1;	GO:0044597~daunorubicin metabolic process	4	9	44.4444444444444	0.00015457420719755	0.00394599648655731	0.539000260497875	0.560331501091138	0.335415573515705	0.538536537876283	0.0346180817937575
down	AKR1B10; AKR1A1; AKR1C2; AKR1C1;	GO:0044598~doxorubicin metabolic process	4	9	44.4444444444444	0.00015457420719755	0.00394599648655731	0.539000260497875	0.560331501091138	0.335415573515705	0.538536537876283	0.0346180817937575
down	UGT1A1; UGT1A7; UGT1A10; UGT1A6;	GO:0052697~xenobiotic glucuronidation	4	9	44.4444444444444	0.00015457420719755	0.00394599648655731	0.539000260497875	0.560331501091138	0.335415573515705	0.538536537876283	0.0346180817937575
up	TRIM24; JAK2; ULK1; ERN1; STK17B; STK10; FES; CSF1R; LYN; HCK; FGR; BCR; FLT3; CSK; TXK; ZAP70; SYK; CLK3; DAPK1; EPHB1; CSNK1G2; MAP3K9; MAP3K10; BTK; STK4; ATM; PTK2B; PRKD1; LRRK2; LMTK2; UHMK1; MAP4K1; MAP3K3; EIF2AK1; PRKD2; TAOK3; NEK6; ATP13A2; STK39; IRAK3; PIM2;	GO:0046777~protein autophosphorylation	41	173	23.6994219653179	0.00015678342623226	0.0137922614061638	0.913733808081643	0.924081514212972	0.731348941116842	0.913733808081643	0.127702419510059
down	FOXP2; NME1; TSPO; PSPH; CA9; BAD;	GO:0033574~response to testosterone	6	31	19.3548387096774	0.00016343796223794	0.00414309519659125	0.569254422474761	0.592462613112549	0.34504989262461	0.569254422474761	0.0363472215151544
down	DEFB4A; GAPDH; S100A7; ROMO1; PGLYRP4; PGLYRP3; CXCL9; CXCL11;	GO:0061844~antimicrobial humoral immune response mediated by antimicrobial peptide	8	62	12.9032258064516	0.0001756534324161	0.00439133581040252	0.611449598240447	0.636743692508365	0.358450166495708	0.611449598240447	0.0385250272741627
down	GJB6; CXCL14; C1QB; BMP2; GJB2; CEBPA; CYTL1;	GO:0048839~inner ear development	7	46	15.2173913043478	0.00017866456213977	0.00443602080655261	0.621752676246414	0.647659037756682	0.361438409208763	0.621752676246414	0.038917047099053
down	PLA2G2A; PLCD1; PLD1; LIPI; ASPG; PLA2G3; PNLIPRP3; CES3; LIPG;	GO:0016042~lipid catabolic process	9	81	11.1111111111111	0.00019759583470813	0.00487268640011547	0.687435908949587	0.716284900816974	0.378198427631362	0.687435908949587	0.0427478982632584
up	TNFSF11; GRIN2D; PLCG2; PLCG1; FPR2; CCR6; CXCR4; BTK; LRRK2; P2RX4; MCOLN1; LAT2; NUDT4; RCAN3; PTGDR2; CXCR2; CCR3; CCR2; CCR1; CCR10; CXCR5; CX3CR1; ACKR2; CXCR3; CCR7;	GO:0019722~calcium-mediated signaling	25	85	29.4117647058824	0.00020101539280159	0.0171707931184435	1	1	0.805111529179752	0.999999976169535	0.15898421307125
down	TAX1BP3; APCDD1; TSKU; FRZB; SFRP2; DKK4; CTNNBIP1;	GO:0030178~negative regulation of Wnt signaling pathway	7	47	14.8936170212766	0.00020131705223303	0.00493090752935631	0.700180707666478	0.729774314344733	0.381495813981592	0.700180707666478	0.0432586700850404
down	LMNA; CDK1; CCNB1; HEY2;	GO:0055015~ventricular cardiac muscle cell development	4	10	40	0.00021254955083527	0.00517108806562324	0.739034788254243	0.770492121777863	0.390453524884396	0.739034788254243	0.0453657650807106
down	MVK; PMVK; MVD;	GO:0019287~isopentenyl diphosphate biosynthetic process, mevalonate pathway	3	3	100	0.00021548464484977	0.00517305852702269	0.74902462549781	0.781131837580426	0.392811854439764	0.74880914085296	0.04538305186597
down	SPINT2; GRHL2; ST14;	GO:0060672~epithelial cell morphogenesis involved in placental branching	3	3	100	0.00021548464484977	0.00517305852702269	0.74902462549781	0.781131837580426	0.392811854439764	0.74880914085296	0.04538305186597
up	TLR4; TYROBP; CD5; CD3E; CD14; ITGAM; CASP1; CASP5; DAPK1; BTK; CASP8; DPF2; CASP10; MOAP1; P2RX4; P2RX7; MAP3K5; ST20; LY96; IFI6; ANXA6;	GO:0097190~apoptotic signaling pathway	21	65	32.3076923076923	0.00022168114206488	0.0181470646018119	1	1	0.828041944852443	0.999999976169535	0.168023501615266
down	CLDN5; IRF6; WNT9B; GABRB3; EPHB3; DLX5; FOXF2; FRAS1;	GO:0060021~roof of mouth development	8	66	12.1212121212121	0.00025915291394984	0.00614006086972672	0.900038070147812	0.939429313068188	0.425529084705645	0.900038070147812	0.0538665277911321
up	TNFSF11; AIM2; TNFSF12; FOXO3; TNFSF14; JAK2; TNFSF13; LTA; TNF; TNFRSF1B; TNFSF4; CD27; PSMB8; PSMB9; TNFRSF8; CD40LG; CD70; PSMB10; TNFRSF4; TMSB4X; PSME1; LTB; PTK2B; PSMA8; PSMF1; TNFRSF14; TNFRSF13C; CDIP1; EDA2R; TNFSF13B; TRAF4;	GO:0033209~tumor necrosis factor-mediated signaling pathway	31	120	25.8333333333333	0.00027028075953539	0.0206355310032464	1	1	0.875712781111841	0.999999976169535	0.191064188778479
up	APAF1; TNFRSF10B; JAK2; TNF; LCK; F3; SNCA; P2RX1; NLRP12; CASP8; PDCD2; ATP2A3; NLRP3; NKX3-1; NLRP1; ST20; NLRC4; CASP9; CASP10; BBC3; BID; CASP4; CASP1; CARD8; CASP5;	GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process	25	87	28.735632183908	0.00027038056387618	0.0206355310032464	1	1	0.875792340108146	0.999999976169535	0.191064188778479
up	PIK3CD; RGL2; JAK2; F2; TNF; CAT; LYN; FGR; CSF3; CCL5; OSM; HCLS1; NCF1; SELP; EPOR; PIK3R1; PTPN6; FLT3; PIK3CG; PRR5L; PIK3AP1; PIK3R5; SEMA4D; NKX3-1; HCST;	GO:0014068~positive regulation of phosphatidylinositol 3-kinase signaling	25	87	28.735632183908	0.00027038056387618	0.0206355310032464	1	1	0.875792340108146	0.999999976169535	0.191064188778479
up	LGALS9; TRIM38; TMPRSS2; CD4; CD74; LGALS1; TRIM21; TRIM11;	GO:0046598~positive regulation of viral entry into host cell	8	10	80	0.0002730864299717	0.0206355310032464	1	1	0.877802184001879	0.999999976169535	0.191064188778479
down	JUP; DSP; DSC2; TRPM4;	GO:0098911~regulation of ventricular cardiac muscle cell action potential	4	11	36.3636363636364	0.00028468201932518	0.00670111896138837	0.988415971097055	1	0.440561224784946	0.988415971097055	0.058788669758151
down	DEFB4A; GAPDH; ROMO1; LCE3A; PGLYRP4; PGLYRP3;	GO:0031640~killing of cells of other organism	6	35	17.1428571428571	0.00029284640950422	0.00680492457982566	1	1	0.445068264439032	0.999480344286979	0.0596993526241788
down	SLC9A3R1; NUPR1; BCAP31; BAD; IL20RA; BOK;	GO:2001244~positive regulation of intrinsic apoptotic signaling pathway	6	35	17.1428571428571	0.00029284640950422	0.00680492457982566	1	1	0.445068264439032	0.999480344286979	0.0596993526241788
down	RAMP2; SLC2A1; SCGB1A1; IDO1; IGFBP2; ADRA2B; ADCYAP1; ADRA2C; COMT;	GO:0007565~female pregnancy	9	86	10.4651162790698	0.00029755840424206	0.00687037716800934	1	1	0.447527839980058	0.999480344286979	0.0602735657688369
up	PALM3; LGALS9; TLR4; JAK2; LTA; MPO; ALPL; SELP; PLCG2; IFNAR1; C5AR1; IL12A; CD6; CPS1; CCR7; CSF2RB; CNR2; OPRM1; PTGER4; SNCA; CD96; PTGER2; PTGIR; SLC11A1; CASP9; IL10RA; CASP8; AKIRIN2; PELI1; OTUD5; P2RX7; PTPN22; IRAK3; LY96;	GO:0032496~response to lipopolysaccharide	34	138	24.6376811594203	0.00029852133208918	0.0217220337201686	1	1	0.896531163007242	0.999999976169535	0.201124107284173
down	SLC9A3R1; RARG; KEL; XK; IQGAP3;	GO:0008361~regulation of cell size	5	22	22.7272727272727	0.00030475430093446	0.00690458963054641	1	1	0.451341119683939	0.999480344286979	0.0605737104421808
down	CKS2; CCND1; CCNB1; CCNO; CCNB2;	GO:0044772~mitotic cell cycle phase transition	5	22	22.7272727272727	0.00030475430093446	0.00690458963054641	1	1	0.451341119683939	0.999480344286979	0.0605737104421808
down	KRT18; KRT16; KRT3; KRT6C; DSP;	GO:0045104~intermediate filament cytoskeleton organization	5	22	22.7272727272727	0.00030475430093446	0.00690458963054641	1	1	0.451341119683939	0.999480344286979	0.0605737104421808
up	RASA4; JAK2; EGF; TNF; IL2RA; MBP; RAF1; SPTB; CCL5; NCAM1; IL2RB; JAK1; ITPKB; PSMB8; PSMB9; YWHAB; CSF2RB; ACTN2; FLT3; PSMB10; JAK3; MAPK12; IL2; GRB2; SHC2; SPTBN1; IL5RA; PSME1; MEF2C; SPTAN1; PTK2B; RASA3; DUSP5; DUSP6; LRRK2; DAB2IP; SETX; RASAL3; KSR1; RASGEF1A; IL31RA; PSMA8; RASGRP4; SHC3; PSMF1; MAP3K5; NRTN; MAP3K3; FGF23; TAOK3; KL; MAP4K2; MAP4K1;	GO:0000165~MAPK cascade	53	254	20.8661417322835	0.00031380577819151	0.0225557470324484	1	1	0.90685386116488	0.999999976169535	0.208843451053882
down	ANXA4; SCGB1A1; NQO1; UGT1A1; SERPINB3; UGT1A7; HSPBP1;	GO:0043086~negative regulation of catalytic activity	7	52	13.4615384615385	0.0003518708119139	0.00792255710054592	1	1	0.475377466895681	0.999480344286979	0.069504301551392
down	ANXA1; GSTP1; ADCYAP1; UGT1A1; STC1;	GO:0071385~cellular response to glucocorticoid stimulus	5	23	21.7391304347826	0.00036416361674906	0.00794996660811853	1	1	0.480742637545785	0.999480344286979	0.0697447641514748
down	CA2; AQP1; AQP5;	GO:0015670~carbon dioxide transport	3	4	75	0.00037077521560435	0.00794996660811853	1	1	0.4837045101579	0.999480344286979	0.0697447641514748
down	ADRA2A; ADRA2B; ADRA2C;	GO:0032811~negative regulation of epinephrine secretion	3	4	75	0.00037077521560435	0.00794996660811853	1	1	0.4837045101579	0.999480344286979	0.0697447641514748
down	SOX18; OVOL2; SOX17;	GO:0060214~endocardium formation	3	4	75	0.00037077521560435	0.00794996660811853	1	1	0.4837045101579	0.999480344286979	0.0697447641514748
down	ANXA8; PLA2R1; ANXA1;	GO:1900138~negative regulation of phospholipase A2 activity	3	4	75	0.00037077521560435	0.00794996660811853	1	1	0.4837045101579	0.999480344286979	0.0697447641514748
down	CTSG; CPA3; CMA1; ACE2;	GO:0002003~angiotensin maturation	4	12	33.3333333333333	0.0003728260202428	0.00794996660811853	1	1	0.484652696848043	0.999480344286979	0.0697447641514748
down	GINS1; GINS3; POLD2; MCM4;	GO:0006271~DNA strand elongation involved in DNA replication	4	12	33.3333333333333	0.0003728260202428	0.00794996660811853	1	1	0.484652696848043	0.999480344286979	0.0697447641514748
down	SCD; SLC25A1; HSD17B8; PPT2;	GO:0046949~fatty-acyl-CoA biosynthetic process	4	12	33.3333333333333	0.0003728260202428	0.00794996660811853	1	1	0.484652696848043	0.999480344286979	0.0697447641514748
down	SPINK1; NTF3; CADM4; SFRP2;	GO:0050732~negative regulation of peptidyl-tyrosine phosphorylation	4	12	33.3333333333333	0.0003728260202428	0.00794996660811853	1	1	0.484652696848043	0.999480344286979	0.0697447641514748
down	GSTA4; IDH1; GSTA1; GSTP1; GLO1; MGST1;	GO:0006749~glutathione metabolic process	6	37	16.2162162162162	0.00038218978199977	0.00800831190606466	1	1	0.488758492134443	0.999480344286979	0.0702566253007336
down	AGR2; FOXF1; VWC2; EGFLAM; NPNT; SMOC2;	GO:0010811~positive regulation of cell-substrate adhesion	6	37	16.2162162162162	0.00038218978199977	0.00800831190606466	1	1	0.488758492134443	0.999480344286979	0.0702566253007336
down	RAMP3; EGFR; SRD5A1; UGT1A1; BCL2L2; RUVBL2;	GO:0071392~cellular response to estradiol stimulus	6	37	16.2162162162162	0.00038218978199977	0.00800831190606466	1	1	0.488758492134443	0.999480344286979	0.0702566253007336
up	AIM2; CAT; ADORA3; TRIM21; ARRB2; ARRB1; NLRP12; TMSB4X; NWD1; LRRC14; PARP10; DAB2IP; COMMD6; NLRC5; ZNF675; PELI1; CDK5RAP3; NLRP3; GFI1; CMKLR1; RBCK1; CARD8; IRAK3;	GO:0032088~negative regulation of NF-kappaB transcription factor activity	23	79	29.1139240506329	0.00039925483530778	0.0283519036060732	1	1	0.942640666161676	0.999999976169535	0.26251001062041
up	CD74; CD3D; PTPRC; ITPKB; ZAP70; DOCK2; CD3E; CD3G;	GO:0045059~positive thymic T cell selection	8	11	72.7272727272727	0.00042761157135051	0.0295267533458951	1	1	0.951561068383336	0.999999976169535	0.273387933385779
up	PIK3CD; TNFSF11; EGF; TNF; LCK; GPX1; CSF3; OSM; F3; HCLS1; RAC2; VAV1; GATA3; IGFBP5; PIK3R1; ARRB2; CCR7; CD80; CHI3L1; CD86; PIK3CG; CX3CR1; GRB2; ADAM8; RHOG; PTPRJ; TRAT1; PIK3AP1; PIK3R5; RASD2; P2RX4; C1QTNF1; FGF23; IL26; KL; ARFGEF1; ICOS; RICTOR;	GO:0051897~positive regulation of protein kinase B signaling	38	165	23.030303030303	0.00042891420675517	0.0295267533458951	1	1	0.951917700299809	0.999999976169535	0.273387933385779
up	SOCS3; JAK2; TNF; IFNG; CSF1R; LYN; IL6R; CCL5; OSM; HCLS1; PECAM1; IL12A; FLT3; STAT3; IL2; PARP14; PARP9; IL31RA; IL21; IL20; IL27RA;	GO:0042531~positive regulation of tyrosine phosphorylation of STAT protein	21	69	30.4347826086957	0.00043082809429029	0.0295267533458951	1	1	0.952456784369427	0.999999976169535	0.273387933385779
down	PLA2G2A; PLA2G4A; PLA2G4F; PLA2G3; ANXA1;	GO:0050482~arachidonic acid secretion	5	24	20.8333333333333	0.00043192127222546	0.00894694063895608	1	1	0.50951168402766	0.999480344286979	0.0784911805923819
down	DVL1; MYO3A; GRHL3; FRZB; EYA1;	GO:0090103~cochlea morphogenesis	5	24	20.8333333333333	0.00043192127222546	0.00894694063895608	1	1	0.50951168402766	0.999480344286979	0.0784911805923819
up	NCK2; CYBB; ITGB3; CYBA; NCF1; VAV1; NCF2; PIK3R1; PXN; NCKAP1L; SHC2; ROCK1; PTK2B; NCF4; PRKD1; ELMO1; CYFIP2; PRKD2; SH2D2A; WASF2;	GO:0048010~vascular endothelial growth factor receptor signaling pathway	20	64	31.25	0.00044148669322885	0.0295695746578508	1	1	0.955355282815705	0.999999976169535	0.273784415513132
down	FOXN1; FCGR2B; CRISP3; MST1R; CXCL9; TPSAB1; ACKR1; COLEC12;	GO:0006952~defense response	8	72	11.1111111111111	0.00044288279188498	0.00907033966431103	1	1	0.513492414001491	0.999480344286979	0.0795737556954161
down	IGHA1; IGHA2; CD34; TMEM63C;	GO:0003094~glomerular filtration	4	13	30.7692307692308	0.00047887858627082	0.00959080041564499	1	1	0.525808687725366	0.999480344286979	0.0841397386914727
down	DDAH2; NQO1; SPR; SLC7A2;	GO:0006809~nitric oxide biosynthetic process	4	13	30.7692307692308	0.00047887858627082	0.00959080041564499	1	1	0.525808687725366	0.999480344286979	0.0841397386914727
down	NQO1; PRDX2; SOD3; PRDX1;	GO:0019430~removal of superoxide radicals	4	13	30.7692307692308	0.00047887858627082	0.00959080041564499	1	1	0.525808687725366	0.999480344286979	0.0841397386914727
up	CCL24; TERT; TNFSF12; SASH1; LRG1; CYBB; ITGB2; SERPINE1; PRKCB; F3; PLCG1; ITGAX; C5AR1; TBXA2R; CXCR2; ITGB8; CHI3L1; TGFBR2; STAT3; CX3CR1; CCR3; HMGA2; BTG1; PTK2B; PRKD1; C3AR1; ECM1; HIPK1; TMIGD2; PRKD2; ERAP1; CELA1;	GO:0045766~positive regulation of angiogenesis	32	131	24.4274809160305	0.00050014620059846	0.0326700238805346	1	1	0.968911786857741	0.999999976169535	0.302491445901047
up	ACKR2; CCL5; CXCR2; CCR1; CXCR5; CCR2; CCR10; CX3CR1; CXCR3; CCR3; CCR6; PTK2B; CMKLR1; GPR35; CCL26; PPBP; CCL4; CCL24; CXCL6; CCL7; PF4;	GO:0070098~chemokine-mediated signaling pathway	21	70	30	0.00050440654447381	0.0326700238805346	1	1	0.969782282184002	0.999999976169535	0.302491445901047
down	CTSV; SPP1; GJA1; GJB2; STC1;	GO:0046697~decidualization	5	25	20	0.00050875877274458	0.0101332447868084	1	1	0.535722987700052	0.999480344286979	0.0888985831743481
up	TESPA1; RAB29; KCNN4; ADA; LCK; CCR7; TRAT1; CARD11; PRKD2;	GO:0050862~positive regulation of T cell receptor signaling pathway	9	15	60	0.00052191766750975	0.0330772336806718	1	1	0.973295772108664	0.999999976169535	0.306261797636296
down	SOD3; GSTP1; HSPA1B; NME2; GJB2; PRDX2; PRDX1; MGAT3; KEAP1;	GO:0034599~cellular response to oxidative stress	9	94	9.57446808510638	0.00054203955844978	0.0106787684748938	1	1	0.546917914475829	0.999480344286979	0.0936844423911279
down	SPP1; SCGB1A1; FBLN1; STC1; EMP2; DDR1;	GO:0007566~embryo implantation	6	40	15	0.00055457607392206	0.0108666933403648	1	1	0.550281722529287	0.999480344286979	0.0953331003121671
up	PIK3CD; PIP5K1C; ITGB2; VAV1; C5AR1; CXCR2; SYK; PIK3CG; NCKAP1L; CXCL6; S100A12; JAML; PREX1; CSF3R; CCL4; PF4; PPBP; FCER1G; CCL5; CCL26; CCL24; CCL7;	GO:0030593~neutrophil chemotaxis	22	76	28.9473684210526	0.00056302545585751	0.0345674170502519	1	1	0.981475409860623	0.999999976169535	0.320059391533696
up	BIN1; ACKR2; INPPL1; TMPRSS2; PSTPIP1; LY75; APP; CFI; CD5; ASGR2; CD6; PIK3CG; TSC2; PRSS12; TMPRSS3; BCL2L1; APOBR; UNC119; DGKD; MIA3; LRRK2; RINL; LRP10; DNER; RIN3; SH3KBP1; FNBP1; SIGLEC1; EHD1; NECAP2; SYNRG; USP20; SNX10; WASF2; MARCO; DENND1C; WIPF1; WAS; RHOQ;	GO:0006897~endocytosis	39	174	22.4137931034483	0.00057184672861931	0.0347470579224976	1	1	0.983252586483982	0.999999976169535	0.321722684691583
down	SHMT1; SHMT2; PSPH;	GO:0006563~L-serine metabolic process	3	5	60	0.0005833047026007	0.0110129143069144	1	1	0.557055990983675	0.999480344286979	0.0966158914644707
down	EDN3; KEL; XK;	GO:0010961~cellular magnesium ion homeostasis	3	5	60	0.0005833047026007	0.0110129143069144	1	1	0.557055990983675	0.999480344286979	0.0966158914644707
down	ADRA2A; ADRA2B; ADRA2C;	GO:0035624~receptor transactivation	3	5	60	0.0005833047026007	0.0110129143069144	1	1	0.557055990983675	0.999480344286979	0.0966158914644707
down	BBOX1; SHMT1; ALDH9A1;	GO:0045329~carnitine biosynthetic process	3	5	60	0.0005833047026007	0.0110129143069144	1	1	0.557055990983675	0.999480344286979	0.0966158914644707
down	CD1A; CD1E; CD1B;	GO:0048006~antigen processing and presentation, endogenous lipid antigen via MHC class Ib	3	5	60	0.0005833047026007	0.0110129143069144	1	1	0.557055990983675	0.999480344286979	0.0966158914644707
down	AKR1B10; AKR1A1; RDH12;	GO:0110095~cellular detoxification of aldehyde	3	5	60	0.0005833047026007	0.0110129143069144	1	1	0.557055990983675	0.999480344286979	0.0966158914644707
down	GSN; GSTP1; CD9; HES5; HDAC11;	GO:0014003~oligodendrocyte development	5	26	19.2307692307692	0.00059543057850985	0.0111836054253795	1	1	0.559819246156113	0.999480344286979	0.0981133583579722
down	AGR2; EGFR; EPHB3; SFRP2;	GO:0048546~digestive tract morphogenesis	4	14	28.5714285714286	0.00060476930048114	0.0112425062268931	1	1	0.562019422569695	0.999480344286979	0.0986300929195619
down	UGT1A6; UGT1A1; UGT1A7; UGT1A10;	GO:0052695~cellular glucuronidation	4	14	28.5714285714286	0.00060476930048114	0.0112425062268931	1	1	0.562019422569695	0.999480344286979	0.0986300929195619
down	WNT9B; SPDEF; FGF1; EDN3; HOXB1; GATM; TPI1; CSRP2; KAZALD1; KCTD15; AMN; PAQR5; DKK4; GTF2IRD1; OSGIN1; RARG; TYRO3; CDH5; DDR1; FGFR3; EGFR; MST1R; SPINK6; CDH1; EPHB3;	GO:0007275~multicellular organism development	25	513	4.87329434697856	0.00061471980818106	0.0113691801257977	1	1	0.564312783910216	0.999480344286979	0.0997413983675911
down	MYO1C; CLDN1; GAPDH; GSN; GBP6; CCL21; CCL22; CCL19; CCL11;	GO:0071346~cellular response to interferon-gamma	9	96	9.375	0.00062373431765006	0.0114773446775709	1	1	0.566418886436692	0.999480344286979	0.100690321995178
up	MEFV; IL10; ARRB2; JAK3; SLAMF1; TIGIT; CMKLR1; IRAK3;	GO:0032695~negative regulation of interleukin-12 production	8	12	66.6666666666667	0.00064618375192049	0.0388081944616859	1	1	0.995436094423218	0.999999976169535	0.359324709968112
up	ARHGEF11; ARHGAP6; PTH; PECAM1; BCL6; WAS; RHOG; ARHGAP4; ARHGAP5; MYO9B; ROCK1; PDPN; EPS8L1; ARHGEF1; ROPN1B; ARHGDIB; CDC42EP3; RAC2; RHOQ; RHOBTB2; RHOBTB1; RHOF;	GO:0007266~Rho protein signal transduction	22	77	28.5714285714286	0.00065185124732047	0.0388081944616859	1	1	0.995999060612662	0.999999976169535	0.359324709968112
down	GSTA1; GSTP1; TXN; MGST1; HBA1; PRDX4; MGST2; TXNDC17;	GO:0098869~cellular oxidant detoxification	8	77	10.3896103896104	0.00066642120168292	0.0122008932126292	1	1	0.576454339455726	0.999480344286979	0.107037986635461
down	CDK1; CCNB1; CCND1; CDC25A; CDC25C;	GO:0010971~positive regulation of G2/M transition of mitotic cell cycle	5	27	18.5185185185185	0.0006927125409355	0.0126137201646968	1	1	0.582571246926758	0.999480344286979	0.110659702276118
down	WNT9B; BMP2; WNT4; NPNT; EYA1; CTNNBIP1;	GO:0001658~branching involved in ureteric bud morphogenesis	6	42	14.2857142857143	0.00069940903533904	0.0126137201646968	1	1	0.584100262813404	0.999480344286979	0.110659702276118
down	TSPAN15; EGFR; BMP7; NRARP; HEY2; NOTCH3;	GO:0045746~negative regulation of Notch signaling pathway	6	42	14.2857142857143	0.00069940903533904	0.0126137201646968	1	1	0.584100262813404	0.999480344286979	0.110659702276118
up	SMTNL1; ULK1; GRK2; TGFBR2; SYK; CSNK1E; DGKQ; MAPK12; SRPK2; CSNK1G2; MAP3K10; PRKCD; STK4; ATM; ROCK1; PDK3; PRKD1; LRRK2; TTBK2; RICTOR; LMTK2; UHMK1; MAP4K1; PRKD2; NEK6; STK39; CSNK1A1L; LATS1; PRKCH; PRKCB; PRKCQ; MAST3; SBK1; VRK3; HIPK1; PKN1;	GO:0018105~peptidyl-serine phosphorylation	36	158	22.7848101265823	0.00070504742092703	0.0407406813621952	1	1	0.999999976169535	0.999999976169535	0.377217588126312
down	IL33; EGFR; PLA2G2A; FABP4; CEBPA; HYAL2; NLRP10; MGST2;	GO:0050729~positive regulation of inflammatory response	8	78	10.2564102564103	0.00072047985244128	0.0128657116507371	1	1	0.589139405311458	0.999480344286979	0.112870414298999
down	GGCT; GGT5; GGT6; MGST2;	GO:0006750~glutathione biosynthetic process	4	15	26.6666666666667	0.00075245090880771	0.0131747710510163	1	1	0.596676584261539	0.999480344286979	0.115581781030936
down	GDPD3; PLA2G4A; PLA2G4F; PLA2G4E;	GO:0046475~glycerophospholipid catabolic process	4	15	26.6666666666667	0.00075245090880771	0.0131747710510163	1	1	0.596676584261539	0.999480344286979	0.115581781030936
down	KRT1; KRT10; RRM2; HSD17B8;	GO:0051290~protein heterotetramerization	4	15	26.6666666666667	0.00075245090880771	0.0131747710510163	1	1	0.596676584261539	0.999480344286979	0.115581781030936
down	RARG; HOXB1; HOXC8; CTNNBIP1; HOXA4; HOXD9; HEY2; HES2; HES5;	GO:0009952~anterior/posterior pattern specification	9	99	9.09090909090909	0.00076490773363291	0.0131747710510163	1	1	0.599557705175112	0.999480344286979	0.115581781030936
down	PTPRZ1; CDC25A; CDC25C; CDKN3; SSH3; EYA1; DUSP9; PALD1; PTPRQ;	GO:0035335~peptidyl-tyrosine dephosphorylation	9	99	9.09090909090909	0.00076490773363291	0.0131747710510163	1	1	0.599557705175112	0.999480344286979	0.115581781030936
down	RAMP2; APLNR; SOX18; FOXF1; SOX17; TMEM100; HEY2;	GO:0001570~vasculogenesis	7	60	11.6666666666667	0.00076805385901568	0.0131747710510163	1	1	0.600210805982366	0.999480344286979	0.115581781030936
down	MUC3A; MUC21; MUC17; B3GNT6; MUC15; MUCL1; MUC13;	GO:0016266~O-glycan processing	7	60	11.6666666666667	0.00076805385901568	0.0131747710510163	1	1	0.600210805982366	0.999480344286979	0.115581781030936
down	GJB6; NME1; NME2; CMA1; ENDOG; GAS6; SLC29A1;	GO:0071333~cellular response to glucose stimulus	7	60	11.6666666666667	0.00076805385901568	0.0131747710510163	1	1	0.600210805982366	0.999480344286979	0.115581781030936
up	PIK3CD; PECAM1; PRTN3; PIK3CG; JAML; CD177;	GO:0072672~neutrophil extravasation	6	6	100	0.00076962138462111	0.0436168119322772	1	1	0.999999976169535	0.999999976169535	0.403847654205409
down	CLDN5; CDH5; GJA4; CDH1; PKP3; PKP1;	GO:0007043~cell-cell junction assembly	6	43	13.953488372093	0.00078198205944213	0.0131845812347801	1	1	0.603549146539889	0.999480344286979	0.115667845411659
down	ANG; CDH1; JUP; DSP; CDH5; NECTIN4;	GO:0034332~adherens junction organization	6	43	13.953488372093	0.00078198205944213	0.0131845812347801	1	1	0.603549146539889	0.999480344286979	0.115667845411659
down	SCGB1A1; IDO1; GPNMB; IL20RB; FOXJ1; PLA2G2A;	GO:0042130~negative regulation of T cell proliferation	6	43	13.953488372093	0.00078198205944213	0.0131845812347801	1	1	0.603549146539889	0.999480344286979	0.115667845411659
down	FANCG; TXN; CDC25A; CCL11; FKBPL;	GO:0009314~response to radiation	5	28	17.8571428571429	0.00080140030577502	0.0134494264279373	1	1	0.608079115707849	0.999480344286979	0.117991322533504
up	TRAV27; TLR2; PGLYRP1; LTA; TNF; FGR; RNASE2; HLA-E; CD36; C5AR1; EPHA2; IL12A; CAMP; GSDMD; DEFA3; LYZ; IL27RA; NLRP3; PGLYRP2; P2RX7; MYD88; CARD9; GBP7; TNFRSF14; GBP2;	GO:0050830~defense response to Gram-positive bacterium	25	95	26.3157894736842	0.00080393908699394	0.0451277807499267	1	1	0.999999976169535	0.999999976169535	0.417837700372302
up	LGALS9; TLR4; TNF; CD4; CD74; GNAI2; APP; CSF1R; PTPRC; ALOX15; CD36; C5AR1; FPR2; ARRB2; CCR1; CCR7; GPR183; OPRM1; CHI3L1; ARRB1; PTEN; RAP1B; SLAMF1; RAPGEF1; PTK2B; SCIMP; DSTYK; NECAB2; ABCA7; GPBAR1; FBXW7; PRKD2; FGF23; GLIPR2; IL26; C5AR2; MARCO; PTPN22; GPR55; CCL7; CCL4; CCL5; CCL24; CCL26;	GO:0070374~positive regulation of ERK1 and ERK2 cascade	44	209	21.0526315789474	0.00082030688899359	0.0456121585257381	1	1	0.999999976169535	0.999999976169535	0.422322549673402
down	PHGDH; SHMT1; SHMT2;	GO:0006544~glycine metabolic process	3	6	50	0.00086032005703384	0.0136304834101946	1	1	0.621880664055349	0.999480344286979	0.119579728768144
down	GJB6; GJA1; GJB2;	GO:0010644~cell communication by electrical coupling	3	6	50	0.00086032005703384	0.0136304834101946	1	1	0.621880664055349	0.999480344286979	0.119579728768144
down	F12; CLEC3B; ENO1;	GO:0010756~positive regulation of plasminogen activation	3	6	50	0.00086032005703384	0.0136304834101946	1	1	0.621880664055349	0.999480344286979	0.119579728768144
down	CYP2E1; CYP2C9; CYP2C19;	GO:0016098~monoterpenoid metabolic process	3	6	50	0.00086032005703384	0.0136304834101946	1	1	0.621880664055349	0.999480344286979	0.119579728768144
down	CYP2E1; UGT1A1; CYP2C19;	GO:0046483~heterocycle metabolic process	3	6	50	0.00086032005703384	0.0136304834101946	1	1	0.621880664055349	0.999480344286979	0.119579728768144
down	ALOX15B; ALOX12B; ALOXE3;	GO:0051122~hepoxilin biosynthetic process	3	6	50	0.00086032005703384	0.0136304834101946	1	1	0.621880664055349	0.999480344286979	0.119579728768144
down	UGT1A1; UGT1A7; UGT1A10;	GO:0051552~flavone metabolic process	3	6	50	0.00086032005703384	0.0136304834101946	1	1	0.621880664055349	0.999480344286979	0.119579728768144
down	JUP; DSP; DSC2;	GO:0086073~bundle of His cell-Purkinje myocyte adhesion involved in cell communication	3	6	50	0.00086032005703384	0.0136304834101946	1	1	0.621880664055349	0.999480344286979	0.119579728768144
down	CYFIP1; CTTNBP2; BAIAP2;	GO:1905274~regulation of modification of postsynaptic actin cytoskeleton	3	6	50	0.00086032005703384	0.0136304834101946	1	1	0.621880664055349	0.999480344286979	0.119579728768144
down	OVOL1; FBLN1; OVOL2;	GO:2000647~negative regulation of stem cell proliferation	3	6	50	0.00086032005703384	0.0136304834101946	1	1	0.621880664055349	0.999480344286979	0.119579728768144
down	UBE2C; PTTG1; CDK1; CCNB1; PSMB6; PSMD8; CDC20; AURKB;	GO:0031145~anaphase-promoting complex-dependent catabolic process	8	81	9.87654320987654	0.00090414021424056	0.0141312378689385	1	1	0.631485030379763	0.999480344286979	0.123972829185349
down	BMP2; ADRA2B; ADRA2C; NBL1; FOXA1; IRX3; DUOXA1; VWC2;	GO:0045666~positive regulation of neuron differentiation	8	81	9.87654320987654	0.00090414021424056	0.0141312378689385	1	1	0.631485030379763	0.999480344286979	0.123972829185349
down	FDXR; FDFT1; LSS; DHRS11; SRD5A1;	GO:0006694~steroid biosynthetic process	5	29	17.2413793103448	0.00092230769026047	0.0141312378689385	1	1	0.635469998589465	0.999480344286979	0.123972829185349
down	IL33; SCGB1A1; GAS6; IL20RB; PGLYRP3;	GO:0032689~negative regulation of interferon-gamma production	5	29	17.2413793103448	0.00092230769026047	0.0141312378689385	1	1	0.635469998589465	0.999480344286979	0.123972829185349
down	CXCL11; APLNR; BDKRB1; CXCL9; F2RL3;	GO:0051281~positive regulation of release of sequestered calcium ion into cytosol	5	29	17.2413793103448	0.00092230769026047	0.0141312378689385	1	1	0.635469998589465	0.999480344286979	0.123972829185349
down	MIF; PLA2G4A; PLA2G4F; MGST1;	GO:0001516~prostaglandin biosynthetic process	4	16	25	0.00092389058618991	0.0141312378689385	1	1	0.63569454615163	0.999480344286979	0.123972829185349
down	CYP2E1; MGST1; CCND1; MGST2;	GO:0010243~response to organonitrogen compound	4	16	25	0.00092389058618991	0.0141312378689385	1	1	0.63569454615163	0.999480344286979	0.123972829185349
down	ALOX15B; ALOX12B; ALOXE3; PLA2G3;	GO:0019372~lipoxygenase pathway	4	16	25	0.00092389058618991	0.0141312378689385	1	1	0.63569454615163	0.999480344286979	0.123972829185349
down	IDH1; KRT1; NQO1; PRDX2; DHCR24; SCARA3; TXN2; PRDX4; PRDX1;	GO:0006979~response to oxidative stress	9	102	8.82352941176471	0.00093106533835352	0.0141811422333257	1	1	0.637428938916005	0.999480344286979	0.124410638335485
up	CR1; CR2; C3AR1; FPR1; CMKLR1; FPR2; C5AR1; C5AR2;	GO:0002430~complement receptor mediated signaling pathway	8	13	61.5384615384615	0.00094658666843539	0.0493732904757362	1	1	0.999999976169535	0.999999976169535	0.457146835261311
up	VNN1; APOA2; B4GALT1; TNFSF4; EIF2AK1; TREM1; HP; HPR;	GO:0002526~acute inflammatory response	8	13	61.5384615384615	0.00094658666843539	0.0493732904757362	1	1	0.999999976169535	0.999999976169535	0.457146835261311
up	CD74; CD27; PRKCD; TCIRG1; IL13RA2; INPP5D; IRF7; FCER1G;	GO:0016064~immunoglobulin mediated immune response	8	13	61.5384615384615	0.00094658666843539	0.0493732904757362	1	1	0.999999976169535	0.999999976169535	0.457146835261311
up	CD4; IL2RB; JAK1; STAT3; STAT5A; STAT5B; JAK3; GRB2;	GO:0035723~interleukin-15-mediated signaling pathway	8	13	61.5384615384615	0.00094658666843539	0.0493732904757362	1	1	0.999999976169535	0.999999976169535	0.457146835261311
down	BMP2; CCNB1; CEBPA; FOXF1; KLF5; PLA2G4F;	GO:0071407~cellular response to organic cyclic compound	6	45	13.3333333333333	0.00096952585970555	0.0146364470077956	1	1	0.6457042225639	0.999480344286979	0.128405010347063
down	EGFR; FGF1; SDC1; GRHL3; EPB41L4B; CCM2L; SPRR3; DSP;	GO:0042060~wound healing	8	82	9.75609756097561	0.00097307137348379	0.0146364470077956	1	1	0.646567555499594	0.999480344286979	0.128405010347063
down	NQO1; IGFBP2; UGT1A1; ALDH3A1; SFRP2; LIPG; SLC27A4;	GO:0007584~response to nutrient	7	63	11.1111111111111	0.00099900464962521	0.0149028471394708	1	1	0.651203479556029	0.999480344286979	0.130742128887238
up	CCL5; CXCR2; CCR1; CCR7; GPR183; CCR2; PIK3CG; CCR6; CXCR4;	GO:0002407~dendritic cell chemotaxis	9	17	52.9411764705882	0.00102335467776815	0.0519970040583231	1	1	0.999999976169535	0.999999976169535	0.481439774811313
up	ADA; CD4; CD3E; CCL4; ZAP70; SYK; TRAT1; P2RX5; P2RX4;	GO:0050850~positive regulation of calcium-mediated signaling	9	17	52.9411764705882	0.00102335467776815	0.0519970040583231	1	1	0.999999976169535	0.999999976169535	0.481439774811313
down	EGFR; GJA1; ADRA2C; GJA5; TRPM4;	GO:0045907~positive regulation of vasoconstriction	5	30	16.6666666666667	0.00105626504260936	0.0156284113447303	1	1	0.659835374187546	0.999480344286979	0.137107476927933
down	ANG; APOD; NPR3; COMT; CTNNBIP1;	GO:0048662~negative regulation of smooth muscle cell proliferation	5	30	16.6666666666667	0.00105626504260936	0.0156284113447303	1	1	0.659835374187546	0.999480344286979	0.137107476927933
up	ADCY9; ADCY5; S1PR4; CALCA; PTH; GHRH; PF4; GNAI2; ADORA2A; PTGER2; PTGIR; GLP1R; ADCY7; GPR65; GPR78; CALCB; TBXA2R; ADGRE1; ADGRG5; PTGER4; ADGRE2; ADGRE3; GNAQ; ADGRG3; PTGDR; RXFP2;	GO:0007189~adenylate cyclase-activating G protein-coupled receptor signaling pathway	26	103	25.2427184466019	0.00107153650572733	0.0536292469559896	1	1	0.999999976169535	0.999999976169535	0.496552696552121
up	PRSS37; NCK2; LCP1; PLCG1; S1PR1; EPHA2; IL12A; L1CAM; PTEN; BTG1; TIAM1; DGKZ; FAT1; PTPRK; SYDE1; SKAP1; PARP9; RASGEF1A; PALLD; ELMO1; MYO18A; SH3KBP1; PSTPIP2; ADGRE2; ITGB2; MERTK; LAMB3; NEDD9; MEGF9; FES; PIK3CG; ITGB3; FMNL1; CASS4; ITGB4; ITGB6; RHOF; NCKAP1L; CORO1A; ITGB8; FSCN3; PIK3CD; ITGB7; RHOQ; LAMA3; LAMC3;	GO:0016477~cell migration	46	225	20.4444444444444	0.00107367681384574	0.0536292469559896	1	1	0.999999976169535	0.999999976169535	0.496552696552121
down	WNT9B; LRAT; RARG; GJA1; IGFBP2; GJB2;	GO:0032526~response to retinoic acid	6	46	13.0434782608696	0.00107536186143697	0.0158462875923131	1	1	0.662254322606156	0.999480344286979	0.139018897220737
up	JAK2; CD4; CD74; ITGB3; CD3E; PTPRC; IL6R; CSF3; OSM; HCLS1; PECAM1; CD36; ARRB2; CD80; SYK; DGKQ; PTPRJ; PTK2B; RICTOR; BANK1; SEMA4D; ARHGEF2; ADNP; TNFRSF14;	GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation	24	92	26.0869565217391	0.00111876754840401	0.0554118985738927	1	1	0.999999976169535	0.999999976169535	0.513058251228456
down	NOL3; CLDN1; STOML2; BOK;	GO:0051259~protein complex oligomerization	4	17	23.5294117647059	0.00112106182435623	0.0163864883600457	1	1	0.667960735483274	0.999480344286979	0.143758058653375
up	INPPL1; NCK2; SORBS2; ACTN1; RAC2; ARHGAP25; TMSB4X; TMSB10; CGNL1; FAT1; ARHGEF2; SH3KBP1; PACSIN1; RHOF; SHROOM3; LMOD3; MYO1G; RHOG; TMOD1; RHOBTB2; MYO7A; MYOM1; CORO1A; CORO7; RHOQ; RHOBTB1; LMOD2; MYO1F; MYO1H;	GO:0007015~actin filament organization	29	121	23.9669421487603	0.00114538054991498	0.0560762354396065	1	1	0.999999976169535	0.999999976169535	0.519209340061755
up	JAK2; EGF; LCK; FES; CSF1R; LYN; HCK; FGR; JAK1; EPHA2; PTPN6; TYK2; FLT3; CSK; ZAP70; SYK; MAP2K3; CLK3; BLK; JAK3; EPHB1; PRKCD; BTK; MERTK; PTK2B; EPHA10; DSTYK; HIPK1; LMTK2; ABI3;	GO:0018108~peptidyl-tyrosine phosphorylation	30	127	23.6220472440945	0.00115740835070122	0.0560762354396065	1	1	0.999999976169535	0.999999976169535	0.519209340061755
up	CCL24; PIK3CD; SDCBP; JAK2; PLAU; EGF; SOD2; GNAI2; CSF1R; LYN; VIL1; FGR; CCL5; F3; MMP9; PECAM1; ITGAX; S1PR1; PIK3R1; CORO1A; CCR1; STAT3; PPM1F; AIF1; CCL7; TIAM1; ATM; LAMC2; PTK2B; NEDD9; CARMIL2; PLET1; FERMT3; PDPN; FAM89B; PREX1; SYNE2; SEMA4D; MYADM; CLEC7A; LGR6; CASS4; SUN2; CCL26; SEMA4F; SEMA4A;	GO:0030335~positive regulation of cell migration	46	226	20.353982300885	0.00116072289169189	0.0560762354396065	1	1	0.999999976169535	0.999999976169535	0.519209340061755
down	ALDOA; TPI1; GPI; HK1; GAPDH;	GO:0006096~glycolytic process	5	31	16.1290322580645	0.00120411758997041	0.0167205509352456	1	1	0.67817248481417	0.999480344286979	0.146688777317697
down	EGFR; CCNB1; CCND1; PSRC1; CKS2;	GO:0045737~positive regulation of cyclin-dependent protein serine/threonine kinase activity	5	31	16.1290322580645	0.00120411758997041	0.0167205509352456	1	1	0.67817248481417	0.999480344286979	0.146688777317697
down	EGFR; SRD5A1; GJB2; AQP1; EIF4EBP1;	GO:0071549~cellular response to dexamethasone stimulus	5	31	16.1290322580645	0.00120411758997041	0.0167205509352456	1	1	0.67817248481417	0.999480344286979	0.146688777317697
down	LRAT; RBP1; RPE65;	GO:0006776~vitamin A metabolic process	3	7	42.8571428571429	0.00120849223311292	0.0167205509352456	1	1	0.678860375823159	0.999480344286979	0.146688777317697
down	MIF; MMP28; SLAMF8;	GO:0010760~negative regulation of macrophage chemotaxis	3	7	42.8571428571429	0.00120849223311292	0.0167205509352456	1	1	0.678860375823159	0.999480344286979	0.146688777317697
down	NPR3; AQP1; AQP5;	GO:0030157~pancreatic juice secretion	3	7	42.8571428571429	0.00120849223311292	0.0167205509352456	1	1	0.678860375823159	0.999480344286979	0.146688777317697
down	CA2; TPD52; CA9;	GO:0046903~secretion	3	7	42.8571428571429	0.00120849223311292	0.0167205509352456	1	1	0.678860375823159	0.999480344286979	0.146688777317697
down	CD1A; CD1B; CD1E;	GO:0048007~antigen processing and presentation, exogenous lipid antigen via MHC class Ib	3	7	42.8571428571429	0.00120849223311292	0.0167205509352456	1	1	0.678860375823159	0.999480344286979	0.146688777317697
down	RARG; ID4; FOXA1;	GO:0060740~prostate gland epithelium morphogenesis	3	7	42.8571428571429	0.00120849223311292	0.0167205509352456	1	1	0.678860375823159	0.999480344286979	0.146688777317697
down	ADRA2A; ADRA2B; ADRA2C;	GO:0071875~adrenergic receptor signaling pathway	3	7	42.8571428571429	0.00120849223311292	0.0167205509352456	1	1	0.678860375823159	0.999480344286979	0.146688777317697
down	SPINK1; ANXA8; SPINK6;	GO:1900004~negative regulation of serine-type endopeptidase activity	3	7	42.8571428571429	0.00120849223311292	0.0167205509352456	1	1	0.678860375823159	0.999480344286979	0.146688777317697
down	CCL21; GAS6; CCL19;	GO:2000669~negative regulation of dendritic cell apoptotic process	3	7	42.8571428571429	0.00120849223311292	0.0167205509352456	1	1	0.678860375823159	0.999480344286979	0.146688777317697
up	LPXN; CD22; GPS2; FCRL3; CD300A; PLCL2;	GO:0050859~negative regulation of B cell receptor signaling pathway	6	7	85.7142857142857	0.00130034225677567	0.0608271211225062	1	1	0.999999976169535	0.999999976169535	0.563197746216155
up	CD36; DAPK1; AIF1; PRKCD; PRKD1; TP53INP1;	GO:0071447~cellular response to hydroperoxide	6	7	85.7142857142857	0.00130034225677567	0.0608271211225062	1	1	0.999999976169535	0.999999976169535	0.563197746216155
down	PLA2G2A; PLA2G4A; PLA2G4F; PLA2G3;	GO:0036148~phosphatidylglycerol acyl-chain remodeling	4	18	22.2222222222222	0.00134593690964646	0.0182734880054997	1	1	0.69584938228722	0.999480344286979	0.160312637019994
down	CLEC3B; MAP2; TIMP3; IQGAP3;	GO:0071310~cellular response to organic substance	4	18	22.2222222222222	0.00134593690964646	0.0182734880054997	1	1	0.69584938228722	0.999480344286979	0.160312637019994
down	KCNK5; SCNN1G; SLC22A18; AMN; UGT1A7;	GO:0007588~excretion	5	32	15.625	0.00136672378173053	0.0184177461292683	1	1	0.698393577164083	0.999480344286979	0.161578208224897
down	KRT1; EFNA1; ID1; EMP2; GPNMB;	GO:0045765~regulation of angiogenesis	5	32	15.625	0.00136672378173053	0.0184177461292683	1	1	0.698393577164083	0.999480344286979	0.161578208224897
up	LST1; GP1BA; EPB42; PSMB10; BCL6; ADAM8; STK4; TBCC; PTPRO; PDPN; SHROOM3; ARHGEF2; P2RX7; STRADB; KLF2; NCKAP1L; FRYL; CYFIP2; CDH8; CDH23; FRY; CAPZB; CDH11;	GO:0000902~cell morphogenesis	23	88	26.1363636363636	0.00137308512941037	0.063543528978826	1	1	0.999999976169535	0.999999976169535	0.588348941180684
up	DNTT; SELL; P2RX1; DGKQ; PTEN; TRPC3; P2RX5; P2RX4; P2RX7;	GO:0033198~response to ATP	9	18	50	0.00139075589383586	0.063543528978826	1	1	0.999999976169535	0.999999976169535	0.588348941180684
up	LGALS9; TLR4; ITGB2; LYN; CD14; ITGAM; SCIMP; PIK3AP1; LY96;	GO:0034142~toll-like receptor 4 signaling pathway	9	18	50	0.00139075589383586	0.063543528978826	1	1	0.999999976169535	0.999999976169535	0.588348941180684
down	ALOX12B; HRAS; ADRA2A; BMP2; ADRA2B; ADRA2C; EFNA1; FGFR3; CAV2;	GO:0043410~positive regulation of MAPK cascade	9	109	8.25688073394496	0.00143408411691215	0.0191828594974411	1	1	0.70604865936371	0.999480344286979	0.168290519614716
down	FANCG; CLUH; CEBPA; CAV2; RAB38; ADGRG6; HSD17B10; STOML2;	GO:0007005~mitochondrion organization	8	88	9.09090909090909	0.00147993738618613	0.0197234302386938	1	1	0.711572656408862	0.999480344286979	0.173032926811415
down	FABP5; SLC44A4; SLC44A1; PEMT; STARD10;	GO:0006656~phosphatidylcholine biosynthetic process	5	33	15.1515151515152	0.00154495363424778	0.0204396238107599	1	1	0.719011850137291	0.999480344286979	0.179316066632347
down	SPINT2; BMP2; BMP7; DLX5; TMEM100;	GO:0071773~cellular response to BMP stimulus	5	33	15.1515151515152	0.00154495363424778	0.0204396238107599	1	1	0.719011850137291	0.999480344286979	0.179316066632347
down	ALOX12B; PSAPL1; ACER1; ALOXE3;	GO:0006665~sphingolipid metabolic process	4	19	21.0526315789474	0.00160047996221957	0.0208557909560258	1	1	0.725440019910936	0.999480344286979	0.18296708566487
down	WNT9B; SRD5A1; DHCR24; LGR4;	GO:0030539~male genitalia development	4	19	21.0526315789474	0.00160047996221957	0.0208557909560258	1	1	0.725440019910936	0.999480344286979	0.18296708566487
down	PLA2G2A; PLA2G4A; PLA2G4E; PLA2G4F;	GO:0036149~phosphatidylinositol acyl-chain remodeling	4	19	21.0526315789474	0.00160047996221957	0.0208557909560258	1	1	0.725440019910936	0.999480344286979	0.18296708566487
down	ADRA2A; ADRA2B; ADRA2C;	GO:0010700~negative regulation of norepinephrine secretion	3	8	37.5	0.00163394334662381	0.0208557909560258	1	1	0.729405681213212	0.999480344286979	0.18296708566487
down	EGFR; TYRO3; TIMP4;	GO:0042698~ovulation cycle	3	8	37.5	0.00163394334662381	0.0208557909560258	1	1	0.729405681213212	0.999480344286979	0.18296708566487
down	TIMM10; TIMM13; ROMO1;	GO:0045039~protein insertion into mitochondrial inner membrane	3	8	37.5	0.00163394334662381	0.0208557909560258	1	1	0.729405681213212	0.999480344286979	0.18296708566487
down	HOXB1; FOXA1; DLX5;	GO:0048646~anatomical structure formation involved in morphogenesis	3	8	37.5	0.00163394334662381	0.0208557909560258	1	1	0.729405681213212	0.999480344286979	0.18296708566487
down	C1QA; C1QB; C1QC;	GO:0098883~synapse pruning	3	8	37.5	0.00163394334662381	0.0208557909560258	1	1	0.729405681213212	0.999480344286979	0.18296708566487
down	HRAS; PSMB6; PSMD8; MUC3A; MUC21; MUC17; MUC15; MUCL1; MUC13;	GO:0002223~stimulatory C-type lectin receptor signaling pathway	9	112	8.03571428571429	0.00170756863237209	0.0216431338893316	1	1	0.737864085383257	0.999480344286979	0.189874416210594
up	CD74; CD3E; PTPRC; CCR7; ZAP70; DOCK2; AIRE;	GO:0045060~negative thymic T cell selection	7	11	63.6363636363636	0.0017218557281472	0.0780662897053817	1	1	0.999999976169535	0.999999976169535	0.722815047073805
down	TUBB; TUBA1B; TUBA1C; TUBG1; TUBB4B;	GO:0007017~microtubule-based process	5	34	14.7058823529412	0.00173968708103844	0.0219431164830254	1	1	0.741666374856229	0.999480344286979	0.192506152452777
down	MYO1C; CCL21; CCL11; CDC42EP5; NCKAP1; BAIAP2;	GO:0030838~positive regulation of actin filament polymerization	6	51	11.7647058823529	0.00174334277161692	0.0219431164830254	1	1	0.742278433646676	0.999480344286979	0.192506152452777
down	CXCL11; ACKR1; CCL22; CCL21; CCL11; CXCL9; CCL19;	GO:0070098~chemokine-mediated signaling pathway	7	70	10	0.00175058669913009	0.0219580511569085	1	1	0.742894390900756	0.999480344286979	0.192637173796513
up	TMEM8B; ITGB3; ITGB2; ITGA2B; ITGA4; ITGB4; ITGA2; VCL; ITGAL; ITGB7; ITGB8; L1CAM; CD96; TIAM1; ITGA7; ZYX; ADAMTS13; MUC4; SORBS1; SIGLEC1; PARVG; MKLN1; ITGB6; COL19A1;	GO:0007160~cell-matrix adhesion	24	96	25	0.00181839195216915	0.0818137569930151	1	1	0.999999976169535	0.999999976169535	0.757512811680538
up	TNF; ITGA4; SELL; SELP; SPN; ITGB7; CX3CR1; ROCK1; SELPLG;	GO:0050901~leukocyte tethering or rolling	9	19	47.3684210526316	0.0018571737684866	0.0823021217403008	1	1	0.999999976169535	0.999999976169535	0.762034576313271
up	TLR4; TNF; CD6; IL17RA; GBP5; MYD88; CLEC7A; TLR6; GPSM3;	GO:1900017~positive regulation of cytokine production involved in inflammatory response	9	19	47.3684210526316	0.0018571737684866	0.0823021217403008	1	1	0.999999976169535	0.999999976169535	0.762034576313271
down	MT-CO2; COX8A; COX5B; COX7B;	GO:0006123~mitochondrial electron transport, cytochrome c to oxygen	4	20	20	0.00188664050759868	0.0232621491158001	1	1	0.75521279862303	0.999480344286979	0.204077977142835
down	EDN3; NMU; TRPM4; HEY2;	GO:0010460~positive regulation of heart rate	4	20	20	0.00188664050759868	0.0232621491158001	1	1	0.75521279862303	0.999480344286979	0.204077977142835
down	DDAH1; DDAH2; EGFR; SPR;	GO:0050999~regulation of nitric-oxide synthase activity	4	20	20	0.00188664050759868	0.0232621491158001	1	1	0.75521279862303	0.999480344286979	0.204077977142835
down	EGFR; GJA1; ADCYAP1; GJA5;	GO:0097755~positive regulation of blood vessel diameter	4	20	20	0.00188664050759868	0.0232621491158001	1	1	0.75521279862303	0.999480344286979	0.204077977142835
down	CCL21; EPCAM; CCL19; PHPT1;	GO:2000147~positive regulation of cell motility	4	20	20	0.00188664050759868	0.0232621491158001	1	1	0.75521279862303	0.999480344286979	0.204077977142835
down	GABRQ; HTR3B; GABRR1; GABRE; GABRB3; GABRA4;	GO:0050877~nervous system process	6	52	11.5384615384615	0.00190801217973358	0.0234459123780821	1	1	0.757084277507304	0.999480344286979	0.205690125472424
down	ADCYAP1; GABRR1; FGF14; GABRE; GABRA4;	GO:0060078~regulation of postsynaptic membrane potential	5	35	14.2857142857143	0.00195181233553332	0.0239031071496902	1	1	0.760475204681865	0.999480344286979	0.209701078359261
down	CCL21; CXCL11; DEFB4A; RGS5; RAMP2; RAMP3; ADGRL2; ANXA1; ADRA2A; EDN3; ADRA2B; ADCYAP1; ADRA2C; APLNR; BDKRB1; NMU; AKR1C2; GNAI1; CXCL9; ADCY2; ACKR1; FFAR4; ARHGEF16; PREX2; ADGRG6; ARHGEF25; ADGRF4; OR2I1P; ADGRG7; QRFPR; F2RL3; CCL19; LPAR5; ADGRL4; GPRC5C; LPAR3; RAPGEFL1; FZD10; CCL11; GPR87; OR13A1; CCL22; GNG12;	GO:0007186~G protein-coupled receptor signaling pathway	43	1152	3.73263888888889	0.0020133034143317	0.0245731477338465	1	1	0.765065949040235	0.999480344286979	0.215579319717681
up	SDCBP; ARHGEF11; TYROBP; PIP5K1C; FLNB; ABLIM3; EPB41; BCR; TNXB; ITPKA; CORO1A; BCL6; CAPZB; RHOG; DMTN; ROCK1; FGD3; ARHGEF18; FGD2; PALLD; ELMO1; DOCK2; AGAP2; INPP5K; WASF2; RHOQ; SPECC1L; IQSEC1; FHL3; SMTNL1; SPECC1; RAC2; MICAL2; SHROOM3;	GO:0030036~actin cytoskeleton organization	34	157	21.656050955414	0.0020175650243146	0.088742748159032	1	1	0.999999976169535	0.999999976169535	0.821668276154894
down	AQP1; SFN; GAS6; DHCR24; TFAP2B; SFRP2; BIRC5;	GO:0043154~negative regulation of cysteine-type endopeptidase activity involved in apoptotic process	7	72	9.72222222222222	0.00203032486531363	0.0246977437475231	1	1	0.766657611799937	0.999480344286979	0.216672395955161
up	RAF1; PTPRN; RAB11FIP2; CCDC186; PTPRN2; RAB11FIP5;	GO:0035773~insulin secretion involved in cellular response to glucose stimulus	6	8	75	0.0020707722256369	0.0897436139551755	1	1	0.999999976169535	0.999999976169535	0.830935283211132
up	CSF1R; PRTN3; CD177; NLGN2; MYADM; PARD6A;	GO:0045217~cell-cell junction maintenance	6	8	75	0.0020707722256369	0.0897436139551755	1	1	0.999999976169535	0.999999976169535	0.830935283211132
up	WTIP; CCL24; AGRN; BIN1; PALM; MICAL2; SVIL; SPTB; ANK1; EPB42; CAPZB; CCL7; ARHGAP4; SPTBN1; DMTN; SPTAN1; NEDD9; FGD3; FGD2; MICAL1; PHIP; PALLD; SH3KBP1; SIPA1; TSPAN32; CNN2; CECR2; PSTPIP2; GPR35; PACSIN1; MAST3;	GO:0007010~cytoskeleton organization	31	139	22.3021582733813	0.00210544316850581	0.0905801608406804	1	1	0.999999976169535	0.999999976169535	0.838680863008861
down	CES2; AADAC; AADACL2;	GO:0009056~catabolic process	3	9	33.3333333333333	0.00214227279456281	0.0257143671532787	1	1	0.775074961956543	0.999480344286979	0.225591195638279
down	ALOX15B; FABP5; STARD10;	GO:0035360~positive regulation of peroxisome proliferator activated receptor signaling pathway	3	9	33.3333333333333	0.00214227279456281	0.0257143671532787	1	1	0.775074961956543	0.999480344286979	0.225591195638279
down	SOX18; ID1; EMP2;	GO:0043534~blood vessel endothelial cell migration	3	9	33.3333333333333	0.00214227279456281	0.0257143671532787	1	1	0.775074961956543	0.999480344286979	0.225591195638279
down	SLC25A5; BOK; TMEM14A;	GO:1901029~negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway	3	9	33.3333333333333	0.00214227279456281	0.0257143671532787	1	1	0.775074961956543	0.999480344286979	0.225591195638279
down	OVOL1; CA2; MPST; ITGA8; WNT4; HYAL2; PCSK9; TFAP2B;	GO:0001822~kidney development	8	94	8.51063829787234	0.00217654878837314	0.0258835271237982	1	1	0.777027917449213	0.999480344286979	0.227075229827266
down	EDN3; KEL; CDH5; CCL11; XK; STC1; CCL19; STOML2;	GO:0006874~cellular calcium ion homeostasis	8	94	8.51063829787234	0.00217654878837314	0.0258835271237982	1	1	0.777027917449213	0.999480344286979	0.227075229827266
down	DVL1; FRZB; FZD10; SFRP2;	GO:0035567~non-canonical Wnt signaling pathway	4	21	19.047619047619	0.00220634755344928	0.0258835271237982	1	1	0.778840686367597	0.999480344286979	0.227075229827266
down	PLA2G2A; PLA2G4A; PLA2G4E; PLA2G4F;	GO:0036150~phosphatidylserine acyl-chain remodeling	4	21	19.047619047619	0.00220634755344928	0.0258835271237982	1	1	0.778840686367597	0.999480344286979	0.227075229827266
down	MT-ATP8; STOML2; COX5B; CYC1;	GO:0042776~mitochondrial ATP synthesis coupled proton transport	4	21	19.047619047619	0.00220634755344928	0.0258835271237982	1	1	0.778840686367597	0.999480344286979	0.227075229827266
down	PLCD1; NSDHL; OVOL2; HEY2;	GO:0060716~labyrinthine layer blood vessel development	4	21	19.047619047619	0.00220634755344928	0.0258835271237982	1	1	0.778840686367597	0.999480344286979	0.227075229827266
down	NOL3; LMNA; BCL2L2; HIGD1A;	GO:0090201~negative regulation of release of cytochrome c from mitochondria	4	21	19.047619047619	0.00220634755344928	0.0258835271237982	1	1	0.778840686367597	0.999480344286979	0.227075229827266
down	DEFB4A; PLA2G2A; ROMO1; LCE3A; PGLYRP4; PGLYRP3; RARRES2; GBP6;	GO:0050830~defense response to Gram-positive bacterium	8	95	8.42105263157895	0.00231419167104863	0.0268876436139464	1	1	0.78496512633219	0.999480344286979	0.235884306800555
down	DVL1; IRF6; ZIC2; EGFR; SPP1; BMP2; CDH1; BMP7; NME2; SOX18; DLX5; MAZ; WNT4; POU3F1; FOXF1; FOXF2; HES5; PSRC1; TFAP2B; SOX7; LGR4; TP63; SOX17; PTGES2; HEY2;	GO:0045893~positive regulation of transcription, DNA-templated	25	570	4.3859649122807	0.00242992883849014	0.0279852625151731	1	1	0.792107461586105	0.999480344286979	0.245513676981316
down	E2F8; DLX3; GJB3; ANG; PHLDA2;	GO:0001890~placenta development	5	37	13.5135135135135	0.00243182281166332	0.0279852625151731	1	1	0.792107461586105	0.999480344286979	0.245513676981316
down	CCL21; SOX18; CEBPA; HES5; CCL19;	GO:0048469~cell maturation	5	37	13.5135135135135	0.00243182281166332	0.0279852625151731	1	1	0.792107461586105	0.999480344286979	0.245513676981316
up	WWP2; CLDN9; ITGB3; CD55; NCAM1; ANPEP; ITGA2; CR1; ITGB6; CR2; GRK2; ITGB7; EPHA2; CD80; CD86; TNFRSF4; SLAMF1; SELPLG; SCARB1; TNFRSF14; HAVCR1; UVRAG;	GO:0046718~viral entry into host cell	22	87	25.2873563218391	0.00244194183761481	0.0999893478089095	1	1	0.999999976169535	0.999999976169535	0.925800437245497
down	ITGB5; ITGA8; EMP2; ADAM15; NPNT; LYVE1; CD34; LYPD3;	GO:0007160~cell-matrix adhesion	8	96	8.33333333333333	0.002458564759936	0.0282034723252152	1	1	0.793154778928635	0.999480344286979	0.247428023605285
up	NCK2; PRF1; CD6; CORO1A; EPHB1; DOCK8; DOCK2;	GO:0001771~immunological synapse formation	7	12	58.3333333333333	0.00247683148627431	0.0999893478089095	1	1	0.999999976169535	0.999999976169535	0.925800437245497
up	IL18RAP; CCL5; CXCR2; CXCL6; PRKCD; KMT2E; PREX1;	GO:0042119~neutrophil activation	7	12	58.3333333333333	0.00247683148627431	0.0999893478089095	1	1	0.999999976169535	0.999999976169535	0.925800437245497
up	IL2RA; LYN; CTLA4; HLA-G; PDCD1; FCRLB; INPP5D;	GO:0050777~negative regulation of immune response	7	12	58.3333333333333	0.00247683148627431	0.0999893478089095	1	1	0.999999976169535	0.999999976169535	0.925800437245497
down	CTDSPL; TSPAN9; TM4SF1; KRTDAP; LMNB2; TCHH; RAD51AP2; EXOC3L2; TTC39A; GGT6; IGFL2; KNDC1; KRT77; UNC93A; FIBIN; TMEM54; TMEM125; CDCA3; TIMP4; TMEM47; TMEM106C; GPR87; GSDMC; LPAR5; CCM2L; LINC01558;	GO:0008150~biological_process	26	603	4.31177446102819	0.00251169681136287	0.0287220849879824	1	1	0.794983407955873	0.999480344286979	0.251977793388435
down	GGCT; SFN; BOK; BAD;	GO:0001836~release of cytochrome c from mitochondria	4	22	18.1818181818182	0.00256150414577883	0.0291080016565776	1	1	0.796627789337215	0.999480344286979	0.255363426103647
down	APOD; GSN; CCNB1; ADAM15;	GO:0042246~tissue regeneration	4	22	18.1818181818182	0.00256150414577883	0.0291080016565776	1	1	0.796627789337215	0.999480344286979	0.255363426103647
down	SCD; FABP4; GJA1; ADCYAP1; GATM; FABP5; FFAR4; PEMT;	GO:0120162~positive regulation of cold-induced thermogenesis	8	97	8.24742268041237	0.00260989098170605	0.0294997266825564	1	1	0.798546198090123	0.999480344286979	0.258800015324188
down	MPZL1; NTF3; EGFR; DDR1; FGFR3; EPHB3; TYRO3; MST1R; EFS;	GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway	9	120	7.5	0.0026447639170486	0.0297741279481403	1	1	0.799568627009247	0.999480344286979	0.261207327517358
down	EDN3; CXCL9; CCL22; CCL21; CCL11; CCL19; CXCL11;	GO:0030593~neutrophil chemotaxis	7	76	9.21052631578947	0.00269243969431554	0.0302170089532317	1	1	0.80132450937352	0.999480344286979	0.265092706257909
down	JUP; DSP; GJA5; DSC2; TRPM4;	GO:0086091~regulation of heart rate by cardiac conduction	5	38	13.1578947368421	0.00270151136817676	0.0302252429309899	1	1	0.801683728055677	0.999480344286979	0.265164942641416
down	FOXF1; SFRP2; HEY2;	GO:0003214~cardiac left ventricle morphogenesis	3	10	30	0.00273858237077573	0.0302663447989696	1	1	0.802778027438773	0.999480344286979	0.265525527814881
down	BANF1; LMNA; REEP4;	GO:0007084~mitotic nuclear envelope reassembly	3	10	30	0.00273858237077573	0.0302663447989696	1	1	0.802778027438773	0.999480344286979	0.265525527814881
down	AP2S1; VLDLR; PCSK9;	GO:0032802~low-density lipoprotein particle receptor catabolic process	3	10	30	0.00273858237077573	0.0302663447989696	1	1	0.802778027438773	0.999480344286979	0.265525527814881
down	SRD5A1; AKR1C2; AKR1C1;	GO:0042448~progesterone metabolic process	3	10	30	0.00273858237077573	0.0302663447989696	1	1	0.802778027438773	0.999480344286979	0.265525527814881
down	CTSV; HLA-DQB2; CTSE; FCGR2B; AP2S1; AP1S1; DYNLL1; AP1M2;	GO:0019886~antigen processing and presentation of exogenous peptide antigen via MHC class II	8	98	8.16326530612245	0.00276839620888403	0.0305028457665793	1	1	0.803897974463659	0.999480344286979	0.267600342090288
up	TBKBP1; BIN1; BNIP3L; DOK2; BRD4; MPDZ; ATG12; APOA2; CFI; ISG15; ASGR1; ASGR2; LYN; PTPRC; TPR; HLA-E; IL2RB; PLCG1; SP100; PIK3R1; PSMB8; PSMB9; IL12A; YWHAB; NUP214; TRIM23; FLT3; PSMB10; STAT3; CCR2; SYK; CX3CR1; TSC2; CCR3; RAD23A; GRB2; SATB1; TAP1; GPS2; IL16; FKBP8; ZYX; MICB; RICTOR; CRTC3; ATF7IP; PACS2; RAB11FIP4; TRIM22; DTX3L; NUP210; CREBBP; UPF1; FBXW7; DHX58; OPTN; BICD1; CDK5RAP3; MAP3K5; GFI1; RBCK1; NLRP1; RBM38; SP110; APOBEC3G; PARD6A; UBN1; APOBEC3C; CLEC1B; MDFIC; ZC3H7B; PILRA; AKAP8L; CLEC4A; SAMHD1; TLN1; USP15; WASF2;	GO:0016032~viral process	78	456	17.1052631578947	0.00279761607758988	0.109927661075432	1	1	0.999999976169535	0.999999976169535	1
down	DVL1; SLPI; ID1; CARD18; AURKB; CTNNBIP1; CCM2L;	GO:0032091~negative regulation of protein binding	7	77	9.09090909090909	0.0028812361444388	0.0307134415673277	1	1	0.807828411854522	0.999480344286979	0.269447891291248
down	TXN; NQO1; TXN2; PTGES2; PRDX4; PRDX2; PRDX1;	GO:0045454~cell redox homeostasis	7	77	9.09090909090909	0.0028812361444388	0.0307134415673277	1	1	0.807828411854522	0.999480344286979	0.269447891291248
up	RPS6KA5; RAF1; LYN; ICAM2; PLCG2; PRKACB; PSMB8; PSMB9; FCER1G; PSMB10; SYK; PRKCD; PSME1; CLEC6A; MUC6; MUC19; PSMA8; CLEC4C; CLEC4D; PSMF1; CREBBP; MUC4; CARD11; CARD9; CLEC4E; CLEC4A;	GO:0002223~stimulatory C-type lectin receptor signaling pathway	26	112	23.2142857142857	0.00290050338387204	0.112470835161459	1	1	0.999999976169535	0.999999976169535	1
down	CCNB1; IGFBP2; BDKRB1; PSPH; ENDOG; PIEZO2;	GO:0009612~response to mechanical stimulus	6	57	10.5263157894737	0.00291394175025161	0.0307134415673277	1	1	0.809070624165708	0.999480344286979	0.269447891291248
down	DLX3; CA2; BMP2; BMP7; AMTN; TP63;	GO:0042475~odontogenesis of dentin-containing tooth	6	57	10.5263157894737	0.00291394175025161	0.0307134415673277	1	1	0.809070624165708	0.999480344286979	0.269447891291248
down	NKX2-8; S100B; MAP2; STMN1; PTPRZ1; CNTN4; BAIAP2;	GO:0007409~axonogenesis	7	78	8.97435897435897	0.00308000158784094	0.0320833498733431	1	1	0.814828008181901	0.999480344286979	0.28146604638823
up	FES; LYN; RAC2; STXBP2; UNC13D; ADGRE2;	GO:0043304~regulation of mast cell degranulation	6	9	66.6666666666667	0.00314138288926058	0.118687889418602	1	1	0.999999976169535	0.999999976169535	1
up	CD3E; PTPRC; TNFSF4; CCR2; ZAP70; SYK;	GO:0046641~positive regulation of alpha-beta T cell proliferation	6	9	66.6666666666667	0.00314138288926058	0.118687889418602	1	1	0.999999976169535	0.999999976169535	1
up	TLR4; AIM2; CD36; GBP5; NLRC4; TLR6;	GO:0050702~interleukin-1 beta secretion	6	9	66.6666666666667	0.00314138288926058	0.118687889418602	1	1	0.999999976169535	0.999999976169535	1
up	BTN3A1; ISG15; GATA3; BTN3A2; TCIRG1; LILRB1;	GO:0072643~interferon-gamma secretion	6	9	66.6666666666667	0.00314138288926058	0.118687889418602	1	1	0.999999976169535	0.999999976169535	1
down	BMP7; LUM; PITX1; HYAL1; HYAL2; HES5;	GO:0051216~cartilage development	6	58	10.3448275862069	0.00315523042031673	0.0327728088070148	1	1	0.817219536927089	0.999480344286979	0.287514644211515
down	FGF1; FGFR3; POLR2I; POLR2L; FGFBP1; ESRP1; ESRP2;	GO:0008543~fibroblast growth factor receptor signaling pathway	7	79	8.86075949367089	0.00328907313421301	0.0339683478960745	1	1	0.822268283553251	0.999480344286979	0.298003064592449
down	EGFR; SLC2A1; GOT1; GJA1; AQP1; BAD; PIEZO2;	GO:0071260~cellular response to mechanical stimulus	7	79	8.86075949367089	0.00328907313421301	0.0339683478960745	1	1	0.822268283553251	0.999480344286979	0.298003064592449
down	CHP2; CDK1; CDH1; JUP; HYAL2;	GO:0042307~positive regulation of protein import into nucleus	5	40	12.5	0.00330478027359593	0.0340336036698445	1	1	0.822874273118982	0.999480344286979	0.298575551091507
down	EFNA1; FOXA1; SFRP2; OVOL2;	GO:0010719~negative regulation of epithelial to mesenchymal transition	4	24	16.6666666666667	0.00338561884006927	0.0344174210402862	1	1	0.825641379780957	0.999480344286979	0.301942766741365
down	CLDN1; HRAS; ANXA1; ADRA2A;	GO:0090303~positive regulation of wound healing	4	24	16.6666666666667	0.00338561884006927	0.0344174210402862	1	1	0.825641379780957	0.999480344286979	0.301942766741365
up	CCDC88B; TNFSF11; LCK; CCR2; PRKCQ; FAM49B; SIRPG; SIRPB1;	GO:0050870~positive regulation of T cell activation	8	17	47.0588235294118	0.00340813642110493	0.127552233827503	1	1	0.999999976169535	0.999999976169535	1
down	EGFR; S100B; GM2A; PTPRZ1; GATM; CCL11;	GO:0007611~learning or memory	6	59	10.1694915254237	0.00341110274116996	0.0344174210402862	1	1	0.826210765190248	0.999480344286979	0.301942766741365
down	BMP7; ID4; IRX3; HES5; CNTN4; NOTCH3;	GO:0045665~negative regulation of neuron differentiation	6	59	10.1694915254237	0.00341110274116996	0.0344174210402862	1	1	0.826210765190248	0.999480344286979	0.301942766741365
down	NME1; NME2; IMPDH2;	GO:0006183~GTP biosynthetic process	3	11	27.2727272727273	0.00342750041256368	0.0344174210402862	1	1	0.826785651907841	0.999480344286979	0.301942766741365
down	SERPINB3; ADRM1; SFRP2;	GO:0010950~positive regulation of endopeptidase activity	3	11	27.2727272727273	0.00342750041256368	0.0344174210402862	1	1	0.826785651907841	0.999480344286979	0.301942766741365
down	CDK1; AURKB; TTK;	GO:0034501~protein localization to kinetochore	3	11	27.2727272727273	0.00342750041256368	0.0344174210402862	1	1	0.826785651907841	0.999480344286979	0.301942766741365
down	IRF6; KLK8; SDR16C5;	GO:0043616~keratinocyte proliferation	3	11	27.2727272727273	0.00342750041256368	0.0344174210402862	1	1	0.826785651907841	0.999480344286979	0.301942766741365
down	KRT18; KRT8; GSN;	GO:0097284~hepatocyte apoptotic process	3	11	27.2727272727273	0.00342750041256368	0.0344174210402862	1	1	0.826785651907841	0.999480344286979	0.301942766741365
up	RPS6KA5; CRYBA1; IL10; SLC11A1; BTK; MERTK; CLEC4A;	GO:0001818~negative regulation of cytokine production	7	13	53.8461538461538	0.00346256488164243	0.127552233827503	1	1	0.999999976169535	0.999999976169535	1
up	CD27; SYK; STAT5B; NCKAP1L; BTK; INPP5D; PPP2R3C;	GO:0045579~positive regulation of B cell differentiation	7	13	53.8461538461538	0.00346256488164243	0.127552233827503	1	1	0.999999976169535	0.999999976169535	1
up	RGS13; RGS14; MGRN1; PLEK; CCL5; YWHAB; RGS2;	GO:0045744~negative regulation of G protein-coupled receptor signaling pathway	7	13	53.8461538461538	0.00346256488164243	0.127552233827503	1	1	0.999999976169535	0.999999976169535	1
down	NKX2-8; EGFR; FGF1; CEBPA; WNT7B; FOXF1; EIF4EBP1;	GO:0030324~lung development	7	80	8.75	0.0035087910388153	0.0350395799330729	1	1	0.829745464711292	0.999480344286979	0.307400943785509
down	DEFB4A; CTSG; S100A7; ROMO1; LCE3A; NLRP10; RARRES2;	GO:0050829~defense response to Gram-negative bacterium	7	80	8.75	0.0035087910388153	0.0350395799330729	1	1	0.829745464711292	0.999480344286979	0.307400943785509
down	AGPAT2; PLA2G2A; PLA2G4A; PLD1; LIPI;	GO:0006654~phosphatidic acid biosynthetic process	5	41	12.1951219512195	0.00364017102959013	0.0361523835130527	1	1	0.834144201893035	0.999480344286979	0.31716352859352
down	XK; SLC7A2; SLC1A5; SLC6A15; SLC7A8;	GO:0006865~amino acid transport	5	41	12.1951219512195	0.00364017102959013	0.0361523835130527	1	1	0.834144201893035	0.999480344286979	0.31716352859352
down	CCL21; HRAS; FCGR2B; TPD52L1; CCL19; WNT7B; TNFRSF19;	GO:0046330~positive regulation of JNK cascade	7	81	8.64197530864197	0.00373949846607213	0.037037382348392	1	1	0.837647656400158	0.999480344286979	0.324927590769836
down	ALOX15B; NUPR1; BMP2; BMP7; ADCYAP1;	GO:0045786~negative regulation of cell cycle	5	42	11.9047619047619	0.00399926967592767	0.0395023230932911	1	1	0.847052844663671	0.999480344286979	0.346552425108735
down	ALDH2; ADH7; ALDH3B2;	GO:0006068~ethanol catabolic process	3	12	25	0.00421320501087941	0.0408365458942188	1	1	0.854544467700202	0.999480344286979	0.358257512584348
down	CYP11A1; FDXR; TSPO;	GO:0006700~C21-steroid hormone biosynthetic process	3	12	25	0.00421320501087941	0.0408365458942188	1	1	0.854544467700202	0.999480344286979	0.358257512584348
down	CCNB2; CDK1; CCNB1;	GO:0007077~mitotic nuclear envelope disassembly	3	12	25	0.00421320501087941	0.0408365458942188	1	1	0.854544467700202	0.999480344286979	0.358257512584348
down	ANG; WNT7B; RHCG;	GO:0042592~homeostatic process	3	12	25	0.00421320501087941	0.0408365458942188	1	1	0.854544467700202	0.999480344286979	0.358257512584348
down	SLC2A1; EBP; SLC22A18;	GO:0042908~xenobiotic transport	3	12	25	0.00421320501087941	0.0408365458942188	1	1	0.854544467700202	0.999480344286979	0.358257512584348
down	RAMP2; CD34; TMEM100;	GO:2001214~positive regulation of vasculogenesis	3	12	25	0.00421320501087941	0.0408365458942188	1	1	0.854544467700202	0.999480344286979	0.358257512584348
down	KLK8; S100B; ITGA8; VLDLR; PAK6; PAK5; NTF3;	GO:0007613~memory	7	83	8.43373493975904	0.00423526761846282	0.0409409203118073	1	1	0.855426714724463	0.999480344286979	0.359173185504373
down	CA2; IGFBP2; SRD5A1; COMT; CCND1; ZNF366;	GO:0043627~response to estrogen	6	62	9.67741935483871	0.00427151366732881	0.041181481500178	1	1	0.856319591230946	0.999480344286979	0.361283619946925
down	YWHAQ; SFN; BAD; TP63;	GO:1900740~positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway	4	26	15.3846153846154	0.00437351070906178	0.0419215889351197	1	1	0.860001328924341	0.999480344286979	0.367776555205804
down	MYO1C; RHOD; SYNGR1; YWHAQ; AP1M2;	GO:0006605~protein targeting	5	43	11.6279069767442	0.00438297440176838	0.0419215889351197	1	1	0.860001328924341	0.999480344286979	0.367776555205804
down	MMP1; COL15A1; MMP12; ADAM15; MMP28;	GO:0030574~collagen catabolic process	5	43	11.6279069767442	0.00438297440176838	0.0419215889351197	1	1	0.860001328924341	0.999480344286979	0.367776555205804
up	TLR4; IL18RAP; EOMES; SPN; AVPR2; LILRB1;	GO:0032609~interferon-gamma production	6	10	60	0.00457599644443696	0.157824846434406	1	1	0.999999976169535	0.999999976169535	1
up	LGALS9; HLA-E; HLA-G; HLA-F; ARRB2; LILRB1;	GO:0045953~negative regulation of natural killer cell mediated cytotoxicity	6	10	60	0.00457599644443696	0.157824846434406	1	1	0.999999976169535	0.999999976169535	1
up	PTPRC; HCK; FGR; SYK; OLFM4; SCARB1;	GO:0050764~regulation of phagocytosis	6	10	60	0.00457599644443696	0.157824846434406	1	1	0.999999976169535	0.999999976169535	1
up	CYBB; GLRA1; ADCY7; PTEN; CCL7; TP53INP1; DNMT3A;	GO:0071361~cellular response to ethanol	7	14	50	0.00472055398828375	0.1617613093427	1	1	0.999999976169535	0.999999976169535	1
down	CDK1; RRM2; MCM4; RFC2; POLD2; MCM10; DSCC1; POLE3; CDT1;	GO:0006260~DNA replication	9	132	6.81818181818182	0.00476639857610395	0.0424703503334785	1	1	0.873332184532305	0.999480344286979	0.372590818735525
down	ANXA1; CCL21; CCL19; CCL22; CCL11;	GO:0002548~monocyte chemotaxis	5	44	11.3636363636364	0.00479217807700638	0.0424703503334785	1	1	0.87445463703152	0.999480344286979	0.372590818735525
down	CLEC3B; BMP2; FGFR3; GPNMB; LGR4;	GO:0030282~bone mineralization	5	44	11.3636363636364	0.00479217807700638	0.0424703503334785	1	1	0.87445463703152	0.999480344286979	0.372590818735525
up	CDC14B; PTP4A3; PTPRC; PTPN4; PTPN6; PTPN7; PTEN; DUSP2; PTPRJ; PTP4A2; DUSP4; DUSP8; PTPRK; DUSP5; PTPRO; DUSP6; PTPRN; TNS2; MTMR14; PTPRU; PTPRN2; PTPN18; PTPN22;	GO:0035335~peptidyl-tyrosine dephosphorylation	23	99	23.2323232323232	0.00484524983343704	0.165074581030508	1	1	0.999999976169535	0.999999976169535	1
down	CCL21; JUP; FUT1; EMP2;	GO:0001954~positive regulation of cell-matrix adhesion	4	27	14.8148148148148	0.00493322628398896	0.0429878492294711	1	1	0.878727656297048	0.999480344286979	0.377130817483796
down	GABRR1; GABRB3; GABRA4; GABRE;	GO:0007214~gamma-aminobutyric acid signaling pathway	4	27	14.8148148148148	0.00493322628398896	0.0429878492294711	1	1	0.878727656297048	0.999480344286979	0.377130817483796
down	CDH1; SRD5A1; ADCYAP1; PITX1;	GO:0021983~pituitary gland development	4	27	14.8148148148148	0.00493322628398896	0.0429878492294711	1	1	0.878727656297048	0.999480344286979	0.377130817483796
down	GJB6; NQO1; CYFIP1; S100A13;	GO:0051602~response to electrical stimulus	4	27	14.8148148148148	0.00493322628398896	0.0429878492294711	1	1	0.878727656297048	0.999480344286979	0.377130817483796
up	TPP1; TNFSF11; PTH; RAC2; TCIRG1; PTK2B; ZNF675; GPR55; SNX10;	GO:0045453~bone resorption	9	23	39.1304347826087	0.00509249121976518	0.171515104281691	1	1	0.999999976169535	0.999999976169535	1
up	PPM1A; RASSF2; NLRP12; TMSB4X; ADGRG3; HDAC7; ADIPOR1; NLRP3; LITAF;	GO:1901223~negative regulation of NIK/NF-kappaB signaling	9	23	39.1304347826087	0.00509249121976518	0.171515104281691	1	1	0.999999976169535	0.999999976169535	1
down	AKR1B15; DHRS11; HSD17B8;	GO:0006703~estrogen biosynthetic process	3	13	23.0769230769231	0.0050994463164038	0.0433931758144689	1	1	0.881321139418827	0.999480344286979	0.380686732680487
down	SLC1A5; SLC6A15; SLC7A8;	GO:0015804~neutral amino acid transport	3	13	23.0769230769231	0.0050994463164038	0.0433931758144689	1	1	0.881321139418827	0.999480344286979	0.380686732680487
down	AQP1; MUC17; ABCA12;	GO:0019725~cellular homeostasis	3	13	23.0769230769231	0.0050994463164038	0.0433931758144689	1	1	0.881321139418827	0.999480344286979	0.380686732680487
down	MAP2; STMN1; CDH5;	GO:0031115~negative regulation of microtubule polymerization	3	13	23.0769230769231	0.0050994463164038	0.0433931758144689	1	1	0.881321139418827	0.999480344286979	0.380686732680487
down	CLDN5; RAMP2; DDAH1;	GO:0043116~negative regulation of vascular permeability	3	13	23.0769230769231	0.0050994463164038	0.0433931758144689	1	1	0.881321139418827	0.999480344286979	0.380686732680487
down	ID4; HES5; TMEM98;	GO:0048715~negative regulation of oligodendrocyte differentiation	3	13	23.0769230769231	0.0050994463164038	0.0433931758144689	1	1	0.881321139418827	0.999480344286979	0.380686732680487
down	WNT4; FOXF1; HEY2;	GO:0051145~smooth muscle cell differentiation	3	13	23.0769230769231	0.0050994463164038	0.0433931758144689	1	1	0.881321139418827	0.999480344286979	0.380686732680487
down	CENPA; CENPW; CENPH;	GO:0051382~kinetochore assembly	3	13	23.0769230769231	0.0050994463164038	0.0433931758144689	1	1	0.881321139418827	0.999480344286979	0.380686732680487
down	BMP2; ADAM15; HEY2;	GO:0060317~cardiac epithelial to mesenchymal transition	3	13	23.0769230769231	0.0050994463164038	0.0433931758144689	1	1	0.881321139418827	0.999480344286979	0.380686732680487
down	GRHL3; SFRP2; DVL1;	GO:0090179~planar cell polarity pathway involved in neural tube closure	3	13	23.0769230769231	0.0050994463164038	0.0433931758144689	1	1	0.881321139418827	0.999480344286979	0.380686732680487
down	CDH16; CDH22; PCDHGB4; CDH1; CDH5;	GO:0016339~calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules	5	45	11.1111111111111	0.00522776692058624	0.0443809252625881	1	1	0.883161675827832	0.999480344286979	0.389352222197068
down	SLC25A5; GJA1; SLC25A1; SLC25A43;	GO:0015867~ATP transport	4	28	14.2857142857143	0.00553901396157763	0.0464789944692568	1	1	0.886889595960056	0.999480344286979	0.407758506047763
down	KRT17; TGM3; TMEM79; TP63;	GO:0031069~hair follicle morphogenesis	4	28	14.2857142857143	0.00553901396157763	0.0464789944692568	1	1	0.886889595960056	0.999480344286979	0.407758506047763
down	PRDX2; HBA1; PRDX1; PRDX4;	GO:0042744~hydrogen peroxide catabolic process	4	28	14.2857142857143	0.00553901396157763	0.0464789944692568	1	1	0.886889595960056	0.999480344286979	0.407758506047763
down	CCNB1; CLDN18; FOXF1; LGR4;	GO:0048565~digestive tract development	4	28	14.2857142857143	0.00553901396157763	0.0464789944692568	1	1	0.886889595960056	0.999480344286979	0.407758506047763
down	GAPDH; CTSG; NLRP10; SPON2;	GO:0050832~defense response to fungus	4	28	14.2857142857143	0.00553901396157763	0.0464789944692568	1	1	0.886889595960056	0.999480344286979	0.407758506047763
down	MT-CO2; NME1; CCND1; DDR1; SLC29A1;	GO:0007595~lactation	5	46	10.8695652173913	0.00569061920985159	0.0474289982820453	1	1	0.888878823832292	0.999480344286979	0.416092854496255
down	CAV2; EIF4EBP1; RPE65; ATP6V1F; RARRES2; SLC2A8; BAIAP2;	GO:0008286~insulin receptor signaling pathway	7	88	7.95454545454545	0.00569147979384543	0.0474289982820453	1	1	0.888878823832292	0.999480344286979	0.416092854496255
down	RAMP3; EGFR; TXN; MIF; NTF3; GAS6; SFRP2;	GO:0033138~positive regulation of peptidyl-serine phosphorylation	7	88	7.95454545454545	0.00569147979384543	0.0474289982820453	1	1	0.888878823832292	0.999480344286979	0.416092854496255
up	PTPRC; SYK; STAT5B; NCKAP1L; SOX4;	GO:0045588~positive regulation of gamma-delta T cell differentiation	5	7	71.4285714285714	0.00574452463583297	0.190214765188761	1	1	0.999999976169535	0.999999976169535	1
down	MRPL28; MRPL41; GADD45GIP1; MRPL37; MRPL40; MRPL15; TUFM;	GO:0070125~mitochondrial translational elongation	7	89	7.86516853932584	0.00602272470216791	0.0491641066849581	1	1	0.891363255920851	0.999480344286979	0.431314896588208
down	PRDX2; PRDX1; PRDX4;	GO:0033554~cellular response to stress	3	14	21.4285714285714	0.00608956797284033	0.0491641066849581	1	1	0.891820466595373	0.999480344286979	0.431314896588208
down	NPR3; HYAL2; TFAP2B;	GO:0035810~positive regulation of urine volume	3	14	21.4285714285714	0.00608956797284033	0.0491641066849581	1	1	0.891820466595373	0.999480344286979	0.431314896588208
down	ALDH9A1; FOXA1; WNT4;	GO:0042445~hormone metabolic process	3	14	21.4285714285714	0.00608956797284033	0.0491641066849581	1	1	0.891820466595373	0.999480344286979	0.431314896588208
down	AKR1C1; SDR16C5; RPE65;	GO:0042574~retinal metabolic process	3	14	21.4285714285714	0.00608956797284033	0.0491641066849581	1	1	0.891820466595373	0.999480344286979	0.431314896588208
down	GSTP1; SERPINB3; SFRP2;	GO:0043508~negative regulation of JUN kinase activity	3	14	21.4285714285714	0.00608956797284033	0.0491641066849581	1	1	0.891820466595373	0.999480344286979	0.431314896588208
down	CDK1; SOD3; S100A13;	GO:0046688~response to copper ion	3	14	21.4285714285714	0.00608956797284033	0.0491641066849581	1	1	0.891820466595373	0.999480344286979	0.431314896588208
down	FABP4; CEBPA; FFAR4;	GO:0050872~white fat cell differentiation	3	14	21.4285714285714	0.00608956797284033	0.0491641066849581	1	1	0.891820466595373	0.999480344286979	0.431314896588208
down	ADRA2A; STC1; PACSIN3;	GO:0051926~negative regulation of calcium ion transport	3	14	21.4285714285714	0.00608956797284033	0.0491641066849581	1	1	0.891820466595373	0.999480344286979	0.431314896588208
down	SCNN1G; TFAP2B; CYP4F12;	GO:0055078~sodium ion homeostasis	3	14	21.4285714285714	0.00608956797284033	0.0491641066849581	1	1	0.891820466595373	0.999480344286979	0.431314896588208
down	E2F8; SOX15; GJB5;	GO:0060707~trophoblast giant cell differentiation	3	14	21.4285714285714	0.00608956797284033	0.0491641066849581	1	1	0.891820466595373	0.999480344286979	0.431314896588208
down	CDH1; FABP4; CEBPA;	GO:0071285~cellular response to lithium ion	3	14	21.4285714285714	0.00608956797284033	0.0491641066849581	1	1	0.891820466595373	0.999480344286979	0.431314896588208
down	BMP7; VLDLR; CYFIP1;	GO:1900006~positive regulation of dendrite development	3	14	21.4285714285714	0.00608956797284033	0.0491641066849581	1	1	0.891820466595373	0.999480344286979	0.431314896588208
down	MYO1C; CLDN5; GJA1;	GO:2000810~regulation of bicellular tight junction assembly	3	14	21.4285714285714	0.00608956797284033	0.0491641066849581	1	1	0.891820466595373	0.999480344286979	0.431314896588208
down	GJA1; BMP7; GNAI1; TIMP4; ANXA1;	GO:0043434~response to peptide hormone	5	47	10.6382978723404	0.00618160403422086	0.0493356756896107	1	1	0.892344219622297	0.999480344286979	0.432820065144888
down	DVL1; PHGDH; HES5; GRHL2;	GO:0021915~neural tube development	4	29	13.7931034482759	0.00619247791414423	0.0493356756896107	1	1	0.892344219622297	0.999480344286979	0.432820065144888
down	EGFR; HRAS; CDK1; CDT1;	GO:0045740~positive regulation of DNA replication	4	29	13.7931034482759	0.00619247791414423	0.0493356756896107	1	1	0.892344219622297	0.999480344286979	0.432820065144888
down	ADRA2C; COMT; FABP5; TMEM100;	GO:0051930~regulation of sensory perception of pain	4	29	13.7931034482759	0.00619247791414423	0.0493356756896107	1	1	0.892344219622297	0.999480344286979	0.432820065144888
down	AOC1; AQP1; MT1X; MT1M;	GO:0071280~cellular response to copper ion	4	29	13.7931034482759	0.00619247791414423	0.0493356756896107	1	1	0.892344219622297	0.999480344286979	0.432820065144888
up	AGRN; TNF; FN1; APP; ITGB3; ITGB2; SERPINE1; ITGA2B; ITGAM; ICAM2; ITGA4; B4GALT1; ITGB4; PECAM1; ITGA2; ITGB6; ITGAL; ITGAX; LAMA1; ITGB7; ITGB8; COL4A5; BSG; MFAP2; HSPG2; ITGA7; LAMB3; LAMC2; COL9A3; COL9A2; COL19A1; LAMA3; SH3PXD2A; MPZL3; ADAMTSL4; CRISPLD2; LAMC3; MMP11; MMP25; COL22A1; MMP9; MMP17; COLQ;	GO:0030198~extracellular matrix organization	43	230	18.695652173913	0.00620956830425179	0.196921751444949	1	1	0.999999976169535	0.999999976169535	1
up	TLR4; TNF; APOA2; CD74; SYK; CLEC7A; TLR7;	GO:0045416~positive regulation of interleukin-8 biosynthetic process	7	15	46.6666666666667	0.00629388318476454	0.196921751444949	1	1	0.999999976169535	0.999999976169535	1
up	APP; CCL5; ITGA4; SPN; AIF1; DOCK8; TNFRSF14;	GO:2000406~positive regulation of T cell migration	7	15	46.6666666666667	0.00629388318476454	0.196921751444949	1	1	0.999999976169535	0.999999976169535	1
up	CORO1A; SRPX; MYO7A; P2RX7;	GO:0001845~phagolysosome assembly	4	4	100	0.00636762890527098	0.196921751444949	1	1	0.999999976169535	0.999999976169535	1
up	TLR2; CD14; TLR1; SCIMP;	GO:0038123~toll-like receptor TLR1:TLR2 signaling pathway	4	4	100	0.00636762890527098	0.196921751444949	1	1	0.999999976169535	0.999999976169535	1
up	TLR2; CD14; CD36; TLR6;	GO:0038124~toll-like receptor TLR6:TLR2 signaling pathway	4	4	100	0.00636762890527098	0.196921751444949	1	1	0.999999976169535	0.999999976169535	1
up	ITGB2; ITGAM; PTAFR; CD177;	GO:0043315~positive regulation of neutrophil degranulation	4	4	100	0.00636762890527098	0.196921751444949	1	1	0.999999976169535	0.999999976169535	1
up	SYK; BTK; SCIMP; CLEC7A;	GO:0071226~cellular response to molecule of fungal origin	4	4	100	0.00636762890527098	0.196921751444949	1	1	0.999999976169535	0.999999976169535	1
up	TLR2; CD14; CD36; TLR6;	GO:0071726~cellular response to diacyl bacterial lipopeptide	4	4	100	0.00636762890527098	0.196921751444949	1	1	0.999999976169535	0.999999976169535	1
up	IFITM1; MX2; IFNAR2; ADAR; IFITM2; BST2;	GO:0035455~response to interferon-alpha	6	11	54.5454545454545	0.00644011517109555	0.196921751444949	1	1	0.999999976169535	0.999999976169535	1
up	IFIT3; IFIT2; TPR; IFNAR1; GATA3; PYHIN1;	GO:0035457~cellular response to interferon-alpha	6	11	54.5454545454545	0.00644011517109555	0.196921751444949	1	1	0.999999976169535	0.999999976169535	1
up	TLR4; FOXO3; CYBA; CD36; RAB27A; TLR6;	GO:1903428~positive regulation of reactive oxygen species biosynthetic process	6	11	54.5454545454545	0.00644011517109555	0.196921751444949	1	1	0.999999976169535	0.999999976169535	1
down	KCNK5; AQP1; GJA5; FXYD3; KCNS3; KCNK7;	GO:0006813~potassium ion transport	6	68	8.82352941176471	0.00645789467576674	0.0512250945287843	1	1	0.894009990527478	0.999480344286979	0.449395867008879
down	SLC25A5; ADRA2A; SLC2A1; ADRA2C; TFAP2B; KCNS3;	GO:0050796~regulation of insulin secretion	6	68	8.82352941176471	0.00645789467576674	0.0512250945287843	1	1	0.894009990527478	0.999480344286979	0.449395867008879
up	LGALS9; TLR4; TLR2; FLNB; CCL5; CASP1; GBP2; IL12RB1; WAS; DAPK1; AIF1; IRF8; STXBP2; ZYX; ADAMTS13; GBP5; RAB20; CCL24; CCL7; GBP7; CCL26; CCL4;	GO:0071346~cellular response to interferon-gamma	22	96	22.9166666666667	0.00660275974202984	0.197546527510273	1	1	0.999999976169535	0.999999976169535	1
down	EGFR; MIF; CCNB1; AQP1; GAS6;	GO:0048146~positive regulation of fibroblast proliferation	5	48	10.4166666666667	0.00670158009424049	0.0524168268390526	1	1	0.895517426437765	0.999480344286979	0.45985089065973
down	WNT9B; GJB3; AQP1; WNT7B; FZD10; RARG;	GO:0071300~cellular response to retinoic acid	6	69	8.69565217391304	0.00688886642035957	0.0524168268390526	1	1	0.896479773522892	0.999480344286979	0.45985089065973
down	PAX1; FGFR3; SFRP2; RARG;	GO:0060349~bone morphogenesis	4	30	13.3333333333333	0.00689516727732864	0.0524168268390526	1	1	0.896479773522892	0.999480344286979	0.45985089065973
down	FDFT1; ME1; HMGCS2; HMGCS1; ACER1; C1QTNF2; PSAPL1;	GO:0019216~regulation of lipid metabolic process	7	92	7.60869565217391	0.00710290054549279	0.0524168268390526	1	1	0.897837133598884	0.999480344286979	0.45985089065973
down	MT-CO2; COX8A; COX7A2; COX7B; ATP6V1F; OTOP3; MFSD3; SLC2A8;	GO:1902600~proton transmembrane transport	8	116	6.89655172413793	0.00712127858620915	0.0524168268390526	1	1	0.897837133598884	0.999480344286979	0.45985089065973
down	UQCRQ; CYC1; UQCRC1;	GO:0006122~mitochondrial electron transport, ubiquinol to cytochrome c	3	15	20	0.00718652770731287	0.0524168268390526	1	1	0.898315963414109	0.999480344286979	0.45985089065973
down	SCD; ELOVL1; ELOVL4;	GO:0006636~unsaturated fatty acid biosynthetic process	3	15	20	0.00718652770731287	0.0524168268390526	1	1	0.898315963414109	0.999480344286979	0.45985089065973
down	CTSV; SEMA3F; NTF3;	GO:0021675~nerve development	3	15	20	0.00718652770731287	0.0524168268390526	1	1	0.898315963414109	0.999480344286979	0.45985089065973
down	SPINT2; CDH1; MUC21;	GO:0022408~negative regulation of cell-cell adhesion	3	15	20	0.00718652770731287	0.0524168268390526	1	1	0.898315963414109	0.999480344286979	0.45985089065973
down	SOX18; GJA5; SOX17;	GO:0035050~embryonic heart tube development	3	15	20	0.00718652770731287	0.0524168268390526	1	1	0.898315963414109	0.999480344286979	0.45985089065973
down	IDH1; CA2; SPP1;	GO:0048545~response to steroid hormone	3	15	20	0.00718652770731287	0.0524168268390526	1	1	0.898315963414109	0.999480344286979	0.45985089065973
down	FCGR2B; FFAR4; LGR4;	GO:0050710~negative regulation of cytokine secretion	3	15	20	0.00718652770731287	0.0524168268390526	1	1	0.898315963414109	0.999480344286979	0.45985089065973
down	PTTG1; CDCA8; CENPW;	GO:0051276~chromosome organization	3	15	20	0.00718652770731287	0.0524168268390526	1	1	0.898315963414109	0.999480344286979	0.45985089065973
down	OVOL2; HEY2; ADGRG6;	GO:0060347~heart trabecula formation	3	15	20	0.00718652770731287	0.0524168268390526	1	1	0.898315963414109	0.999480344286979	0.45985089065973
down	FOXA1; FOXF1; ESRP2;	GO:0060441~epithelial tube branching involved in lung morphogenesis	3	15	20	0.00718652770731287	0.0524168268390526	1	1	0.898315963414109	0.999480344286979	0.45985089065973
down	MIF; SLC1A5; ITLN1;	GO:0070207~protein homotrimerization	3	15	20	0.00718652770731287	0.0524168268390526	1	1	0.898315963414109	0.999480344286979	0.45985089065973
down	GSN; BMP2; ID1; ISOC2; SOX17;	GO:0031648~protein destabilization	5	49	10.2040816326531	0.007251394546961	0.0526779663982638	1	1	0.898915544676208	0.999480344286979	0.462141858391494
down	GSTP1; CD34; TSPO; GAS6; GPNMB;	GO:0032720~negative regulation of tumor necrosis factor production	5	49	10.2040816326531	0.007251394546961	0.0526779663982638	1	1	0.898915544676208	0.999480344286979	0.462141858391494
up	QRICH2; PARVB; RHOQ; NCKAP1L; PARVG; RHOG; CYFIP2; RAC2;	GO:0030031~cell projection assembly	8	20	40	0.00732636333436221	0.216992891923271	1	1	0.999999976169535	0.999999976169535	1
up	WDR1; KCNE1; KCNQ1; CACNA2D1; SCN1B; SCN4B; AKAP9; KCNE3;	GO:0060307~regulation of ventricular cardiac muscle cell membrane repolarization	8	20	40	0.00732636333436221	0.216992891923271	1	1	0.999999976169535	0.999999976169535	1
up	PIK3CD; CHL1; DOK2; SLIT3; RPS6KA5; SEMA4F; CSF1R; GLI2; SPTB; NCAM1; PLCG1; GATA3; PAX6; PIK3R1; L1CAM; EPHB1; CXCR4; GRB2; SPTBN1; PRKCQ; SCN1B; SPTAN1; PTPRO; DRAXIN; SHC3; SH3KBP1; FEZ1; DOK1; NRTN; OR10A4; MYOT; BSG; EFNA2; LAMA1; LGR6; EPHA10; CYFIP2; EPHA2; PALLD;	GO:0007411~axon guidance	39	206	18.9320388349515	0.00740736767241257	0.218295125305998	1	1	0.999999976169535	0.999999976169535	1
down	ZWINT; KIFC1; CDCA8; TUBG1;	GO:0000070~mitotic sister chromatid segregation	4	31	12.9032258064516	0.00764857401730179	0.0551214330272743	1	1	0.901245682896855	0.999480344286979	0.483578301102877
down	HOXB1; GRHL3; FOXJ1; EYA1;	GO:0007389~pattern specification process	4	31	12.9032258064516	0.00764857401730179	0.0551214330272743	1	1	0.901245682896855	0.999480344286979	0.483578301102877
down	IGHA1; IGHA2; SLPI; CTSG;	GO:0019731~antibacterial humoral response	4	31	12.9032258064516	0.00764857401730179	0.0551214330272743	1	1	0.901245682896855	0.999480344286979	0.483578301102877
down	PRMT5; CLDN1; EGFR; CCND1;	GO:0097421~liver regeneration	4	31	12.9032258064516	0.00764857401730179	0.0551214330272743	1	1	0.901245682896855	0.999480344286979	0.483578301102877
down	NUPR1; CDH1; NQO1; CYP2F1; MPST; SLC7A8;	GO:0009636~response to toxic substance	6	71	8.45070422535211	0.00781264174048979	0.0561921156930069	1	1	0.902078883836359	0.999480344286979	0.492971360682063
down	EYA1; TFAP2B; NR2F6; TFAP2C; SPARCL1;	GO:0048856~anatomical structure development	5	50	10	0.00783188189650053	0.0562189542075533	1	1	0.902078883836359	0.999480344286979	0.493206813981363
down	RAB25; GRHL2; POF1B;	GO:0003382~epithelial cell morphogenesis	3	16	18.75	0.00839291710705337	0.0593066754640711	1	1	0.904475945053924	0.999480344286979	0.520295278803519
down	ADRA2A; EDN3; ACE2;	GO:0019229~regulation of vasoconstriction	3	16	18.75	0.00839291710705337	0.0593066754640711	1	1	0.904475945053924	0.999480344286979	0.520295278803519
down	HYAL1; HYAL2; LYVE1;	GO:0030214~hyaluronan catabolic process	3	16	18.75	0.00839291710705337	0.0593066754640711	1	1	0.904475945053924	0.999480344286979	0.520295278803519
down	SPP1; BMP7; STC1;	GO:0033280~response to vitamin D	3	16	18.75	0.00839291710705337	0.0593066754640711	1	1	0.904475945053924	0.999480344286979	0.520295278803519
down	EDN3; KEL; TRPM4;	GO:0042310~vasoconstriction	3	16	18.75	0.00839291710705337	0.0593066754640711	1	1	0.904475945053924	0.999480344286979	0.520295278803519
down	BMP7; CDKN2C; DYNLL1;	GO:0042326~negative regulation of phosphorylation	3	16	18.75	0.00839291710705337	0.0593066754640711	1	1	0.904475945053924	0.999480344286979	0.520295278803519
down	ALOX15B; NME2; OVOL2;	GO:0045618~positive regulation of keratinocyte differentiation	3	16	18.75	0.00839291710705337	0.0593066754640711	1	1	0.904475945053924	0.999480344286979	0.520295278803519
down	KRT20; RHBDF1; LLGL2;	GO:0050708~regulation of protein secretion	3	16	18.75	0.00839291710705337	0.0593066754640711	1	1	0.904475945053924	0.999480344286979	0.520295278803519
down	AQP1; CDC25A; AURKB; PBK; RUVBL2;	GO:0034644~cellular response to UV	5	51	9.80392156862745	0.00844386293289801	0.0595072332648167	1	1	0.904475945053924	0.999480344286979	0.522054765000285
down	EGFR; HYAL1; ANXA1; CCND1;	GO:1900087~positive regulation of G1/S transition of mitotic cell cycle	4	32	12.5	0.00845413107072568	0.0595072332648167	1	1	0.904592024567648	0.999480344286979	0.522054765000285
up	PALM3; PTPRC; ECM1; SIGIRR; IRAK3;	GO:0001960~negative regulation of cytokine-mediated signaling pathway	5	8	62.5	0.00852213862278361	0.24148790885907	1	1	0.999999976169535	0.999999976169535	1
up	CD48; IRF1; TNFSF4; ADCY7; IRF7;	GO:0002819~regulation of adaptive immune response	5	8	62.5	0.00852213862278361	0.24148790885907	1	1	0.999999976169535	0.999999976169535	1
up	TLR4; IRF1; SYK; LTB; CLEC7A;	GO:0045084~positive regulation of interleukin-12 biosynthetic process	5	8	62.5	0.00852213862278361	0.24148790885907	1	1	0.999999976169535	0.999999976169535	1
up	TNF; IL10; DAB2IP; HIPK1; MAP3K5;	GO:0072577~endothelial cell apoptotic process	5	8	62.5	0.00852213862278361	0.24148790885907	1	1	0.999999976169535	0.999999976169535	1
up	MYO1G; S1PR1; ITGB7; ZAP70; CCR6;	GO:0072678~T cell migration	5	8	62.5	0.00852213862278361	0.24148790885907	1	1	0.999999976169535	0.999999976169535	1
up	LGALS9; CD160; CD2; CD244; PTPN22;	GO:1902715~positive regulation of interferon-gamma secretion	5	8	62.5	0.00852213862278361	0.24148790885907	1	1	0.999999976169535	0.999999976169535	1
up	GADD45B; TNF; MAP4K2; DAB2IP; KSR1; MAP4K1;	GO:0000185~activation of MAPKKK activity	6	12	50	0.00879924489258588	0.243487086370428	1	1	0.999999976169535	0.999999976169535	1
up	PIK3CD; TOX; PTPRC; HNF1A; STAT5B; MERTK;	GO:0001779~natural killer cell differentiation	6	12	50	0.00879924489258588	0.243487086370428	1	1	0.999999976169535	0.999999976169535	1
up	HLA-E; HLA-G; HLA-F; MICB; HLA-H; FCGRT;	GO:0002476~antigen processing and presentation of endogenous peptide antigen via MHC class Ib	6	12	50	0.00879924489258588	0.243487086370428	1	1	0.999999976169535	0.999999976169535	1
up	HLA-G; HLA-H; FCGRT; MICB; HLA-F; HLA-E;	GO:0002486~antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent	6	12	50	0.00879924489258588	0.243487086370428	1	1	0.999999976169535	0.999999976169535	1
up	JAK3; TIGIT; LAX1; PTPN22; PAG1; TNFAIP8L2;	GO:0050868~negative regulation of T cell activation	6	12	50	0.00879924489258588	0.243487086370428	1	1	0.999999976169535	0.999999976169535	1
down	HRAS; ADRA2A; PLD1; DHCR24; IQGAP3; RASL12;	GO:0007265~Ras protein signal transduction	6	73	8.21917808219178	0.00882234094707812	0.0618587735651029	1	1	0.906167819249685	0.999480344286979	0.542684741416622
down	EPHB3; TYRO3; DDR1; EGFR; MST1R; FGFR3;	GO:0033674~positive regulation of kinase activity	6	73	8.21917808219178	0.00882234094707812	0.0618587735651029	1	1	0.906167819249685	0.999480344286979	0.542684741416622
down	ALDOA; CCL11; EMP2; PDLIM3; POF1B; RHOV; MYO1C; RHOD;	GO:0007015~actin filament organization	8	121	6.61157024793388	0.00894976663688118	0.0626310889163983	1	1	0.906526910915725	0.999480344286979	0.549460235539032
up	SOCS3; MEFV; PGLYRP1; ADA; IL2RA; ALOX5; BCR; NT5E; IL10; GATA3; FPR2; ADORA2A; CNR2; PTGER4; NLRP12; IL2; PRKCD; GPS2; NLRP3; SHARPIN; TNFAIP8L2;	GO:0050728~negative regulation of inflammatory response	21	93	22.5806451612903	0.00898041520788151	0.247339099230157	1	1	0.999999976169535	0.999999976169535	1
up	FGR; IRF1; XIAP; DHX58; ERAP1; PTPN22; SAMHD1; TREML2;	GO:0045088~regulation of innate immune response	8	21	38.0952380952381	0.00918763673310941	0.25186944606952	1	1	0.999999976169535	0.999999976169535	1
down	TYRO3; NYAP1; PREX2; PIK3C2G;	GO:0014065~phosphatidylinositol 3-kinase signaling	4	33	12.1212121212121	0.00931321074204872	0.0644863124043175	1	1	0.908039680062017	0.999480344286979	0.565736042846331
down	CCL22; CCL21; CCL19; CCL11;	GO:0048247~lymphocyte chemotaxis	4	33	12.1212121212121	0.00931321074204872	0.0644863124043175	1	1	0.908039680062017	0.999480344286979	0.565736042846331
down	DVL1; IL33; CEBPA; KEAP1; HSPBP1; HSPA1B;	GO:0032436~positive regulation of proteasomal ubiquitin-dependent protein catabolic process	6	74	8.10810810810811	0.00936070275327339	0.0644863124043175	1	1	0.908039680062017	0.999480344286979	0.565736042846331
up	RGS3; DUSP4; DUSP8; GPS2; DUSP6; LAX1; SPRED3; DUSP5; DUSP2;	GO:0000188~inactivation of MAPK activity	9	26	34.6153846153846	0.00956471478918008	0.259789995241601	1	1	0.999999976169535	0.999999976169535	1
down	EIF6; FBXW9; NHP2;	GO:0000470~maturation of LSU-rRNA	3	17	17.6470588235294	0.00971098061070719	0.0644863124043175	1	1	0.909686917576869	0.999480344286979	0.565736042846331
down	CCL21; TRPM4; CCL19;	GO:0002407~dendritic cell chemotaxis	3	17	17.6470588235294	0.00971098061070719	0.0644863124043175	1	1	0.909686917576869	0.999480344286979	0.565736042846331
down	GCAT; GGT5; PHGDH;	GO:0006520~cellular amino acid metabolic process	3	17	17.6470588235294	0.00971098061070719	0.0644863124043175	1	1	0.909686917576869	0.999480344286979	0.565736042846331
down	IL33; PLA2G4A; CEBPA;	GO:0043032~positive regulation of macrophage activation	3	17	17.6470588235294	0.00971098061070719	0.0644863124043175	1	1	0.909686917576869	0.999480344286979	0.565736042846331
down	CCL21; CCL19; RARRES2;	GO:0050921~positive regulation of chemotaxis	3	17	17.6470588235294	0.00971098061070719	0.0644863124043175	1	1	0.909686917576869	0.999480344286979	0.565736042846331
down	APOD; IL1R2; CHID1;	GO:1900016~negative regulation of cytokine production involved in inflammatory response	3	17	17.6470588235294	0.00971098061070719	0.0644863124043175	1	1	0.909686917576869	0.999480344286979	0.565736042846331
down	CLDN18; TRIM29; TMEM98;	GO:1900181~negative regulation of protein localization to nucleus	3	17	17.6470588235294	0.00971098061070719	0.0644863124043175	1	1	0.909686917576869	0.999480344286979	0.565736042846331
down	SPINT2; MAP7; PARD6G; RHOD; RHOV;	GO:0007163~establishment or maintenance of cell polarity	5	53	9.43396226415094	0.0097655146174318	0.0644863124043175	1	1	0.909686917576869	0.999480344286979	0.565736042846331
down	KEL; XK; ADGRG6; MAL2; PLLP;	GO:0042552~myelination	5	53	9.43396226415094	0.0097655146174318	0.0644863124043175	1	1	0.909686917576869	0.999480344286979	0.565736042846331
down	CCL21; ADCYAP1; VLDLR; GAS6; CCL19;	GO:0045860~positive regulation of protein kinase activity	5	53	9.43396226415094	0.0097655146174318	0.0644863124043175	1	1	0.909686917576869	0.999480344286979	0.565736042846331
down	AQP1; ADCY2; TFAP2B; CYP4F12;	GO:0003091~renal water homeostasis	4	34	11.7647058823529	0.0102271233430571	0.0665589266042764	1	1	0.911487386488451	0.999480344286979	0.583919010861003
down	VSNL1; TRPM4; BAD; PHPT1;	GO:0035774~positive regulation of insulin secretion involved in cellular response to glucose stimulus	4	34	11.7647058823529	0.0102271233430571	0.0665589266042764	1	1	0.911487386488451	0.999480344286979	0.583919010861003
down	DVL1; MAP2; VLDLR; PREX2;	GO:0048813~dendrite morphogenesis	4	34	11.7647058823529	0.0102271233430571	0.0665589266042764	1	1	0.911487386488451	0.999480344286979	0.583919010861003
down	NOL3; LMNA; GSTP1; PAK5;	GO:2001237~negative regulation of extrinsic apoptotic signaling pathway	4	34	11.7647058823529	0.0102271233430571	0.0665589266042764	1	1	0.911487386488451	0.999480344286979	0.583919010861003
down	FGF1; GPI; FUT1; TSTA3; SMOC2;	GO:0010595~positive regulation of endothelial cell migration	5	54	9.25925925925926	0.0104767493850422	0.0680613199297095	1	1	0.91245192340537	0.999480344286979	0.597099452152175
up	OXT; SLC4A1; AVPR2; MLLT6;	GO:0035811~negative regulation of urine volume	4	5	80	0.0104991350218699	0.279164631634933	1	1	0.999999976169535	0.999999976169535	1
up	IRF1; CTLA4; LAG3; TNFSF4;	GO:0045590~negative regulation of regulatory T cell differentiation	4	5	80	0.0104991350218699	0.279164631634933	1	1	0.999999976169535	0.999999976169535	1
up	GZMB; GZMA; PRF1; GZMM; LYZ; MMD; MICB;	GO:0019835~cytolysis	7	17	41.1764705882353	0.0105622179936529	0.279164631634933	1	1	0.999999976169535	0.999999976169535	1
up	HMGA2; APOBEC3H; APOBEC3F; INPP5K; APOBEC3G; MORC2; APOBEC3C;	GO:0045869~negative regulation of single stranded viral RNA replication via double stranded DNA intermediate	7	17	41.1764705882353	0.0105622179936529	0.279164631634933	1	1	0.999999976169535	0.999999976169535	1
up	TYROBP; TNF; CD247; FCER1G; STX3; ABCA7; RANGRF;	GO:2000010~positive regulation of protein localization to cell surface	7	17	41.1764705882353	0.0105622179936529	0.279164631634933	1	1	0.999999976169535	0.999999976169535	1
down	SMIM22; GRHL3; FZD10; BAIAP2; RHOD; RHOV;	GO:0032956~regulation of actin cytoskeleton organization	6	77	7.79220779220779	0.0111159170370174	0.0716171051666177	1	1	0.915076928938757	0.999480344286979	0.628294225029359
down	CTSV; HYAL2; TP63;	GO:0010259~multicellular organism aging	3	18	16.6666666666667	0.0111426337417855	0.0716171051666177	1	1	0.915076928938757	0.999480344286979	0.628294225029359
down	F12; CTSE; PCSK9;	GO:0016540~protein autoprocessing	3	18	16.6666666666667	0.0111426337417855	0.0716171051666177	1	1	0.915076928938757	0.999480344286979	0.628294225029359
down	ALOX15B; MT1X; MT1M;	GO:0045926~negative regulation of growth	3	18	16.6666666666667	0.0111426337417855	0.0716171051666177	1	1	0.915076928938757	0.999480344286979	0.628294225029359
down	FGF1; FUT1; JMJD8;	GO:1903672~positive regulation of sprouting angiogenesis	3	18	16.6666666666667	0.0111426337417855	0.0716171051666177	1	1	0.915076928938757	0.999480344286979	0.628294225029359
down	HSPA1B; PRDX2; UNC5B; EYA1;	GO:2001240~negative regulation of extrinsic apoptotic signaling pathway in absence of ligand	4	35	11.4285714285714	0.0111971160587647	0.0718399039168533	1	1	0.915642314745948	0.999480344286979	0.630248830256576
down	BMP2; HEY2; WNT7B; WNT9B; WNT4;	GO:0045165~cell fate commitment	5	55	9.09090909090909	0.0112226042882119	0.0718762200437598	1	1	0.915642314745948	0.999480344286979	0.630567430299927
up	IFNG; CD4; CSF1R; MMP9; CASP8; IL31RA; GAB3; EIF2AK1;	GO:0030225~macrophage differentiation	8	22	36.3636363636364	0.0113794382581441	0.29416846093641	1	1	0.999999976169535	0.999999976169535	1
up	TNFSF14; PTPRC; CCND3; PSMB10; TNFRSF4; PIK3CG; P2RX7; RC3H2;	GO:0042098~T cell proliferation	8	22	36.3636363636364	0.0113794382581441	0.29416846093641	1	1	0.999999976169535	0.999999976169535	1
up	BRINP1; TNF; PAX6; REST; PCM1; SORL1; ARHGEF2; TRIM11;	GO:0050768~negative regulation of neurogenesis	8	22	36.3636363636364	0.0113794382581441	0.29416846093641	1	1	0.999999976169535	0.999999976169535	1
up	AIM2; IL12RB1; APOBEC3F; PARP9; LILRB1; DTX3L; TRIM44; APOBEC3G; PTPN22;	GO:0002230~positive regulation of defense response to virus by host	9	27	33.3333333333333	0.011570594192703	0.296509052920833	1	1	0.999999976169535	0.999999976169535	1
up	PITPNM1; GNGT2; GNAT2; ARRB1; CABP4; UNC119; TRPC3; PLEKHB1; OPN1SW;	GO:0007602~phototransduction	9	27	33.3333333333333	0.011570594192703	0.296509052920833	1	1	0.999999976169535	0.999999976169535	1
down	GABRA4; HTR3B; GABRQ; GABRB3; GABRR1; PIEZO2; GABRE;	GO:0042391~regulation of membrane potential	7	102	6.86274509803922	0.0117482678748833	0.0749848738643613	1	1	0.917428933896672	0.999480344286979	0.657839535735569
down	ANXA1; SCGB1A1; CMA1; SLC7A2; DUOXA1; ACE2;	GO:0050727~regulation of inflammatory response	6	78	7.69230769230769	0.0117493540289537	0.0749848738643613	1	1	0.917428933896672	0.999480344286979	0.657839535735569
up	CALCA; ITGB3; TGFBR2; SLC11A1; NCKAP1L; PRKCD; SPDYA; PPP2R3C; AGAP2; STRADB; ADNP; RGCC; MAP2K3; STK10; MAP3K19; MAP3K3; STK4; MAP4K2; MAP4K1; TAOK3; STK39;	GO:0032147~activation of protein kinase activity	21	96	21.875	0.0119954702062391	0.298552828037334	1	1	0.999999976169535	0.999999976169535	1
down	E2F8; CDK1; CCNB1; CDC25C; SFN;	GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest	5	56	8.92857142857143	0.0120038172856659	0.0762063706839561	1	1	0.918701594113626	0.999480344286979	0.668555682330123
down	ARL4D; STEAP3; TVP23B; RAB3D; RAB13;	GO:0009306~protein secretion	5	56	8.92857142857143	0.0120038172856659	0.0762063706839561	1	1	0.918701594113626	0.999480344286979	0.668555682330123
down	CLDN1; CLEC3B; WNT4; HYAL2; OVOL2;	GO:0071560~cellular response to transforming growth factor beta stimulus	5	56	8.92857142857143	0.0120038172856659	0.0762063706839561	1	1	0.918701594113626	0.999480344286979	0.668555682330123
up	BIN1; FCHO1; TGOLN2; PIP5K1C; EGF; CD4; MBP; CD3D; CD3G; UBB; IGF2R; SYT1; AVPR2; YWHAB; ARRB2; ARRB1; ACTB; UBA52; GRB2; AP2B1; LDLRAP1; KIAA0319; TBC1D1; REPS2; STON2; SH3KBP1; FNBP1;	GO:0061024~membrane organization	27	134	20.1492537313433	0.0120217019262802	0.298552828037334	1	1	0.999999976169535	0.999999976169535	1
up	NCR3; CRTAM; CD5; PECAM1; CLEC7A;	GO:0008037~cell recognition	5	9	55.5555555555556	0.0121062310656469	0.298552828037334	1	1	0.999999976169535	0.999999976169535	1
up	JAK1; STAT3; STAT5A; STAT5B; JAK3;	GO:0038113~interleukin-9-mediated signaling pathway	5	9	55.5555555555556	0.0121062310656469	0.298552828037334	1	1	0.999999976169535	0.999999976169535	1
up	BTN3A1; DYSF; LYN; S100A12; NOX5;	GO:0050663~cytokine secretion	5	9	55.5555555555556	0.0121062310656469	0.298552828037334	1	1	0.999999976169535	0.999999976169535	1
up	TYROBP; JAK2; TNF; IFNG; APP;	GO:0050725~positive regulation of interleukin-1 beta biosynthetic process	5	9	55.5555555555556	0.0121062310656469	0.298552828037334	1	1	0.999999976169535	0.999999976169535	1
up	CRTAM; CD4; CCL5; PAG1; SIT1;	GO:0050863~regulation of T cell activation	5	9	55.5555555555556	0.0121062310656469	0.298552828037334	1	1	0.999999976169535	0.999999976169535	1
up	TLR4; CD74; CD36; HLA-G; LILRB1;	GO:0060907~positive regulation of macrophage cytokine production	5	9	55.5555555555556	0.0121062310656469	0.298552828037334	1	1	0.999999976169535	0.999999976169535	1
up	CACNB4; GRIN3B; TRPA1; ANXA6; OPRM1; TRPC3; CACNA1E; CACNA2D4; CACNA2D3; CATSPER1; SLC24A4; CACNG8; ATP2A3; ORAI1; ORAI2; P2RX4; P2RX7; ORAI3; MCOLN1; PKD2L2; CACNA1I; TRPC5; TRPV2; CLCA3P;	GO:0070588~calcium ion transmembrane transport	24	115	20.8695652173913	0.0122092345610827	0.299838452095922	1	1	0.999999976169535	0.999999976169535	1
down	DDAH1; DDAH2; MT1M;	GO:0007263~nitric oxide mediated signal transduction	3	19	15.7894736842105	0.012689480610018	0.0772988138016839	1	1	0.921468246759178	0.999480344286979	0.67813964555294
down	DLX3; DLX5; LRRC1;	GO:0009790~embryo development	3	19	15.7894736842105	0.012689480610018	0.0772988138016839	1	1	0.921468246759178	0.999480344286979	0.67813964555294
down	RARG; PTPRZ1; HES5;	GO:0031641~regulation of myelination	3	19	15.7894736842105	0.012689480610018	0.0772988138016839	1	1	0.921468246759178	0.999480344286979	0.67813964555294
down	EGFR; CA2; SPP1;	GO:0045780~positive regulation of bone resorption	3	19	15.7894736842105	0.012689480610018	0.0772988138016839	1	1	0.921468246759178	0.999480344286979	0.67813964555294
down	FOLR1; SHMT1; SHMT2;	GO:0046655~folic acid metabolic process	3	19	15.7894736842105	0.012689480610018	0.0772988138016839	1	1	0.921468246759178	0.999480344286979	0.67813964555294
down	HRAS; NTF3; BAIAP2;	GO:2000251~positive regulation of actin cytoskeleton reorganization	3	19	15.7894736842105	0.012689480610018	0.0772988138016839	1	1	0.921468246759178	0.999480344286979	0.67813964555294
down	EGFR; SDC1; CCND1; BAD; S100A16;	GO:0051592~response to calcium ion	5	57	8.7719298245614	0.0128211072508968	0.0772988138016839	1	1	0.922210767505962	0.999480344286979	0.67813964555294
down	CDK1; TUBB; TUBG1; CETN2; DYNLL1; TUBB4B;	GO:0010389~regulation of G2/M transition of mitotic cell cycle	6	80	7.5	0.013091689314358	0.0780548910601114	1	1	0.922975453051158	0.999480344286979	0.684772683484882
down	UBE2C; CDK1; CCNB1; PSMB6; PSMD8; CDC20;	GO:1901990~regulation of mitotic cell cycle phase transition	6	80	7.5	0.013091689314358	0.0780548910601114	1	1	0.922975453051158	0.999480344286979	0.684772683484882
down	EPCAM; BMP7; SDC1; NPNT;	GO:0001657~ureteric bud development	4	37	10.8108108108108	0.0133100096233432	0.0789669147047774	1	1	0.923763310885602	0.999480344286979	0.692773833317743
down	BMP2; FGFR3; HES5; CYTL1;	GO:0002062~chondrocyte differentiation	4	37	10.8108108108108	0.0133100096233432	0.0789669147047774	1	1	0.923763310885602	0.999480344286979	0.692773833317743
down	CLIC3; TSPO; FXYD3; SLC26A9;	GO:0006821~chloride transport	4	37	10.8108108108108	0.0133100096233432	0.0789669147047774	1	1	0.923763310885602	0.999480344286979	0.692773833317743
up	ASGR1; LYN; PTPRC; CDKN2B; AIF1; GSDMD; ADNP;	GO:0031668~cellular response to extracellular stimulus	7	18	38.8888888888889	0.0133443608274086	0.322958679971939	1	1	0.999999976169535	0.999999976169535	1
down	WNT9B; EDN3; HOXC8; ID1; WNT7B; PCSK9; FZD10; WNT4;	GO:0030182~neuron differentiation	8	131	6.10687022900763	0.0136270539661119	0.0807158016783586	1	1	0.925412888226469	0.999480344286979	0.708116754302524
down	HYAL1; HYAL2; CCL21; CCL22; CCL11; CCL19;	GO:0071347~cellular response to interleukin-1	6	81	7.40740740740741	0.0138015336307978	0.0816159207367735	1	1	0.925412888226469	0.999480344286979	0.716013465638806
up	FFAR2; DYSF; CD36; STAT5B; B4GALNT1; PLIN5; PNPLA2; DGAT2;	GO:0019915~lipid storage	8	23	34.7826086956522	0.0139333719429534	0.329718387439549	1	1	0.999999976169535	0.999999976169535	1
up	CPNE6; SYT1; CXCR4; NEDD4L; RNF157; SYT4; CPNE5; RIMS2;	GO:1903861~positive regulation of dendrite extension	8	23	34.7826086956522	0.0139333719429534	0.329718387439549	1	1	0.999999976169535	0.999999976169535	1
down	BMP2; ID4; DLX5; GPNMB; ALYREF; LGR4; SPP1;	GO:0001649~osteoblast differentiation	7	106	6.60377358490566	0.014112241632229	0.0833173874866941	1	1	0.927168889911908	0.999480344286979	0.730940370748521
up	CCL24; EFNA2; SH2D1A; GRAP2; SEMA4F; GHRH; LTA; WNT1; ITGB2; INHBA; CCL4; CCL5; CD33; TRH; ADORA2A; CCR1; SSTR3; CD70; PTGIR; CX3CR1; AFDN; IL2; GRB2; CCL7; CXCL6; CRB1; LTB; MERTK; GRAP; FAT1; ZYX; LILRB2; SH3KBP1; TSPAN32; IL26; SIRPG; CCL26; PTH; ADRA1D; FGFBP2; DRD3;	GO:0007267~cell-cell signaling	41	230	17.8260869565217	0.0142197734959231	0.329718387439549	1	1	0.999999976169535	0.999999976169535	1
down	CYP2C9; COMT; UGT1A1;	GO:0008210~estrogen metabolic process	3	20	15	0.0143528307071645	0.0839177601830184	1	1	0.928090071123942	0.999480344286979	0.736207418293773
down	GSTP1; GAS6; CCDC3;	GO:0010804~negative regulation of tumor necrosis factor-mediated signaling pathway	3	20	15	0.0143528307071645	0.0839177601830184	1	1	0.928090071123942	0.999480344286979	0.736207418293773
down	CYFIP1; NCKAP1; RHOV;	GO:0030031~cell projection assembly	3	20	15	0.0143528307071645	0.0839177601830184	1	1	0.928090071123942	0.999480344286979	0.736207418293773
down	RPS6KA4; SYT14P1; LPAR5;	GO:0032793~positive regulation of CREB transcription factor activity	3	20	15	0.0143528307071645	0.0839177601830184	1	1	0.928090071123942	0.999480344286979	0.736207418293773
down	SYNGR1; ABCA12; TMEM79;	GO:0045055~regulated exocytosis	3	20	15	0.0143528307071645	0.0839177601830184	1	1	0.928090071123942	0.999480344286979	0.736207418293773
down	SHMT2; TRPM1; TP63;	GO:0051262~protein tetramerization	3	20	15	0.0143528307071645	0.0839177601830184	1	1	0.928090071123942	0.999480344286979	0.736207418293773
down	SDC1; GPC1; HS3ST6; UGDH;	GO:0006024~glycosaminoglycan biosynthetic process	4	38	10.5263157894737	0.0144550819193925	0.0842438455913147	1	1	0.928090071123942	0.999480344286979	0.739068153566753
down	C1QA; FCGR2B; AIMP2; BAD;	GO:1901216~positive regulation of neuron death	4	38	10.5263157894737	0.0144550819193925	0.0842438455913147	1	1	0.928090071123942	0.999480344286979	0.739068153566753
up	SMTNL1; WWP2; ARNTL; TRIM24; CBFA2T3; ZNF217; NCOR1; NR1I2; RPS6KA5; CALCA; TNF; IFNG; RARA; IRF1; ZNF12; TNFSF4; GATA3; YWHAB; CIITA; ZNF93; BCL6; TNFRSF4; PPM1F; CEBPD; SMARCA2; HMGA2; NR1H2; SOX8; BASP1; MAP3K10; ARID5A; ZNF91; ZBTB16; REST; RUNX2; PTPRK; TAF7; ZNF174; GON4L; LBH; DAB2IP; NIPBL; HMBOX1; ATF7IP; BEND5; CIR1; KDM8; ZGPAT; ZBTB38; SMARCC2; DEDD2; PBXIP1; TRIM11; HIC2; PHF12; CIC; RSF1; PFDN5; GFI1; NKX3-1; INPP5K; ZNF350; KAT8; PATZ1; DMAP1; PRDM5; RLIM; RBAK; MDFIC; DACH1; SIX4; TBX21; ZNF148; SBNO2; ZNF281; TSC22D4; NCOR2; ZC3H4; C11orf95; ZNF586; DPF2; ZNF263; DPF3;	GO:0045892~negative regulation of transcription, DNA-templated	83	530	15.6603773584906	0.014530017176051	0.329718387439549	1	1	0.999999976169535	0.999999976169535	1
down	EGFR; SFN; KRT17; HYAL1; SLC44A4; SFRP2;	GO:0030307~positive regulation of cell growth	6	82	7.31707317073171	0.0145377801063991	0.0845898120155643	1	1	0.929041958376377	0.999480344286979	0.742103304260214
down	ADRA2A; NPR3; GNAI1; ADCY2; PSAPL1;	GO:0007193~adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway	5	59	8.47457627118644	0.0145666938204317	0.0846222197100402	1	1	0.929041958376377	0.999480344286979	0.74238761576985
up	NUAK1; PLAU; PF4; FES; MELTF; DBH; FUT3; CCND3; TCF7; TGFBR2; PTGER2; BID; XIAP; KSR1; MZB1; ARHGEF2; TXNIP; CHST11; BIRC6; CELA1; FRK; FGR; BLK; STAT3; SLA; BCL6; STAT5B; HCK; LYN; LCK; STAT5A;	GO:0042127~regulation of cell population proliferation	31	163	19.0184049079755	0.014764224163761	0.329718387439549	1	1	0.999999976169535	0.999999976169535	1
down	CDK1; NR2F6; RARG; CCNB1; CCND1; POLR2I; MAZ; POLR2L; NOTCH3;	GO:0006367~transcription initiation from RNA polymerase II promoter	9	161	5.59006211180124	0.015222618003918	0.0876451593291628	1	1	0.931044203976326	0.999480344286979	0.768907753673895
up	IL2; PRKCQ; SLAMF6; MYD88; IL21; LY9;	GO:0032740~positive regulation of interleukin-17 production	6	14	42.8571428571429	0.0152550176925916	0.329718387439549	1	1	0.999999976169535	0.999999976169535	1
up	DGKQ; DGKZ; DGKD; PGS1; DGAT2; DGKG;	GO:0046339~diacylglycerol metabolic process	6	14	42.8571428571429	0.0152550176925916	0.329718387439549	1	1	0.999999976169535	0.999999976169535	1
up	TLR2; DYSF; PRTN3; CSK; PTEN; SYT11;	GO:0050765~negative regulation of phagocytosis	6	14	42.8571428571429	0.0152550176925916	0.329718387439549	1	1	0.999999976169535	0.999999976169535	1
up	JAK2; LYN; STAT3; STAT5A; STAT5B; JAK3;	GO:0060397~growth hormone receptor signaling pathway via JAK-STAT	6	14	42.8571428571429	0.0152550176925916	0.329718387439549	1	1	0.999999976169535	0.999999976169535	1
up	GATA3; SMARCA1; ATRX; SMARCA2; BPTF; PABPC1L; BRDT; SMARCD3; SMARCC2; RSF1; PIH1D1; CHD7; RERE; BAZ2B; BAZ2A; PADI4; MORC2; TADA2B; KDM5A; SATB1; KDM4B; KDM4E;	GO:0006338~chromatin remodeling	22	105	20.952380952381	0.0153435698794681	0.329718387439549	1	1	0.999999976169535	0.999999976169535	1
down	BMP7; GJA5; DLX5; FRAS1;	GO:0030326~embryonic limb morphogenesis	4	39	10.2564102564103	0.0156605763348814	0.0876451593291628	1	1	0.933189467119128	0.999480344286979	0.768907753673895
down	GSTP1; BMP7; HYAL2; CBLC;	GO:0043407~negative regulation of MAP kinase activity	4	39	10.2564102564103	0.0156605763348814	0.0876451593291628	1	1	0.933189467119128	0.999480344286979	0.768907753673895
down	EGFR; GSN; MT1X; MT1M;	GO:0071276~cellular response to cadmium ion	4	39	10.2564102564103	0.0156605763348814	0.0876451593291628	1	1	0.933189467119128	0.999480344286979	0.768907753673895
up	TLR4; PLCL2; CD180; GAPT;	GO:0002322~B cell proliferation involved in immune response	4	6	66.6666666666667	0.0160352107334969	0.329718387439549	1	1	0.999999976169535	0.999999976169535	1
up	TNF; APOA2; IL10; LILRB1;	GO:0002740~negative regulation of cytokine secretion involved in immune response	4	6	66.6666666666667	0.0160352107334969	0.329718387439549	1	1	0.999999976169535	0.999999976169535	1
up	LYN; FGR; FPR2; BTLA;	GO:0002768~immune response-regulating cell surface receptor signaling pathway	4	6	66.6666666666667	0.0160352107334969	0.329718387439549	1	1	0.999999976169535	0.999999976169535	1
up	JAK2; CD4; JAK3; GP6;	GO:0007167~enzyme linked receptor protein signaling pathway	4	6	66.6666666666667	0.0160352107334969	0.329718387439549	1	1	0.999999976169535	0.999999976169535	1
up	PALM3; PELI1; MYD88; PELI3;	GO:0008063~Toll signaling pathway	4	6	66.6666666666667	0.0160352107334969	0.329718387439549	1	1	0.999999976169535	0.999999976169535	1
up	ISG15; UBA7; HERC5; UBE2L6;	GO:0032020~ISG15-protein conjugation	4	6	66.6666666666667	0.0160352107334969	0.329718387439549	1	1	0.999999976169535	0.999999976169535	1
up	C5AR1; IRF5; CARD9; IRAK3;	GO:0032494~response to peptidoglycan	4	6	66.6666666666667	0.0160352107334969	0.329718387439549	1	1	0.999999976169535	0.999999976169535	1
up	CD3E; CCL5; SKAP1; PIEZO1;	GO:0033634~positive regulation of cell-cell adhesion mediated by integrin	4	6	66.6666666666667	0.0160352107334969	0.329718387439549	1	1	0.999999976169535	0.999999976169535	1
up	LGALS9; IL13RA2; CD300A; CD84;	GO:0043305~negative regulation of mast cell degranulation	4	6	66.6666666666667	0.0160352107334969	0.329718387439549	1	1	0.999999976169535	0.999999976169535	1
up	IFNG; PRF1; SYK; CLEC7A;	GO:0051712~positive regulation of killing of cells of other organism	4	6	66.6666666666667	0.0160352107334969	0.329718387439549	1	1	0.999999976169535	0.999999976169535	1
up	IRGM; TXK; NLRC5; PARP9;	GO:0060335~positive regulation of interferon-gamma-mediated signaling pathway	4	6	66.6666666666667	0.0160352107334969	0.329718387439549	1	1	0.999999976169535	0.999999976169535	1
up	SYT1; DOC2A; RIMS2; RPH3A;	GO:0061669~spontaneous neurotransmitter secretion	4	6	66.6666666666667	0.0160352107334969	0.329718387439549	1	1	0.999999976169535	0.999999976169535	1
up	PTH; HMGA2; MEF2C; MAP3K3;	GO:0071864~positive regulation of cell proliferation in bone marrow	4	6	66.6666666666667	0.0160352107334969	0.329718387439549	1	1	0.999999976169535	0.999999976169535	1
up	STAT3; IRF4; SLAMF6; LY9;	GO:0072540~T-helper 17 cell lineage commitment	4	6	66.6666666666667	0.0160352107334969	0.329718387439549	1	1	0.999999976169535	0.999999976169535	1
up	KCNE1; GDI1; DMTN; INPP5K;	GO:0090315~negative regulation of protein targeting to membrane	4	6	66.6666666666667	0.0160352107334969	0.329718387439549	1	1	0.999999976169535	0.999999976169535	1
down	TCN1; PRSS3; AMN;	GO:0009235~cobalamin metabolic process	3	21	14.2857142857143	0.0161337150214018	0.0876451593291628	1	1	0.935493638642879	0.999480344286979	0.768907753673895
down	NUPR1; SFRP2; HEY2;	GO:0010667~negative regulation of cardiac muscle cell apoptotic process	3	21	14.2857142857143	0.0161337150214018	0.0876451593291628	1	1	0.935493638642879	0.999480344286979	0.768907753673895
down	TUBB; TUBA1B; TUBA1C;	GO:0030705~cytoskeleton-dependent intracellular transport	3	21	14.2857142857143	0.0161337150214018	0.0876451593291628	1	1	0.935493638642879	0.999480344286979	0.768907753673895
down	ADRA2A; ADRA2C; ADRA2B;	GO:0071880~adenylate cyclase-activating adrenergic receptor signaling pathway	3	21	14.2857142857143	0.0161337150214018	0.0876451593291628	1	1	0.935493638642879	0.999480344286979	0.768907753673895
up	PIK3CD; PRKCB; LYN; PTPRC; MS4A1; CD79A; CTLA4; PLCG2; PTPN6; MNDA; SYK; BLK; NCKAP1L; BTK; MEF2C; RFTN1; LAT2; IGHM; IGHV3-35; TRBC2; LCK; TRBC1; TRDC; IGHE; IGHD;	GO:0050853~B cell receptor signaling pathway	25	125	20	0.0163499602952702	0.329718387439549	1	1	0.999999976169535	0.999999976169535	1
up	TAPBP; HLA-H; HLA-E; HLA-G; HLA-F; SEC24C; TAP1; ABCB9; ERAP1;	GO:0002474~antigen processing and presentation of peptide antigen via MHC class I	9	29	31.0344827586207	0.0165004667250657	0.329718387439549	1	1	0.999999976169535	0.999999976169535	1
up	FMNL1; TNF; PLEK; EPB41; RHOQ; NCKAP1L; ROCK1; STRIP1; TLN1;	GO:0030866~cortical actin cytoskeleton organization	9	29	31.0344827586207	0.0165004667250657	0.329718387439549	1	1	0.999999976169535	0.999999976169535	1
up	TLR4; CD14; UBB; UBE2D1; UBA52; CASP8; IRF7; TLR6; LY96;	GO:0035666~TRIF-dependent toll-like receptor signaling pathway	9	29	31.0344827586207	0.0165004667250657	0.329718387439549	1	1	0.999999976169535	0.999999976169535	1
up	F2; TNF; CCL5; AKR1B1; IL10; IL10RA; CRLF3; ADIPOR1; IL26;	GO:0046427~positive regulation of receptor signaling pathway via JAK-STAT	9	29	31.0344827586207	0.0165004667250657	0.329718387439549	1	1	0.999999976169535	0.999999976169535	1
up	JAK2; LYN; VAV1; EPOR; ITPKB; GRB2; RAPGEF1; RASGEF1A; RASGRP4;	GO:0046579~positive regulation of Ras protein signal transduction	9	29	31.0344827586207	0.0165004667250657	0.329718387439549	1	1	0.999999976169535	0.999999976169535	1
up	FTL; MELTF; EPB42; SLC11A1; STEAP4; EIF2AK1; SLC25A37; FBXL5; SLC40A1;	GO:0055072~iron ion homeostasis	9	29	31.0344827586207	0.0165004667250657	0.329718387439549	1	1	0.999999976169535	0.999999976169535	1
up	TESPA1; VNN1; ADA; GLI2; ADAM8;	GO:0033089~positive regulation of T cell differentiation in thymus	5	10	50	0.0165886551538448	0.329718387439549	1	1	0.999999976169535	0.999999976169535	1
up	NIN; CEP19; CCDC68; PCM1; NINL;	GO:0034454~microtubule anchoring at centrosome	5	10	50	0.0165886551538448	0.329718387439549	1	1	0.999999976169535	0.999999976169535	1
up	TLR4; JAK2; IFNG; IL10; CIITA;	GO:0045348~positive regulation of MHC class II biosynthetic process	5	10	50	0.0165886551538448	0.329718387439549	1	1	0.999999976169535	0.999999976169535	1
up	PTPN6; ZFP36L2; NFAM1; FCRL3; CARD11;	GO:0045577~regulation of B cell differentiation	5	10	50	0.0165886551538448	0.329718387439549	1	1	0.999999976169535	0.999999976169535	1
up	TLR4; CD36; MIA3; MYD88; TLR6;	GO:0140052~cellular response to oxidised low-density lipoprotein particle stimulus	5	10	50	0.0165886551538448	0.329718387439549	1	1	0.999999976169535	0.999999976169535	1
up	CBLB; KPNB1; RGPD5; RGPD3; RGPD1; KPNA5; RGPD4;	GO:0006607~NLS-bearing protein import into nucleus	7	19	36.8421052631579	0.0166145845045039	0.329718387439549	1	1	0.999999976169535	0.999999976169535	1
up	IL2RA; CD74; RAG1; GATA3; CD27; IL12A; ZAP70;	GO:0045582~positive regulation of T cell differentiation	7	19	36.8421052631579	0.0166145845045039	0.329718387439549	1	1	0.999999976169535	0.999999976169535	1
up	GATA3; RAP1B; ROCK1; PTK2B; RICTOR; FAM49B; ARFGEF1;	GO:2000114~regulation of establishment of cell polarity	7	19	36.8421052631579	0.0166145845045039	0.329718387439549	1	1	0.999999976169535	0.999999976169535	1
up	FOXO3; CD160; ITGA4; HLA-G; PLCG1; CD40LG; RGCC;	GO:2000353~positive regulation of endothelial cell apoptotic process	7	19	36.8421052631579	0.0166145845045039	0.329718387439549	1	1	0.999999976169535	0.999999976169535	1
up	ATM; TDRD12; BRDT; SPDYA; TAF1L; TDRD9; AGO4; MLH3;	GO:0007140~male meiotic nuclear division	8	24	33.3333333333333	0.0168803321840156	0.331642259641961	1	1	0.999999976169535	0.999999976169535	1
up	TLR4; LILRB3; PIK3R1; TMEM178A; LILRB4; ZNF675; INPP5D; GPR55;	GO:0045671~negative regulation of osteoclast differentiation	8	24	33.3333333333333	0.0168803321840156	0.331642259641961	1	1	0.999999976169535	0.999999976169535	1
down	YWHAQ; RRAD; RAB38; PLD1; KNDC1; RAPGEFL1;	GO:0007264~small GTPase mediated signal transduction	6	85	7.05882352941176	0.0169094183443179	0.0898416945067299	1	1	0.937975054129996	0.999480344286979	0.788177875859489
down	FAM83G; BMP2; BMP7; ID1; DLX5; TMEM100;	GO:0030509~BMP signaling pathway	6	85	7.05882352941176	0.0169094183443179	0.0898416945067299	1	1	0.937975054129996	0.999480344286979	0.788177875859489
down	BMP2; BMP7; WNT4; FOXF2;	GO:0001837~epithelial to mesenchymal transition	4	40	10	0.0169274144408542	0.0898416945067299	1	1	0.937975054129996	0.999480344286979	0.788177875859489
down	FA2H; MCAT; HSD17B8; ELOVL4;	GO:0006633~fatty acid biosynthetic process	4	40	10	0.0169274144408542	0.0898416945067299	1	1	0.937975054129996	0.999480344286979	0.788177875859489
down	CCNB1; CDCA8; PSRC1; KIFC1;	GO:0007080~mitotic metaphase plate congression	4	40	10	0.0169274144408542	0.0898416945067299	1	1	0.937975054129996	0.999480344286979	0.788177875859489
down	GAPDH; FAM162A; TP63; BOK;	GO:0051402~neuron apoptotic process	4	40	10	0.0169274144408542	0.0898416945067299	1	1	0.937975054129996	0.999480344286979	0.788177875859489
down	ADCY2; ADRA2B; ADRA2C; GNAI1; ADRA2A;	GO:0007188~adenylate cyclase-modulating G protein-coupled receptor signaling pathway	5	62	8.06451612903226	0.0174724481431144	0.0925988662555407	1	1	0.940654982856081	0.999480344286979	0.812366442029005
up	CCS; FOXO3; CAT; SOD2; CYBB; GPX1; CYBA; NCF1; NCF2; SNCA; AIF1; DHRS2; NCF4; PRKD1; LRRK2; PRR5L; SETX; NOX5; TXNRD2; ATP13A2;	GO:0034599~cellular response to oxidative stress	20	94	21.2765957446809	0.0176844032081449	0.34628529072693	1	1	0.999999976169535	0.999999976169535	1
down	HRAS; EFNA1; EFNA3; AP2S1; EPHB3; APH1A;	GO:0048013~ephrin receptor signaling pathway	6	86	6.97674418604651	0.0177557144097884	0.093962722241581	1	1	0.941052863718785	0.999480344286979	0.824331500345831
down	HRAS; PTPRZ1; GABRB3; TYRO3; UNC5B; TFAP2B; BOK; NTF3;	GO:0043524~negative regulation of neuron apoptotic process	8	138	5.79710144927536	0.0178217551186609	0.0941747263923408	1	1	0.942076985853596	0.999480344286979	0.826191404949553
up	CLEC4D; CLEC4E; FCER1G;	GO:0002292~T cell differentiation involved in immune response	3	3	100	0.0189572883749154	0.351365590194187	1	1	0.999999976169535	0.999999976169535	1
up	SH2D1B; SYK; IL2;	GO:0002366~leukocyte activation involved in immune response	3	3	100	0.0189572883749154	0.351365590194187	1	1	0.999999976169535	0.999999976169535	1
up	FCER1G; SYK; P2RX1;	GO:0002554~serotonin secretion by platelet	3	3	100	0.0189572883749154	0.351365590194187	1	1	0.999999976169535	0.999999976169535	1
up	ADA; TNFRSF13C; TNFSF13B;	GO:0002636~positive regulation of germinal center formation	3	3	100	0.0189572883749154	0.351365590194187	1	1	0.999999976169535	0.999999976169535	1
up	PIK3CD; MPO; PIK3CG;	GO:0002679~respiratory burst involved in defense response	3	3	100	0.0189572883749154	0.351365590194187	1	1	0.999999976169535	0.999999976169535	1
up	HLA-G; LILRB2; LILRB1;	GO:0002767~immune response-inhibiting cell surface receptor signaling pathway	3	3	100	0.0189572883749154	0.351365590194187	1	1	0.999999976169535	0.999999976169535	1
up	LYN; LILRB2; LILRB1;	GO:0002774~Fc receptor mediated inhibitory signaling pathway	3	3	100	0.0189572883749154	0.351365590194187	1	1	0.999999976169535	0.999999976169535	1
up	PTEN; BTK; LYN;	GO:0002902~regulation of B cell apoptotic process	3	3	100	0.0189572883749154	0.351365590194187	1	1	0.999999976169535	0.999999976169535	1
up	ADAR; APOBEC3F; APOBEC3G;	GO:0016553~base conversion or substitution editing	3	3	100	0.0189572883749154	0.351365590194187	1	1	0.999999976169535	0.999999976169535	1
up	CLEC4D; CLEC4E; FCER1G;	GO:0038094~Fc-gamma receptor signaling pathway	3	3	100	0.0189572883749154	0.351365590194187	1	1	0.999999976169535	0.999999976169535	1
up	CD4; CD74; CD1D;	GO:0045058~T cell selection	3	3	100	0.0189572883749154	0.351365590194187	1	1	0.999999976169535	0.999999976169535	1
up	TLR2; CPS1; TLR6;	GO:0046209~nitric oxide metabolic process	3	3	100	0.0189572883749154	0.351365590194187	1	1	0.999999976169535	0.999999976169535	1
up	TLR2; CD14; TLR1;	GO:0071727~cellular response to triacyl bacterial lipopeptide	3	3	100	0.0189572883749154	0.351365590194187	1	1	0.999999976169535	0.999999976169535	1
up	TLR4; REST; TLR6;	GO:1903223~positive regulation of oxidative stress-induced neuron death	3	3	100	0.0189572883749154	0.351365590194187	1	1	0.999999976169535	0.999999976169535	1
up	AIM2; CASP1; CASP8; CLEC7A; MNDA; PYHIN1;	GO:0032731~positive regulation of interleukin-1 beta production	6	15	40	0.0194688031743497	0.35747391249102	1	1	0.999999976169535	0.999999976169535	1
up	ARRB2; NLRP6; GPS2; LRRC14; IRF4; IRAK3;	GO:0034122~negative regulation of toll-like receptor signaling pathway	6	15	40	0.0194688031743497	0.35747391249102	1	1	0.999999976169535	0.999999976169535	1
up	SRGN; PTGER4; NLRP12; SYT11; RGCC; TNFRSF4;	GO:0050710~negative regulation of cytokine secretion	6	15	40	0.0194688031743497	0.35747391249102	1	1	0.999999976169535	0.999999976169535	1
down	RAMP2; GJB2; TSPO; BAD;	GO:0032570~response to progesterone	4	42	9.52380952380952	0.0196484786721511	0.100515158178896	1	1	0.948396999175884	0.999480344286979	0.88181577941173
down	ADH7; LYPD6; PCSK9; DKK4;	GO:2000272~negative regulation of signaling receptor activity	4	42	9.52380952380952	0.0196484786721511	0.100515158178896	1	1	0.948396999175884	0.999480344286979	0.88181577941173
down	ADRA2A; CEBPA; FOXA1; FAM3B; FABP5; TFAP2B; BAD;	GO:0042593~glucose homeostasis	7	114	6.14035087719298	0.0198254602718951	0.100515158178896	1	1	0.950156548339476	0.999480344286979	0.88181577941173
up	PRSS51; PRSS37; TPP1; TMPRSS2; XPNPEP2; TLL1; RHBDL1; F2; HP; HPR; CFD; CFI; MME; GZMB; CTSA; MMP9; PROZ; PRTN3; MMP11; CTSS; CASP1; CPS1; CTSO; CASP4; GZMK; GZMM; CASP5; CASP9; TMPRSS3; YBEY; ADAM8; FGL2; CASP8; PRSS53; PM20D1; RHBDF2; ADAMTSL4; ADAMTS13; ASRGL1; OVCH1; TMPRSS9; DPP9; AMZ2; PRSS58; KDM8; ADAMTSL1; KY; ADAMTS16; CASP10; NUDT16; PIK3IP1; CNDP1; PRSS22; ADAMTS10; DPEP2; DPEP3; RNPEPL1; MMP25; FBXO2; MMP17; AGTPBP1; NAALADL1; CPQ; CPA5; ERAP1; ANPEP; PLAU; PGPEP1; CELA1;	GO:0006508~proteolysis	69	436	15.8256880733945	0.0199486694906356	0.365147385024242	1	1	0.999999976169535	0.999999976169535	1
down	SLC9A3R1; TLCD1; BAIAP2;	GO:0007009~plasma membrane organization	3	23	13.0434782608696	0.0200509098441681	0.100515158178896	1	1	0.950156548339476	0.999480344286979	0.88181577941173
down	CYP11A1; FDXR; CYP39A1;	GO:0016125~sterol metabolic process	3	23	13.0434782608696	0.0200509098441681	0.100515158178896	1	1	0.950156548339476	0.999480344286979	0.88181577941173
down	MRPL28; MRPL41; GADD45GIP1; MRPL37; MRPL40; MRPL15;	GO:0070126~mitochondrial translational termination	6	89	6.74157303370786	0.0204676755806046	0.101916653818258	1	1	0.951997936999049	0.999480344286979	0.894111049020385
up	WWP2; SOCS2; SOCS3; ENC1; UBE2L6; TRIM24; MYCBP2; HERC2; UBB; TRIM21; ARRB2; TRIM23; UBA7; ARRB1; CDC34; UBE2D1; UBA52; XIAP; ZBTB16; CBLB; DCST1; DCAF12; RNF220; RNF123; RNF213; KLHL24; UBE2R2; DET1; FBXO33; DTX2; RNF130; DTX1; TRIM22; ARRDC1; RNF182; RNF149; ARRDC4; LRRC29; SOCS4; ASB15; FBXW7; UBE2F; TRIM11; MED30; VCPIP1; DCAF5; NEDD4L; RNF157; CRBN; TRIM62; TRIM8; ASB8; JADE2; BIRC6; RLIM; KLHL3; HERC5; FBXO2; FBXO9; FBXL5; RNF24; NOSIP; FBXO7; NUB1; MGRN1; HUWE1; MSL2; HECW1; DTX3L; ISG15;	GO:0016567~protein ubiquitination	70	444	15.7657657657658	0.0205094751560672	0.373603355197009	1	1	0.999999976169535	0.999999976169535	1
up	LIN7A; TAPBP; WIPF1; LPXN; SKAP2; CD74; CD3E; VIL1; CD3G; EPB41; IL2RB; TEAD1; WAS; NCKAP1L; BID; DMTN; PTK2B; DET1; REPS2; NUP210; CREBBP; PARD6B; MDN1; ZNF148; ST13;	GO:0065003~protein-containing complex assembly	25	128	19.53125	0.020537408734956	0.373603355197009	1	1	0.999999976169535	0.999999976169535	1
down	PHGDH; MAP2; CDH1; ADCYAP1; RAB13; CNTN4; STMN1;	GO:0031175~neuron projection development	7	115	6.08695652173913	0.0206381071509584	0.102624332540774	1	1	0.951997936999049	0.999480344286979	0.900319488379929
down	PRMT5; CIART; LGR4; ID4; ID1;	GO:0032922~circadian regulation of gene expression	5	65	7.69230769230769	0.0207376290969465	0.10297795270744	1	1	0.953927010832887	0.999480344286979	0.903421785073622
down	DLX3; GJA4; FOXF1; APLNR;	GO:0001568~blood vessel development	4	43	9.30232558139535	0.0211042190438435	0.104227239828246	1	1	0.953927010832887	0.999480344286979	0.914381734956824
down	MAOB; YWHAQ; DYNLL1; INA;	GO:0021762~substantia nigra development	4	43	9.30232558139535	0.0211042190438435	0.104227239828246	1	1	0.953927010832887	0.999480344286979	0.914381734956824
down	CDK1; GSTP1; UGT1A1; GAS6;	GO:0031100~animal organ regeneration	4	43	9.30232558139535	0.0211042190438435	0.104227239828246	1	1	0.953927010832887	0.999480344286979	0.914381734956824
down	EGFR; GSTP1; ID1; BAIAP2;	GO:0071364~cellular response to epidermal growth factor stimulus	4	43	9.30232558139535	0.0211042190438435	0.104227239828246	1	1	0.953927010832887	0.999480344286979	0.914381734956824
up	MYO1G; ARPC1B; WIPF1; IGKV3-20; IGLV2-14; LYN; HCK; FCGR3A; CD3G; FGR; FCGR1A; FCGR2A; VAV1; PLCG2; PLCG1; CD247; PIK3R1; WAS; SYK; NCKAP1L; ACTB; GRB2; PRKCD; ELMO1; CYFIP2; WASF2;	GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis	26	135	19.2592592592593	0.0211684630172008	0.376685618026469	1	1	0.999999976169535	0.999999976169535	1
up	SOCS2; SOCS3; IFIT3; BNIP3L; FCMR; CAT; RAF1; CD74; WNT1; MPO; CSF1R; HCK; IFI6; UBB; GLI2; RARA; MMP9; IL2RB; AKR1B1; SON; IL10; CD27; PIK3R1; CD40LG; EVI2B; DRD3; SNCA; PPT1; STAT5B; HMGA2; DAPK1; AIF1; NCKAP1L; ADAR; BID; TCL1A; SOX8; PTEN; IL2; UBA52; TMF1; XIAP; BCL2L1; BNIP2; NAIP; DHRS2; PTK2B; FKBP8; PDCD1; RPS6KA1; BCL2A1; FXN; NUGGC; DSTYK; SETX; PDPN; STK40; IL31RA; PHIP; RXFP2; MYO18A; SEMA4D; RNF157; MYD88; BAG1; ARNT2; PROK2; AGO4; SLC40A1; CHST11; BIRC6; C8orf17; PIM2; NAT8; SIX4; UBE2O;	GO:0043066~negative regulation of apoptotic process	76	489	15.5419222903885	0.0213365448517944	0.376685618026469	1	1	0.999999976169535	0.999999976169535	1
down	KRT75; PTPRZ1; HYAL2; SERPINB12; ANLN;	GO:0002244~hematopoietic progenitor cell differentiation	5	66	7.57575757575758	0.0219084871013063	0.108052062234334	1	1	0.958074519575638	0.999480344286979	0.947936761007052
up	ADORA2A; OPRM1; OPRL1; TRPV2; PNOC;	GO:0007600~sensory perception	5	11	45.4545454545455	0.0220489545672093	0.376685618026469	1	1	0.999999976169535	0.999999976169535	1
up	PIK3CD; GPR183; PIK3CG; CXCR3; CCL26;	GO:0010818~T cell chemotaxis	5	11	45.4545454545455	0.0220489545672093	0.376685618026469	1	1	0.999999976169535	0.999999976169535	1
up	TLR4; IFNG; TNFSF4; IL12A; NCKAP1L;	GO:0032700~negative regulation of interleukin-17 production	5	11	45.4545454545455	0.0220489545672093	0.376685618026469	1	1	0.999999976169535	0.999999976169535	1
up	IFITM1; IFNAR2; IFITM2; BST2; XAF1;	GO:0035456~response to interferon-beta	5	11	45.4545454545455	0.0220489545672093	0.376685618026469	1	1	0.999999976169535	0.999999976169535	1
up	HLA-G; BCL6; IL2; LILRB2; LILRB4;	GO:0045591~positive regulation of regulatory T cell differentiation	5	11	45.4545454545455	0.0220489545672093	0.376685618026469	1	1	0.999999976169535	0.999999976169535	1
up	ITGB3; INHBA; ITGB4; ITGA2; HMGA2;	GO:0048333~mesodermal cell differentiation	5	11	45.4545454545455	0.0220489545672093	0.376685618026469	1	1	0.999999976169535	0.999999976169535	1
up	LYN; ELF1; BLK; PAX5; PTPN22;	GO:0050855~regulation of B cell receptor signaling pathway	5	11	45.4545454545455	0.0220489545672093	0.376685618026469	1	1	0.999999976169535	0.999999976169535	1
up	SLC12A1; SLC12A3; SLC12A9; SLC12A4; SLC12A7;	GO:0055064~chloride ion homeostasis	5	11	45.4545454545455	0.0220489545672093	0.376685618026469	1	1	0.999999976169535	0.999999976169535	1
up	JAK2; JAK1; TYK2; STAT3; IL27RA;	GO:0070106~interleukin-27-mediated signaling pathway	5	11	45.4545454545455	0.0220489545672093	0.376685618026469	1	1	0.999999976169535	0.999999976169535	1
up	JAK2; JAK1; IL12A; STAT3; IL27RA;	GO:0070757~interleukin-35-mediated signaling pathway	5	11	45.4545454545455	0.0220489545672093	0.376685618026469	1	1	0.999999976169535	0.999999976169535	1
up	PIK3CG; BID; BCL2L1; STK4; DNMT3A;	GO:0097284~hepatocyte apoptotic process	5	11	45.4545454545455	0.0220489545672093	0.376685618026469	1	1	0.999999976169535	0.999999976169535	1
up	PARP14; PARP10; PARP8; PARP12; PARP4;	GO:0140289~protein mono-ADP-ribosylation	5	11	45.4545454545455	0.0220489545672093	0.376685618026469	1	1	0.999999976169535	0.999999976169535	1
up	IL27RA; BANK1; SYT11; C5AR2; PTPN22;	GO:1900165~negative regulation of interleukin-6 secretion	5	11	45.4545454545455	0.0220489545672093	0.376685618026469	1	1	0.999999976169535	0.999999976169535	1
down	CDC20; AURKB; TTK;	GO:0007094~mitotic spindle assembly checkpoint	3	24	12.5	0.0221880257771457	0.108544660515726	1	1	0.958074519575638	0.999480344286979	0.952258307580853
down	RFC2; POLD2; POLE3;	GO:0032201~telomere maintenance via semi-conservative replication	3	24	12.5	0.0221880257771457	0.108544660515726	1	1	0.958074519575638	0.999480344286979	0.952258307580853
down	AP2S1; CES3; PCSK9;	GO:0034383~low-density lipoprotein particle clearance	3	24	12.5	0.0221880257771457	0.108544660515726	1	1	0.958074519575638	0.999480344286979	0.952258307580853
down	KEL; CAV2; XK;	GO:0048741~skeletal muscle fiber development	3	24	12.5	0.0221880257771457	0.108544660515726	1	1	0.958074519575638	0.999480344286979	0.952258307580853
down	CCNB1; NME1; NME2;	GO:0071398~cellular response to fatty acid	3	24	12.5	0.0221880257771457	0.108544660515726	1	1	0.958074519575638	0.999480344286979	0.952258307580853
down	SLC2A1; SLC5A1; SLC2A8;	GO:1904659~glucose transmembrane transport	3	24	12.5	0.0221880257771457	0.108544660515726	1	1	0.958074519575638	0.999480344286979	0.952258307580853
down	EGFR; NME2; FGFR3; TTK; EPHB3; TYRO3; DDR1; MYO3A; AURKB;	GO:0046777~protein autophosphorylation	9	173	5.20231213872832	0.0225997880860387	0.109937271046562	1	1	0.960307793514043	0.999480344286979	0.964475628459761
down	WNT9B; HSPB1; CDH5; CADM4;	GO:0001932~regulation of protein phosphorylation	4	44	9.09090909090909	0.0226243321933063	0.109937271046562	1	1	0.960307793514043	0.999480344286979	0.964475628459761
down	CCNB2; PAX1; PRDX2; EPHB3;	GO:0048538~thymus development	4	44	9.09090909090909	0.0226243321933063	0.109937271046562	1	1	0.960307793514043	0.999480344286979	0.964475628459761
down	HOXB1; EYA1; HOXD9; HOXA4;	GO:0048704~embryonic skeletal system morphogenesis	4	44	9.09090909090909	0.0226243321933063	0.109937271046562	1	1	0.960307793514043	0.999480344286979	0.964475628459761
down	IL33; KRT18; KRT8; BAD;	GO:0097191~extrinsic apoptotic signaling pathway	4	44	9.09090909090909	0.0226243321933063	0.109937271046562	1	1	0.960307793514043	0.999480344286979	0.964475628459761
up	FOXO3; BRD1; ISG15; INHBA; STAT3; STAT5B; NCKAP1L; INPP5D; FAM210B;	GO:0045648~positive regulation of erythrocyte differentiation	9	31	29.0322580645161	0.0228114170458876	0.38461019887733	1	1	0.999999976169535	0.999999976169535	1
up	LGALS9; WWP2; PIK3CD; TERT; INPPL1; SLIT3; DYSF; TNF; IFNG; APP; CD3E; ITGB8; CCR1; DGKQ; AIF1; TMF1; MEF2C; REST; FLOT2; PARP14; PARP10; PARP9; SMCR8; FBXW7; TP53INP1; MYADM; NKX3-1; ADNP; GGNBP2; AGO4; TNRC6B; ZNF148; PTPN22; ZNF281; LGALS9C; LGALS9B;	GO:0010629~negative regulation of gene expression	36	204	17.6470588235294	0.0230384625323087	0.38461019887733	1	1	0.999999976169535	0.999999976169535	1
up	PLEK; RAP1B; SKAP1; PIEZO1;	GO:0033625~positive regulation of integrin activation	4	7	57.1428571428571	0.0231001035633822	0.38461019887733	1	1	0.999999976169535	0.999999976169535	1
up	TLR4; CD14; SARM1; LY96;	GO:0034128~negative regulation of MyD88-independent toll-like receptor signaling pathway	4	7	57.1428571428571	0.0231001035633822	0.38461019887733	1	1	0.999999976169535	0.999999976169535	1
up	IFNG; IL12A; ARRB1; RBM10;	GO:0034393~positive regulation of smooth muscle cell apoptotic process	4	7	57.1428571428571	0.0231001035633822	0.38461019887733	1	1	0.999999976169535	0.999999976169535	1
up	RARA; TNFSF4; CD86; NLRP3;	GO:0045630~positive regulation of T-helper 2 cell differentiation	4	7	57.1428571428571	0.0231001035633822	0.38461019887733	1	1	0.999999976169535	0.999999976169535	1
up	HP; SLC4A1; GZMA; GZMK;	GO:0051354~negative regulation of oxidoreductase activity	4	7	57.1428571428571	0.0231001035633822	0.38461019887733	1	1	0.999999976169535	0.999999976169535	1
up	ADA; RAG1; JAK3; PTCRA;	GO:0070244~negative regulation of thymocyte apoptotic process	4	7	57.1428571428571	0.0231001035633822	0.38461019887733	1	1	0.999999976169535	0.999999976169535	1
up	LGALS9; IL12A; CCR7; CCR6;	GO:2000510~positive regulation of dendritic cell chemotaxis	4	7	57.1428571428571	0.0231001035633822	0.38461019887733	1	1	0.999999976169535	0.999999976169535	1
down	CTSV; GJA1; GYS2; BAD; TXN2;	GO:0009749~response to glucose	5	67	7.46268656716418	0.0231214231237346	0.112202354516115	1	1	0.962658608186048	0.999480344286979	0.984347122285412
up	RASA4B; RASA4; FBP1; TIMP2; RAPGEF1; RASA3; DAB2IP; RASAL3;	GO:0046580~negative regulation of Ras protein signal transduction	8	26	30.7692307692308	0.0240708528267383	0.395191104626171	1	1	0.999999976169535	0.999999976169535	1
up	ARHGAP6; S1PR1; WAS; CGNL1; ARHGEF18; FRMD7; INPP5K; WASF2;	GO:0051497~negative regulation of stress fiber assembly	8	26	30.7692307692308	0.0240708528267383	0.395191104626171	1	1	0.999999976169535	0.999999976169535	1
up	DYSF; CD74; RAC2; C5AR1; CXCR2; CCR7; NCKAP1L; C3AR1;	GO:0090023~positive regulation of neutrophil chemotaxis	8	26	30.7692307692308	0.0240708528267383	0.395191104626171	1	1	0.999999976169535	0.999999976169535	1
down	SFN; BAD; BCL2L2; BOK;	GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage	4	45	8.88888888888889	0.0242094125591745	0.113603385205025	1	1	0.967752039975392	0.999480344286979	0.996638312900886
down	RHOD; BAIAP2; PLS3; ESPN;	GO:0051017~actin filament bundle assembly	4	45	8.88888888888889	0.0242094125591745	0.113603385205025	1	1	0.967752039975392	0.999480344286979	0.996638312900886
up	PPEF1; PPEF2; PPP1R12A; CDC14B; LCK; PTPRC; PTPN4; PTPN6; PPM1A; PTEN; DUSP2; CAMK2G; PTPRK; DUSP5; PTPRO; PPP1R3B; PPM1N; PTPRU; PTPRN2; PTPN18; CPPED1; PTPN22; PPP2R5B; PTPRJ; PTPN7; DUSP6;	GO:0006470~protein dephosphorylation	26	137	18.978102189781	0.0243810727910765	0.397167496888133	1	1	0.999999976169535	0.999999976169535	1
up	CYBB; CYBA; NCF1; NCF2; NOX5; DUOX2;	GO:0042554~superoxide anion generation	6	16	37.5	0.0244093981704541	0.397167496888133	1	1	0.999999976169535	0.999999976169535	1
up	BCR; LYL1; HOXA9; ZFP36L2; ADAR; HIPK1;	GO:0060216~definitive hemopoiesis	6	16	37.5	0.0244093981704541	0.397167496888133	1	1	0.999999976169535	0.999999976169535	1
down	AGPAT2; ADRA2A; IL33;	GO:0001819~positive regulation of cytokine production	3	25	12	0.024444314609633	0.113603385205025	1	1	0.967752039975392	0.999480344286979	0.996638312900886
down	SDC1; GPC1; HYAL2;	GO:0006027~glycosaminoglycan catabolic process	3	25	12	0.024444314609633	0.113603385205025	1	1	0.967752039975392	0.999480344286979	0.996638312900886
down	OAT; GOT1; ASPG;	GO:0008652~cellular amino acid biosynthetic process	3	25	12	0.024444314609633	0.113603385205025	1	1	0.967752039975392	0.999480344286979	0.996638312900886
down	CDK1; CCNB1; HEY2;	GO:0060045~positive regulation of cardiac muscle cell proliferation	3	25	12	0.024444314609633	0.113603385205025	1	1	0.967752039975392	0.999480344286979	0.996638312900886
down	TSPO; MT1X; MT1M;	GO:0071294~cellular response to zinc ion	3	25	12	0.024444314609633	0.113603385205025	1	1	0.967752039975392	0.999480344286979	0.996638312900886
down	IMPDH2; TUBA1B; KEAP1;	GO:0071353~cellular response to interleukin-4	3	25	12	0.024444314609633	0.113603385205025	1	1	0.967752039975392	0.999480344286979	0.996638312900886
up	TYROBP; ITGB3; RARA; ALOX15; CD36; MERTK; MARCO;	GO:0043277~apoptotic cell clearance	7	21	33.3333333333333	0.0247743867160443	0.398962391541981	1	1	0.999999976169535	0.999999976169535	1
up	TNF; IL10; CDH8; IL10RA; PTPRO; TUBA1A; SLITRK4;	GO:0050807~regulation of synapse organization	7	21	33.3333333333333	0.0247743867160443	0.398962391541981	1	1	0.999999976169535	0.999999976169535	1
up	TRIM38; TNFSF11; JAK2; TNF; WNT1; APP; CSF3; HCLS1; TRIM21; IL10; PTEN; FZD2; PPP2R5B; TRIM22; ABRA; NFAM1; NKX3-1; TRIM62; PRKD2; TRIM8; RGCC; BEX1;	GO:0051091~positive regulation of DNA-binding transcription factor activity	22	111	19.8198198198198	0.0250472848389807	0.402258029539379	1	1	0.999999976169535	0.999999976169535	1
down	KRT18; KRT8; PSMB6; PSMD8; TXNDC17; PLVAP; TNFRSF19;	GO:0033209~tumor necrosis factor-mediated signaling pathway	7	120	5.83333333333333	0.0250500952412364	0.116269648206763	1	1	0.970517045803893	0.999480344286979	1
down	GSTP1; GOT1; SRD5A1; RAB13; CYFIP1; PCSK9;	GO:0032869~cellular response to insulin stimulus	6	94	6.38297872340426	0.0255876057877581	0.11861262273737	1	1	0.972329019934808	0.999480344286979	1
down	FOXP2; SLC2A1; SRD5A1; BAD; GNG12;	GO:0021987~cerebral cortex development	5	69	7.2463768115942	0.0256753870726052	0.118715915992594	1	1	0.973444699034071	0.999480344286979	1
down	NUPR1; ID1; KEAP1; GAS6; CTNNBIP1;	GO:0043433~negative regulation of DNA-binding transcription factor activity	5	69	7.2463768115942	0.0256753870726052	0.118715915992594	1	1	0.973444699034071	0.999480344286979	1
down	CDK1; COMT; LUM; TXN2;	GO:0014070~response to organic cyclic compound	4	46	8.69565217391304	0.0258599904407164	0.118811743152848	1	1	0.973444699034071	0.999480344286979	1
down	MAP2; BMP7; BAIAP2; EGFLAM;	GO:0016358~dendrite development	4	46	8.69565217391304	0.0258599904407164	0.118811743152848	1	1	0.973444699034071	0.999480344286979	1
down	ADRA2A; IGFBP2; RAMP2; RAMP3;	GO:0032870~cellular response to hormone stimulus	4	46	8.69565217391304	0.0258599904407164	0.118811743152848	1	1	0.973444699034071	0.999480344286979	1
down	DEFB4A; MIF; NTF3; GPNMB;	GO:0050918~positive chemotaxis	4	46	8.69565217391304	0.0258599904407164	0.118811743152848	1	1	0.973444699034071	0.999480344286979	1
down	PLS3; GJA1; SRD5A1; STC1;	GO:0060348~bone development	4	46	8.69565217391304	0.0258599904407164	0.118811743152848	1	1	0.973444699034071	0.999480344286979	1
up	GZMA; CTSS; CASP8; ADAMTS7; CPVL; CTSW; RNF123; CTSA; CTSO;	GO:0051603~proteolysis involved in cellular protein catabolic process	9	32	28.125	0.0265405546044142	0.420510830210799	1	1	0.999999976169535	0.999999976169535	1
down	CDK1; TUBB; TUBG1; CETN2; DYNLL1; TUBB4B;	GO:0097711~ciliary basal body-plasma membrane docking	6	95	6.31578947368421	0.0267048038398909	0.122537865721019	1	1	0.97565913733789	0.999480344286979	1
down	EGFR; ANG; MIF;	GO:0042327~positive regulation of phosphorylation	3	26	11.5384615384615	0.0268196343202375	0.122599211110796	1	1	0.97565913733789	0.999480344286979	1
down	EFNA3; EYA1; NTF3;	GO:0045664~regulation of neuron differentiation	3	26	11.5384615384615	0.0268196343202375	0.122599211110796	1	1	0.97565913733789	0.999480344286979	1
down	FOLR1; KREMEN1; SOX7;	GO:0060828~regulation of canonical Wnt signaling pathway	3	26	11.5384615384615	0.0268196343202375	0.122599211110796	1	1	0.97565913733789	0.999480344286979	1
down	CCND1; ID4; CEBPA; TFAP2B; ALOXE3;	GO:0045444~fat cell differentiation	5	70	7.14285714285714	0.027017281405004	0.12330009303897	1	1	0.97565913733789	0.999480344286979	1
down	GJA1; ADCYAP1; BDKRB1; NMU; BCAP31; FFAR4; TRPM4; LPAR3;	GO:0007204~positive regulation of cytosolic calcium ion concentration	8	150	5.33333333333333	0.0270409859216499	0.12330009303897	1	1	0.97565913733789	0.999480344286979	1
down	NPR3; ID1; LGR4; NOVA2;	GO:0120163~negative regulation of cold-induced thermogenesis	4	47	8.51063829787234	0.0275765326731681	0.125584084095772	1	1	0.976412542077147	0.999480344286979	1
down	CLDN10; PLP2; SLC26A9; SLC25A10; STEAP1; PLLP;	GO:0006811~ion transport	6	96	6.25	0.0278538375699771	0.126529024049081	1	1	0.976412542077147	0.999480344286979	1
down	TOM1L1; ADRA2A; EMP2; GPRC5C; PAK5; PAK6;	GO:0032147~activation of protein kinase activity	6	96	6.25	0.0278538375699771	0.126529024049081	1	1	0.976412542077147	0.999480344286979	1
up	PIK3CD; CD4; DBH; PTAFR; TXK; PIK3CG; NFATC1; NFATC3;	GO:0001816~cytokine production	8	27	29.6296296296296	0.0283689678007918	0.431564289175597	1	1	0.999999976169535	0.999999976169535	1
up	ARHGAP6; BCR; ACTN1; ITGA2; ACTN2; PTK2B; PTPRK; SORBS1;	GO:0048041~focal adhesion assembly	8	27	29.6296296296296	0.0283689678007918	0.431564289175597	1	1	0.999999976169535	0.999999976169535	1
up	LILRA5; CCL4; CCL5; ARRB2; CCR1; LILRA2; ORAI1; P2RX4;	GO:0051928~positive regulation of calcium ion transport	8	27	29.6296296296296	0.0283689678007918	0.431564289175597	1	1	0.999999976169535	0.999999976169535	1
down	CTDSPL; CCNB1; FBLN1; BDKRB1; CADM4;	GO:0001933~negative regulation of protein phosphorylation	5	71	7.04225352112676	0.028402986164751	0.127192342685086	1	1	0.977210264742243	0.999480344286979	1
up	CDA; APOBEC3H; APOBEC3F; APOBEC3G; APOBEC3C;	GO:0009972~cytidine deamination	5	12	41.6666666666667	0.0285526376488989	0.431564289175597	1	1	0.999999976169535	0.999999976169535	1
up	CD4; TRPC3; P2RX5; P2RX4; P2RX7;	GO:0010524~positive regulation of calcium ion transport into cytosol	5	12	41.6666666666667	0.0285526376488989	0.431564289175597	1	1	0.999999976169535	0.999999976169535	1
up	BRINP1; OXT; DBH; PTEN; CREBRF;	GO:0042711~maternal behavior	5	12	41.6666666666667	0.0285526376488989	0.431564289175597	1	1	0.999999976169535	0.999999976169535	1
up	PRKCB; CD36; UNC119; MIA3; ZDHHC17;	GO:0042953~lipoprotein transport	5	12	41.6666666666667	0.0285526376488989	0.431564289175597	1	1	0.999999976169535	0.999999976169535	1
up	CCL4; CCL5; HMGA2; REST; INPP5K;	GO:0043922~negative regulation by host of viral transcription	5	12	41.6666666666667	0.0285526376488989	0.431564289175597	1	1	0.999999976169535	0.999999976169535	1
up	SOCS2; JAK2; PIK3R1; STAT3; PXN;	GO:0060396~growth hormone receptor signaling pathway	5	12	41.6666666666667	0.0285526376488989	0.431564289175597	1	1	0.999999976169535	0.999999976169535	1
down	NME1; NME2; RRM2;	GO:0015949~nucleobase-containing small molecule interconversion	3	27	11.1111111111111	0.0293136480547919	0.129115399998324	1	1	0.978056334235526	0.999480344286979	1
down	ADCYAP1; ADCY2; ADGRG6;	GO:0019933~cAMP-mediated signaling	3	27	11.1111111111111	0.0293136480547919	0.129115399998324	1	1	0.978056334235526	0.999480344286979	1
down	RAMP2; ANXA1; HSPB1;	GO:0035924~cellular response to vascular endothelial growth factor stimulus	3	27	11.1111111111111	0.0293136480547919	0.129115399998324	1	1	0.978056334235526	0.999480344286979	1
down	AP2S1; AP1S1; AP1M2;	GO:0050690~regulation of defense response to virus by virus	3	27	11.1111111111111	0.0293136480547919	0.129115399998324	1	1	0.978056334235526	0.999480344286979	1
down	TSPO; ROMO1; ACE2;	GO:2000379~positive regulation of reactive oxygen species metabolic process	3	27	11.1111111111111	0.0293136480547919	0.129115399998324	1	1	0.978056334235526	0.999480344286979	1
down	EFNA1; ITGA8; EPHB3; TYRO3;	GO:0034446~substrate adhesion-dependent cell spreading	4	48	8.33333333333333	0.0293594433931472	0.129160172694367	1	1	0.978056334235526	0.999480344286979	1
up	PIK3CD; NCR3; ITGB2; CD2; IL2; CASP8; SLAMF7;	GO:0030101~natural killer cell activation	7	22	31.8181818181818	0.0297338071650446	0.431564289175597	1	1	0.999999976169535	0.999999976169535	1
up	ITGB3; ITGA2; ITGB6; ITGB8; ITGB2; ITGB7; ITGB4;	GO:0033627~cell adhesion mediated by integrin	7	22	31.8181818181818	0.0297338071650446	0.431564289175597	1	1	0.999999976169535	0.999999976169535	1
down	DVL1; HSPB1; GSTP1; FABP4; SFN;	GO:0006469~negative regulation of protein kinase activity	5	72	6.94444444444444	0.0298328711941835	0.130925130846144	1	1	0.978955283072139	0.999480344286979	1
down	RAB38; RAB25; RAB3D; IFT22; RAB13;	GO:0032482~Rab protein signal transduction	5	72	6.94444444444444	0.0298328711941835	0.130925130846144	1	1	0.978955283072139	0.999480344286979	1
up	TPP1; ADAMTS13; NAALADL1; CPQ; ERAP1; ANPEP;	GO:0043171~peptide catabolic process	6	17	35.2941176470588	0.030121024260533	0.431564289175597	1	1	0.999999976169535	0.999999976169535	1
up	TNF; IFNG; APP; C5AR1; FPR2; ADORA2A;	GO:0048143~astrocyte activation	6	17	35.2941176470588	0.030121024260533	0.431564289175597	1	1	0.999999976169535	0.999999976169535	1
up	TOX; LTA; CXCR5; LTB; PDPN; RC3H2;	GO:0048535~lymph node development	6	17	35.2941176470588	0.030121024260533	0.431564289175597	1	1	0.999999976169535	0.999999976169535	1
up	MEFV; F2; ABCD1; ADCY7; NLRP7; ABCD2;	GO:1900016~negative regulation of cytokine production involved in inflammatory response	6	17	35.2941176470588	0.030121024260533	0.431564289175597	1	1	0.999999976169535	0.999999976169535	1
up	EGF; PTEN; PTK2B; PYHIN1; FBXW7; CDK5RAP3;	GO:2000060~positive regulation of ubiquitin-dependent protein catabolic process	6	17	35.2941176470588	0.030121024260533	0.431564289175597	1	1	0.999999976169535	0.999999976169535	1
down	CCL21; S100B; GJA1; WLS; JMJD8; S100A13; CCL19; TNFRSF19; IL36G;	GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling	9	183	4.91803278688525	0.0304610350561489	0.133520256443216	1	1	0.978955283072139	0.999480344286979	1
up	ITGAL; FGL2; APBB1IP;	GO:0002291~T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell	3	4	75	0.0305674694631981	0.431564289175597	1	1	0.999999976169535	0.999999976169535	1
up	HLA-G; TGFBR2; LILRB2;	GO:0002666~positive regulation of T cell tolerance induction	3	4	75	0.0305674694631981	0.431564289175597	1	1	0.999999976169535	0.999999976169535	1
up	TLR4; PLEK; SELP;	GO:0010572~positive regulation of platelet activation	3	4	75	0.0305674694631981	0.431564289175597	1	1	0.999999976169535	0.999999976169535	1
up	TLR2; APP; NRROS;	GO:0014005~microglia development	3	4	75	0.0305674694631981	0.431564289175597	1	1	0.999999976169535	0.999999976169535	1
up	PADI1; PADI4; PADI2;	GO:0018101~protein citrullination	3	4	75	0.0305674694631981	0.431564289175597	1	1	0.999999976169535	0.999999976169535	1
up	TLR2; TENM4; ABCA2;	GO:0032289~central nervous system myelin formation	3	4	75	0.0305674694631981	0.431564289175597	1	1	0.999999976169535	0.999999976169535	1
up	TLR4; SCARB1; LY96;	GO:0032497~detection of lipopolysaccharide	3	4	75	0.0305674694631981	0.431564289175597	1	1	0.999999976169535	0.999999976169535	1
up	CD247; FCER1G; SLC11A1;	GO:0032623~interleukin-2 production	3	4	75	0.0305674694631981	0.431564289175597	1	1	0.999999976169535	0.999999976169535	1
up	FCER1G; CSF2RB; SYK;	GO:0038156~interleukin-3-mediated signaling pathway	3	4	75	0.0305674694631981	0.431564289175597	1	1	0.999999976169535	0.999999976169535	1
up	IFI30; CLEC4A; FCER1G;	GO:0042590~antigen processing and presentation of exogenous peptide antigen via MHC class I	3	4	75	0.0305674694631981	0.431564289175597	1	1	0.999999976169535	0.999999976169535	1
up	SYK; IRF4; CLEC7A;	GO:0045082~positive regulation of interleukin-10 biosynthetic process	3	4	75	0.0305674694631981	0.431564289175597	1	1	0.999999976169535	0.999999976169535	1
up	LILRA5; JAK2; LILRA2;	GO:0050867~positive regulation of cell activation	3	4	75	0.0305674694631981	0.431564289175597	1	1	0.999999976169535	0.999999976169535	1
up	AP3D1; TGFBR2; ZBTB16;	GO:0051138~positive regulation of NK T cell differentiation	3	4	75	0.0305674694631981	0.431564289175597	1	1	0.999999976169535	0.999999976169535	1
up	TNF; SERPINE1; ALOX5;	GO:0061044~negative regulation of vascular wound healing	3	4	75	0.0305674694631981	0.431564289175597	1	1	0.999999976169535	0.999999976169535	1
up	TLR2; TLR1; TLR6;	GO:0071221~cellular response to bacterial lipopeptide	3	4	75	0.0305674694631981	0.431564289175597	1	1	0.999999976169535	0.999999976169535	1
up	GATA3; CCR6; TBX21;	GO:0072676~lymphocyte migration	3	4	75	0.0305674694631981	0.431564289175597	1	1	0.999999976169535	0.999999976169535	1
up	EPHB1; AKIRIN1; SIX4;	GO:1902725~negative regulation of satellite cell differentiation	3	4	75	0.0305674694631981	0.431564289175597	1	1	0.999999976169535	0.999999976169535	1
up	LATS1; PTK2B; NUB1;	GO:2000058~regulation of ubiquitin-dependent protein catabolic process	3	4	75	0.0305674694631981	0.431564289175597	1	1	0.999999976169535	0.999999976169535	1
up	TNFRSF10B; TNF; PIK3R1; DAPK1; BID; DAB2IP; DEDD2; MOAP1; CASP8;	GO:0008625~extrinsic apoptotic signaling pathway via death domain receptors	9	33	27.2727272727273	0.0306795224357475	0.431564289175597	1	1	0.999999976169535	0.999999976169535	1
up	NCK2; ABLIM3; VCL; S1PR1; ARHGEF6; PTPRO; PARVB; WASF2; DMTN;	GO:0030032~lamellipodium assembly	9	33	27.2727272727273	0.0306795224357475	0.431564289175597	1	1	0.999999976169535	0.999999976169535	1
down	COX8A; FDXR; CEBPA; GYS2;	GO:0006091~generation of precursor metabolites and energy	4	49	8.16326530612245	0.0312090648868306	0.133733242646166	1	1	0.979912228607889	0.999480344286979	1
down	DVL1; KLK8; C1QA; WNT7B;	GO:0050808~synapse organization	4	49	8.16326530612245	0.0312090648868306	0.133733242646166	1	1	0.979912228607889	0.999480344286979	1
down	ANG; BMP2; CAV2; CCL11; NRARP;	GO:0001938~positive regulation of endothelial cell proliferation	5	73	6.84931506849315	0.0313072807538126	0.133733242646166	1	1	0.979912228607889	0.999480344286979	1
up	SPOP; MGRN1; SASH1; UBB; TRIM21; PSMB8; PSMB9; PSMB10; CDC34; UBE2D1; UBA52; PSME1; RNF213; HUWE1; RNF180; DZIP3; FBXL13; TRIM58; PSMA8; DTX3L; FBXO41; PSMF1; FBXW7; NEDD4L; RBCK1; UNKL; RC3H2; RLIM; FBXO40; MKRN1; HERC5; FBXO2; FBXO9; FBXL5; FBXO7; PELI1; WWP2; ANKIB1; RNF166; PELI3; HECW1;	GO:0000209~protein polyubiquitination	41	245	16.734693877551	0.031642490174801	0.431564289175597	1	1	0.999999976169535	0.999999976169535	1
up	ADCY5; ADORA3; ADORA2A; GNAI2;	GO:0001973~G protein-coupled adenosine receptor signaling pathway	4	8	50	0.0317778930271817	0.431564289175597	1	1	0.999999976169535	0.999999976169535	1
up	MS4A1; ORAI1; ORAI3; ORAI2;	GO:0002115~store-operated calcium entry	4	8	50	0.0317778930271817	0.431564289175597	1	1	0.999999976169535	0.999999976169535	1
up	CXCR2; CD6; OPRM1; IL31RA;	GO:0002438~acute inflammatory response to antigenic stimulus	4	8	50	0.0317778930271817	0.431564289175597	1	1	0.999999976169535	0.999999976169535	1
up	CD160; HLA-E; HLA-G; HLA-F;	GO:0002729~positive regulation of natural killer cell cytokine production	4	8	50	0.0317778930271817	0.431564289175597	1	1	0.999999976169535	0.999999976169535	1
up	NCK2; CD3E; PXN; PTK2B;	GO:0007172~signal complex assembly	4	8	50	0.0317778930271817	0.431564289175597	1	1	0.999999976169535	0.999999976169535	1
up	FOLR3; SLC19A1; PDPN; SLC25A32;	GO:0015884~folic acid transport	4	8	50	0.0317778930271817	0.431564289175597	1	1	0.999999976169535	0.999999976169535	1
up	UBA7; ISG15; UBA52; UBB;	GO:0019941~modification-dependent protein catabolic process	4	8	50	0.0317778930271817	0.431564289175597	1	1	0.999999976169535	0.999999976169535	1
up	RARA; HLA-E; TNFSF4; NLRP3;	GO:0032736~positive regulation of interleukin-13 production	4	8	50	0.0317778930271817	0.431564289175597	1	1	0.999999976169535	0.999999976169535	1
up	P2RX1; P2RX5; P2RX4; P2RX7;	GO:0035590~purinergic nucleotide receptor signaling pathway	4	8	50	0.0317778930271817	0.431564289175597	1	1	0.999999976169535	0.999999976169535	1
up	JAK1; STAT3; JAK3; IL21;	GO:0038114~interleukin-21-mediated signaling pathway	4	8	50	0.0317778930271817	0.431564289175597	1	1	0.999999976169535	0.999999976169535	1
up	PPM1F; ADAR; ADARB1; CDK5RAP3;	GO:0044387~negative regulation of protein kinase activity by regulation of protein phosphorylation	4	8	50	0.0317778930271817	0.431564289175597	1	1	0.999999976169535	0.999999976169535	1
up	JAK2; EGF; PTPRC; JAK3;	GO:0046425~regulation of receptor signaling pathway via JAK-STAT	4	8	50	0.0317778930271817	0.431564289175597	1	1	0.999999976169535	0.999999976169535	1
up	PRKCB; PRKCH; NFAM1; CMTM3;	GO:0050861~positive regulation of B cell receptor signaling pathway	4	8	50	0.0317778930271817	0.431564289175597	1	1	0.999999976169535	0.999999976169535	1
up	PTH; PTAFR; SNCA; CD244;	GO:0060732~positive regulation of inositol phosphate biosynthetic process	4	8	50	0.0317778930271817	0.431564289175597	1	1	0.999999976169535	0.999999976169535	1
up	CCL5; CD27; PRKCQ; DOCK8;	GO:0070233~negative regulation of T cell apoptotic process	4	8	50	0.0317778930271817	0.431564289175597	1	1	0.999999976169535	0.999999976169535	1
up	AQP7; AQP9; SLC14A1; AQP10;	GO:0071918~urea transmembrane transport	4	8	50	0.0317778930271817	0.431564289175597	1	1	0.999999976169535	0.999999976169535	1
up	ACTN2; PTEN; NEDD4L; STK39;	GO:1901017~negative regulation of potassium ion transmembrane transporter activity	4	8	50	0.0317778930271817	0.431564289175597	1	1	0.999999976169535	0.999999976169535	1
up	PPP1R12A; TNF; VCL; ROCK1;	GO:1903140~regulation of establishment of endothelial barrier	4	8	50	0.0317778930271817	0.431564289175597	1	1	0.999999976169535	0.999999976169535	1
up	ITGA4; SELP; PTAFR; CCR2;	GO:1903238~positive regulation of leukocyte tethering or rolling	4	8	50	0.0317778930271817	0.431564289175597	1	1	0.999999976169535	0.999999976169535	1
down	ELN; EFNA1; HEY2;	GO:0003180~aortic valve morphogenesis	3	28	10.7142857142857	0.0319258361016924	0.133733242646166	1	1	0.980932970512689	0.999480344286979	1
down	ADRA2A; ADRA2B; ADRA2C;	GO:0007610~behavior	3	28	10.7142857142857	0.0319258361016924	0.133733242646166	1	1	0.980932970512689	0.999480344286979	1
down	RARG; PITX1; TP63;	GO:0035116~embryonic hindlimb morphogenesis	3	28	10.7142857142857	0.0319258361016924	0.133733242646166	1	1	0.980932970512689	0.999480344286979	1
down	TK1; POLD2; POLE3;	GO:0071897~DNA biosynthetic process	3	28	10.7142857142857	0.0319258361016924	0.133733242646166	1	1	0.980932970512689	0.999480344286979	1
down	RAB38; ATP6V1F; SLAMF8;	GO:0090383~phagosome acidification	3	28	10.7142857142857	0.0319258361016924	0.133733242646166	1	1	0.980932970512689	0.999480344286979	1
up	TLR4; TLR2; TNF; SERPINE1; AFAP1L2; MYD88; PRKD2; TLR7;	GO:0032757~positive regulation of interleukin-8 production	8	28	28.5714285714286	0.0331685031174805	0.447357339529589	1	1	0.999999976169535	0.999999976169535	1
down	RFC2; DQX1; DSCC1; RUVBL2; ANXA1;	GO:0032508~DNA duplex unwinding	5	75	6.66666666666667	0.034390922156132	0.133733242646166	1	1	0.98319318473046	0.999480344286979	1
down	CD1B; CD1E; CD1A;	GO:0001916~positive regulation of T cell mediated cytotoxicity	3	29	10.3448275862069	0.0346555073575754	0.133733242646166	1	1	0.98319318473046	0.999480344286979	1
down	ANG; GSN; DIAPH3;	GO:0030041~actin filament polymerization	3	29	10.3448275862069	0.0346555073575754	0.133733242646166	1	1	0.98319318473046	0.999480344286979	1
down	GOT1; ITGA8; NPNT;	GO:0030511~positive regulation of transforming growth factor beta receptor signaling pathway	3	29	10.3448275862069	0.0346555073575754	0.133733242646166	1	1	0.98319318473046	0.999480344286979	1
down	RAB13; LLGL2; NCKAP1;	GO:0030866~cortical actin cytoskeleton organization	3	29	10.3448275862069	0.0346555073575754	0.133733242646166	1	1	0.98319318473046	0.999480344286979	1
down	UQCRQ; CMA1; WLS;	GO:0030901~midbrain development	3	29	10.3448275862069	0.0346555073575754	0.133733242646166	1	1	0.98319318473046	0.999480344286979	1
down	NUPR1; TP63; PHLDA3;	GO:0042771~intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator	3	29	10.3448275862069	0.0346555073575754	0.133733242646166	1	1	0.98319318473046	0.999480344286979	1
down	PTPRZ1; CDKN2C; BOK;	GO:0048709~oligodendrocyte differentiation	3	29	10.3448275862069	0.0346555073575754	0.133733242646166	1	1	0.98319318473046	0.999480344286979	1
down	PRMT5; EGFR; GSTP1;	GO:0070372~regulation of ERK1 and ERK2 cascade	3	29	10.3448275862069	0.0346555073575754	0.133733242646166	1	1	0.98319318473046	0.999480344286979	1
up	IRGM; LGALS9; RIOK3; IFI6; IL12A; ADAR; VWCE;	GO:0098586~cellular response to virus	7	23	30.4347826086957	0.0353199194410416	0.474204112039862	1	1	0.999999976169535	0.999999976169535	1
down	ADRA2A; ADRA2B; ADRA2C; CD9; TYRO3; F2RL3;	GO:0030168~platelet activation	6	102	5.88235294117647	0.0354327108902295	0.133733242646166	1	1	0.984448859295889	0.999480344286979	1
down	EGFR; CLEC3B; BMP7; STC1; KAZALD1;	GO:0001503~ossification	5	76	6.57894736842105	0.0360007140628867	0.133733242646166	1	1	0.984448859295889	0.999480344286979	1
up	A1CF; APOBEC3G; APOBEC3F; APOBEC3C; APOBEC3H;	GO:0016554~cytidine to uridine editing	5	13	38.4615384615385	0.0361500964013414	0.477732439886785	1	1	0.999999976169535	0.999999976169535	1
up	PLOD3; TNXB; TNS2; P2RX7; P3H3;	GO:0032963~collagen metabolic process	5	13	38.4615384615385	0.0361500964013414	0.477732439886785	1	1	0.999999976169535	0.999999976169535	1
up	LPXN; PLAU; LYN; EPHA2; PIK3CG;	GO:0033628~regulation of cell adhesion mediated by integrin	5	13	38.4615384615385	0.0361500964013414	0.477732439886785	1	1	0.999999976169535	0.999999976169535	1
up	CRTAM; CD2; CCR2; CARD11; TBX21;	GO:0045580~regulation of T cell differentiation	5	13	38.4615384615385	0.0361500964013414	0.477732439886785	1	1	0.999999976169535	0.999999976169535	1
up	VIL1; SPTB; SPTBN1; DMTN; SPTAN1;	GO:0051693~actin filament capping	5	13	38.4615384615385	0.0361500964013414	0.477732439886785	1	1	0.999999976169535	0.999999976169535	1
up	YBX3; CASP8; ARHGEF2; PELI1; RBCK1;	GO:0060546~negative regulation of necroptotic process	5	13	38.4615384615385	0.0361500964013414	0.477732439886785	1	1	0.999999976169535	0.999999976169535	1
up	HMGA2; PRKCD; ANKLE1; NKX3-1; EID3;	GO:2001022~positive regulation of response to DNA damage stimulus	5	13	38.4615384615385	0.0361500964013414	0.477732439886785	1	1	0.999999976169535	0.999999976169535	1
up	EFNA2; EOMES; CSF1R; LRRK2; CHD7; AGTPBP1;	GO:0021772~olfactory bulb development	6	18	33.3333333333333	0.0366406263495027	0.479910781564375	1	1	0.999999976169535	0.999999976169535	1
up	SERPINE1; CCL5; FPR2; CCR1; CCR2; AIF1;	GO:0090026~positive regulation of monocyte chemotaxis	6	18	33.3333333333333	0.0366406263495027	0.479910781564375	1	1	0.999999976169535	0.999999976169535	1
up	RAB29; UBB; CCL5; EPHB1; LRRK2; SARM1;	GO:1901214~regulation of neuron death	6	18	33.3333333333333	0.0366406263495027	0.479910781564375	1	1	0.999999976169535	0.999999976169535	1
up	SDCBP; TNFSF13; F2; EGF; GHRH; IFNG; FN1; WNT1; GNAI2; CSF1R; LYN; HCK; IL6R; RARA; OSM; HCLS1; RAC2; ITGAX; TNFSF4; PRTN3; CXCR2; ADRA1D; PTPN6; AVPR2; DRD3; FLT3; TGFBR2; CD86; LIFR; MARCKSL1; DHPS; ARRB1; PGGT1B; AIF1; NAP1L1; TCL1A; PTEN; IL2; SRPK2; RHOG; SOX4; BCL2L1; BST1; TIAM1; STX3; SLAMF1; TCIRG1; LAMC2; RUNX2; PTK2B; HLX; FXN; AKIRIN2; SPDYA; SHC4; HIPK1; TET1; IL31RA; MZB1; PHIP; NUDT16; NKX3-1; CLEC7A; IL21; ARNT2; BIRC6; C8orf17; SIRPG; CNOT8; TRPC5; MAB21L2; IL11RA; CSF3; PROK2;	GO:0008284~positive regulation of cell population proliferation	74	490	15.1020408163265	0.0371383600852956	0.485351428697854	1	1	0.999999976169535	0.999999976169535	1
down	NUPR1; NQO1; PCSK9; TFAP2B;	GO:0043525~positive regulation of neuron apoptotic process	4	52	7.69230769230769	0.0371607089895609	0.133733242646166	1	1	0.985801124212504	0.999480344286979	1
down	TSPO; TIMM10; TIMM13;	GO:0006626~protein targeting to mitochondrion	3	30	10	0.0375018103019578	0.133733242646166	1	1	0.985801124212504	0.999480344286979	1
down	MT1X; SLC39A7; MT1M;	GO:0006882~cellular zinc ion homeostasis	3	30	10	0.0375018103019578	0.133733242646166	1	1	0.985801124212504	0.999480344286979	1
down	DVL1; PIGR; LRRC1;	GO:0043113~receptor clustering	3	30	10	0.0375018103019578	0.133733242646166	1	1	0.985801124212504	0.999480344286979	1
down	APOD; CDK1; TXN2;	GO:0048678~response to axon injury	3	30	10	0.0375018103019578	0.133733242646166	1	1	0.985801124212504	0.999480344286979	1
down	EPCAM; ELL3; SOX21;	GO:0048863~stem cell differentiation	3	30	10	0.0375018103019578	0.133733242646166	1	1	0.985801124212504	0.999480344286979	1
down	FABP4; CEBPA; FFAR4;	GO:0050873~brown fat cell differentiation	3	30	10	0.0375018103019578	0.133733242646166	1	1	0.985801124212504	0.999480344286979	1
down	TAX1BP3; ADRA2A; RHOD; CDC42EP5; RHOV;	GO:0007266~Rho protein signal transduction	5	77	6.49350649350649	0.037656150627661	0.133733242646166	1	1	0.985801124212504	0.999480344286979	1
down	GJA1; GJB2; EIF4EBP1; BCL2L2;	GO:0002931~response to ischemia	4	53	7.54716981132075	0.0392793931610724	0.133733242646166	1	1	0.987261570322448	0.999480344286979	1
down	ADCYAP1; BDKRB1; NMU; ALOXE3;	GO:0019233~sensory perception of pain	4	53	7.54716981132075	0.0392793931610724	0.133733242646166	1	1	0.987261570322448	0.999480344286979	1
down	RAMP3; AGR2; EGFR; ARHGEF16;	GO:1903078~positive regulation of protein localization to plasma membrane	4	53	7.54716981132075	0.0392793931610724	0.133733242646166	1	1	0.987261570322448	0.999480344286979	1
down	SPINT2; RARG; GRHL2; GRHL3; ST14;	GO:0001843~neural tube closure	5	78	6.41025641025641	0.0393574476526886	0.133733242646166	1	1	0.987261570322448	0.999480344286979	1
up	IFNG; VIL1; ITGA2; PLCG1; TGFBR2; PPM1F; CCR6; GLIPR2; PLCG2;	GO:0010634~positive regulation of epithelial cell migration	9	35	25.7142857142857	0.0402598771527254	0.511048040702223	1	1	0.999999976169535	0.999999976169535	1
down	RAMP2; ANG; SOD3; SLC2A1; BMP2; ALDH3A1; TXN2; SLC2A8;	GO:0001666~response to hypoxia	8	163	4.9079754601227	0.040282302992109	0.133733242646166	1	1	0.988843720274888	0.999480344286979	1
down	GJA1; CENPA; SAPCD2;	GO:0000132~establishment of mitotic spindle orientation	3	31	9.67741935483871	0.0404637434978897	0.133733242646166	1	1	0.988843720274888	0.999480344286979	1
down	CA2; KRT14; GGH;	GO:0010043~response to zinc ion	3	31	9.67741935483871	0.0404637434978897	0.133733242646166	1	1	0.988843720274888	0.999480344286979	1
down	CCL21; FGFR3; CCL19;	GO:0043552~positive regulation of phosphatidylinositol 3-kinase activity	3	31	9.67741935483871	0.0404637434978897	0.133733242646166	1	1	0.988843720274888	0.999480344286979	1
down	WNT7B; RARG; GTPBP3;	GO:0048568~embryonic organ development	3	31	9.67741935483871	0.0404637434978897	0.133733242646166	1	1	0.988843720274888	0.999480344286979	1
down	CDC20; KIFC1; BIRC5;	GO:0090307~mitotic spindle assembly	3	31	9.67741935483871	0.0404637434978897	0.133733242646166	1	1	0.988843720274888	0.999480344286979	1
down	EGFR; CLTB; YWHAQ; SFN; AP2S1; DHCR24; SLC2A8;	GO:0061024~membrane organization	7	134	5.22388059701492	0.0407172741786934	0.133733242646166	1	1	0.988843720274888	0.999480344286979	1
up	CD36; SOAT1; AP2B1; LDLRAP1; SCARB1; DGAT2; EHD1;	GO:0034383~low-density lipoprotein particle clearance	7	24	29.1666666666667	0.0415576624613392	0.511048040702223	1	1	0.999999976169535	0.999999976169535	1
down	MYO1C; IGHV3-48; IGHG4; FCGR2B; CYFIP1; BAIAP2; NCKAP1;	GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis	7	135	5.18518518518519	0.0420338858196985	0.133733242646166	1	1	0.990563448484062	0.999480344286979	1
up	HLA-H; HLA-E; HLA-G; HLA-F;	GO:0002480~antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent	4	9	44.4444444444444	0.0421137838736152	0.511048040702223	1	1	0.999999976169535	0.999999976169535	1
up	CCR2; IL12RB1; SLC11A1; IL27RA;	GO:0002827~positive regulation of T-helper 1 type immune response	4	9	44.4444444444444	0.0421137838736152	0.511048040702223	1	1	0.999999976169535	0.999999976169535	1
up	SASH1; SCIMP; CD180; LY96;	GO:0031666~positive regulation of lipopolysaccharide-mediated signaling pathway	4	9	44.4444444444444	0.0421137838736152	0.511048040702223	1	1	0.999999976169535	0.999999976169535	1
up	FN1; FERMT3; MZB1; TLN1;	GO:0033622~integrin activation	4	9	44.4444444444444	0.0421137838736152	0.511048040702223	1	1	0.999999976169535	0.999999976169535	1
up	JAK2; TYK2; STAT3; IL12RB1;	GO:0038155~interleukin-23-mediated signaling pathway	4	9	44.4444444444444	0.0421137838736152	0.511048040702223	1	1	0.999999976169535	0.999999976169535	1
up	ITGB3; CSF1R; S1PR1; SIGLEC15;	GO:0045124~regulation of bone resorption	4	9	44.4444444444444	0.0421137838736152	0.511048040702223	1	1	0.999999976169535	0.999999976169535	1
up	GNAI2; RAP1B; REST; SYT4;	GO:0045955~negative regulation of calcium ion-dependent exocytosis	4	9	44.4444444444444	0.0421137838736152	0.511048040702223	1	1	0.999999976169535	0.999999976169535	1
up	PTEN; STK4; FXN; WWC3;	GO:0046621~negative regulation of organ growth	4	9	44.4444444444444	0.0421137838736152	0.511048040702223	1	1	0.999999976169535	0.999999976169535	1
up	APP; SLFN14; LRRK2; ATP13A2;	GO:0071287~cellular response to manganese ion	4	9	44.4444444444444	0.0421137838736152	0.511048040702223	1	1	0.999999976169535	0.999999976169535	1
up	TLR4; CD36; GBP5; TLR6;	GO:1900227~positive regulation of NLRP3 inflammasome complex assembly	4	9	44.4444444444444	0.0421137838736152	0.511048040702223	1	1	0.999999976169535	0.999999976169535	1
up	UCP1; PM20D1; SORL1; UCP2;	GO:1990845~adaptive thermogenesis	4	9	44.4444444444444	0.0421137838736152	0.511048040702223	1	1	0.999999976169535	0.999999976169535	1
up	LILRA5; LGALS9; LGALS9C; LGALS9B;	GO:2001181~positive regulation of interleukin-10 secretion	4	9	44.4444444444444	0.0421137838736152	0.511048040702223	1	1	0.999999976169535	0.999999976169535	1
up	TNFRSF21; CALCA; CYBA; CCL5; YBX3; GATA3; GBP2; CHI3L1; ZFP36L2; TCL1A; DAB2IP; ADAMTS13; ARHGEF2; MAP3K5; NKX3-1; INPP5K; DCSTAMP; ADAMTS7; KLF2; CCL26; CCL24; CCL7; CCL4;	GO:0071356~cellular response to tumor necrosis factor	23	125	18.4	0.042321956684265	0.511048040702223	1	1	0.999999976169535	0.999999976169535	1
down	MAP2; PSRC1; CAPN6;	GO:0001578~microtubule bundle formation	3	32	9.375	0.0435401656367036	0.133733242646166	1	1	0.992439515621342	0.999480344286979	1
down	BMP7; WLS; MESP2;	GO:0001707~mesoderm formation	3	32	9.375	0.0435401656367036	0.133733242646166	1	1	0.992439515621342	0.999480344286979	1
down	E2F8; RAMP2; ESM1;	GO:0002040~sprouting angiogenesis	3	32	9.375	0.0435401656367036	0.133733242646166	1	1	0.992439515621342	0.999480344286979	1
down	SLC6A15; SLC6A9; SLC6A11;	GO:0006810~transport	3	32	9.375	0.0435401656367036	0.133733242646166	1	1	0.992439515621342	0.999480344286979	1
down	UQCRC1; MDH2; NDUFS7;	GO:0009060~aerobic respiration	3	32	9.375	0.0435401656367036	0.133733242646166	1	1	0.992439515621342	0.999480344286979	1
down	SQLE; TIMP3; TIMP4;	GO:0010033~response to organic substance	3	32	9.375	0.0435401656367036	0.133733242646166	1	1	0.992439515621342	0.999480344286979	1
down	PHGDH; SRD5A1; MPST;	GO:0021510~spinal cord development	3	32	9.375	0.0435401656367036	0.133733242646166	1	1	0.992439515621342	0.999480344286979	1
down	EPB41L4B; LIMCH1; FRMD6;	GO:0031032~actomyosin structure organization	3	32	9.375	0.0435401656367036	0.133733242646166	1	1	0.992439515621342	0.999480344286979	1
down	GSTP1; BAD; PEMT;	GO:0043200~response to amino acid	3	32	9.375	0.0435401656367036	0.133733242646166	1	1	0.992439515621342	0.999480344286979	1
down	YIF1A; LMNA; ACADVL; ERN2;	GO:0036498~IRE1-mediated unfolded protein response	4	55	7.27272727272727	0.0437193414410957	0.133733242646166	1	1	0.992439515621342	0.999480344286979	1
up	APAF1; TNFRSF10B; TNFRSF10C; TRIM24; BNIP3L; RAF1; CD3E; LGALS1; ACTN1; PTPN6; CASP1; ACTN2; FLT3; BCL6; DAPK1; BID; ATM; TNFAIP8L2; SARM1; OLFM4; RASSF5; CREBBP; CASP10; TP53INP1; TRAF4; CARD11; ALX4; NLRC4; MOAP1; NME3; JAK3; NME4; USP17L7; JAK2;	GO:0042981~regulation of apoptotic process	34	202	16.8316831683168	0.0439519969814719	0.511048040702223	1	1	0.999999976169535	0.999999976169535	1
up	KCNN4; SLC12A7; SLC12A9; SLC12A4; SLC12A3; SLC12A1;	GO:0006884~cell volume homeostasis	6	19	31.5789473684211	0.0439973417775206	0.511048040702223	1	1	0.999999976169535	0.999999976169535	1
up	WDR1; ACTN1; PTPN6; CASP9; MEF2C; CLEC1B;	GO:0030220~platelet formation	6	19	31.5789473684211	0.0439973417775206	0.511048040702223	1	1	0.999999976169535	0.999999976169535	1
up	MYO1G; ITGB3; ATP1B2; ITGA2; CORO1A; EPHB1;	GO:0031589~cell-substrate adhesion	6	19	31.5789473684211	0.0439973417775206	0.511048040702223	1	1	0.999999976169535	0.999999976169535	1
up	TLR4; FFAR2; TLR2; TNF; IL6R; TLR7;	GO:0032722~positive regulation of chemokine production	6	19	31.5789473684211	0.0439973417775206	0.511048040702223	1	1	0.999999976169535	0.999999976169535	1
up	SOCS2; JAK1; STAT3; STAT5A; STAT5B; JAK3;	GO:0038111~interleukin-7-mediated signaling pathway	6	19	31.5789473684211	0.0439973417775206	0.511048040702223	1	1	0.999999976169535	0.999999976169535	1
up	SOCS2; SOCS3; PIK3R1; WDR81; SOCS4; PIK3R5;	GO:0043551~regulation of phosphatidylinositol 3-kinase activity	6	19	31.5789473684211	0.0439973417775206	0.511048040702223	1	1	0.999999976169535	0.999999976169535	1
up	TNFSF11; SYK; ADAM8; DEF8; DCSTAMP; PLEKHM1;	GO:0045780~positive regulation of bone resorption	6	19	31.5789473684211	0.0439973417775206	0.511048040702223	1	1	0.999999976169535	0.999999976169535	1
up	RGS14; JAK2; ZFAND5; BCR; PTEN; PTPRJ; RAPGEF1; TXNIP;	GO:0048008~platelet-derived growth factor receptor signaling pathway	8	30	26.6666666666667	0.0443551214716758	0.511048040702223	1	1	0.999999976169535	0.999999976169535	1
up	CHST6; CHST7; NAGK; CHST2; RENBP;	GO:0006044~N-acetylglucosamine metabolic process	5	14	35.7142857142857	0.044876101598481	0.511048040702223	1	1	0.999999976169535	0.999999976169535	1
up	ST8SIA4; MGAT4A; MAN2A2; MAN1A1; MAN1A2;	GO:0006491~N-glycan processing	5	14	35.7142857142857	0.044876101598481	0.511048040702223	1	1	0.999999976169535	0.999999976169535	1
up	SLC11A1; ATP6V0E2; ATP6V0D1; TCIRG1; ATP6V0A4;	GO:0007035~vacuolar acidification	5	14	35.7142857142857	0.044876101598481	0.511048040702223	1	1	0.999999976169535	0.999999976169535	1
up	CRYBA1; TSC2; PTEN; DAB2IP; PIK3IP1;	GO:0014067~negative regulation of phosphatidylinositol 3-kinase signaling	5	14	35.7142857142857	0.044876101598481	0.511048040702223	1	1	0.999999976169535	0.999999976169535	1
up	F2; SERPINE1; CD36; TBXA2R; DMTN;	GO:0030194~positive regulation of blood coagulation	5	14	35.7142857142857	0.044876101598481	0.511048040702223	1	1	0.999999976169535	0.999999976169535	1
up	PTH; CD33; LILRB2; LILRB1; INPP5K;	GO:0051926~negative regulation of calcium ion transport	5	14	35.7142857142857	0.044876101598481	0.511048040702223	1	1	0.999999976169535	0.999999976169535	1
up	INPPL1; AIF1; INPP5K; SNX10; AIF1L;	GO:0097178~ruffle assembly	5	14	35.7142857142857	0.044876101598481	0.511048040702223	1	1	0.999999976169535	0.999999976169535	1
up	ITGB2; MME; ITGAM; C5AR1; MARCO;	GO:0097242~amyloid-beta clearance	5	14	35.7142857142857	0.044876101598481	0.511048040702223	1	1	0.999999976169535	0.999999976169535	1
up	SYK; LILRA2; FCER1G;	GO:0002283~neutrophil activation involved in immune response	3	5	60	0.0450873737979566	0.511048040702223	1	1	0.999999976169535	0.999999976169535	1
up	BCL6; MEF2C; PKN1;	GO:0002634~regulation of germinal center formation	3	5	60	0.0450873737979566	0.511048040702223	1	1	0.999999976169535	0.999999976169535	1
up	IL13RA2; ZPBP2; FCRL3;	GO:0002638~negative regulation of immunoglobulin production	3	5	60	0.0450873737979566	0.511048040702223	1	1	0.999999976169535	0.999999976169535	1
up	LTA; TNF; PTPRC;	GO:0002925~positive regulation of humoral immune response mediated by circulating immunoglobulin	3	5	60	0.0450873737979566	0.511048040702223	1	1	0.999999976169535	0.999999976169535	1
up	PTH; SSTR3; METTL21C;	GO:0008628~hormone-mediated apoptotic signaling pathway	3	5	60	0.0450873737979566	0.511048040702223	1	1	0.999999976169535	0.999999976169535	1
up	PIK3CG; PLIN5; SORL1;	GO:0010897~negative regulation of triglyceride catabolic process	3	5	60	0.0450873737979566	0.511048040702223	1	1	0.999999976169535	0.999999976169535	1
up	CAT; EPB42; AHSP;	GO:0020027~hemoglobin metabolic process	3	5	60	0.0450873737979566	0.511048040702223	1	1	0.999999976169535	0.999999976169535	1
up	DEDD2; CDK5RAP3; SHARPIN;	GO:0030262~apoptotic nuclear changes	3	5	60	0.0450873737979566	0.511048040702223	1	1	0.999999976169535	0.999999976169535	1
up	IFNG; IL17RA; MYD88;	GO:0032747~positive regulation of interleukin-23 production	3	5	60	0.0450873737979566	0.511048040702223	1	1	0.999999976169535	0.999999976169535	1
up	CNR2; MILR1; CD84;	GO:0033004~negative regulation of mast cell activation	3	5	60	0.0450873737979566	0.511048040702223	1	1	0.999999976169535	0.999999976169535	1
up	TNFSF11; CCL5; JAK1;	GO:0034112~positive regulation of homotypic cell-cell adhesion	3	5	60	0.0450873737979566	0.511048040702223	1	1	0.999999976169535	0.999999976169535	1
up	SCIMP; PIK3AP1; TLR7;	GO:0034154~toll-like receptor 7 signaling pathway	3	5	60	0.0450873737979566	0.511048040702223	1	1	0.999999976169535	0.999999976169535	1
up	TNF; NCKAP1L; ROCK1;	GO:0035509~negative regulation of myosin-light-chain-phosphatase activity	3	5	60	0.0450873737979566	0.511048040702223	1	1	0.999999976169535	0.999999976169535	1
up	PECAM1; CCR2; JAML;	GO:0035696~monocyte extravasation	3	5	60	0.0450873737979566	0.511048040702223	1	1	0.999999976169535	0.999999976169535	1
up	LRRK2; TMEM175; CXorf21;	GO:0035751~regulation of lysosomal lumen pH	3	5	60	0.0450873737979566	0.511048040702223	1	1	0.999999976169535	0.999999976169535	1
up	ALOX5; NLRP12; DOCK8;	GO:0036336~dendritic cell migration	3	5	60	0.0450873737979566	0.511048040702223	1	1	0.999999976169535	0.999999976169535	1
up	PADI4; PADI2; PADI1;	GO:0036414~histone citrullination	3	5	60	0.0450873737979566	0.511048040702223	1	1	0.999999976169535	0.999999976169535	1
up	ABCD1; CXCR4; ABCD2;	GO:0043217~myelin maintenance	3	5	60	0.0450873737979566	0.511048040702223	1	1	0.999999976169535	0.999999976169535	1
up	CIITA; NLRP12; NLRC5;	GO:0045345~positive regulation of MHC class I biosynthetic process	3	5	60	0.0450873737979566	0.511048040702223	1	1	0.999999976169535	0.999999976169535	1
up	TOX; ADA; STAT5B;	GO:0048541~Peyer's patch development	3	5	60	0.0450873737979566	0.511048040702223	1	1	0.999999976169535	0.999999976169535	1
up	ABCD1; LRRK2; PPP2R3C;	GO:0051900~regulation of mitochondrial depolarization	3	5	60	0.0450873737979566	0.511048040702223	1	1	0.999999976169535	0.999999976169535	1
up	RARA; RXRA; MEF2C;	GO:0055012~ventricular cardiac muscle cell differentiation	3	5	60	0.0450873737979566	0.511048040702223	1	1	0.999999976169535	0.999999976169535	1
up	LYN; SYK; PRKCQ;	GO:0090330~regulation of platelet aggregation	3	5	60	0.0450873737979566	0.511048040702223	1	1	0.999999976169535	0.999999976169535	1
up	LGALS9; PRTN3; CCR7;	GO:0097029~mature conventional dendritic cell differentiation	3	5	60	0.0450873737979566	0.511048040702223	1	1	0.999999976169535	0.999999976169535	1
up	CST7; CARD16; CARD8;	GO:0097340~inhibition of cysteine-type endopeptidase activity	3	5	60	0.0450873737979566	0.511048040702223	1	1	0.999999976169535	0.999999976169535	1
up	RAB32; HPS1; TRAPPC6A;	GO:1903232~melanosome assembly	3	5	60	0.0450873737979566	0.511048040702223	1	1	0.999999976169535	0.999999976169535	1
up	CTSA; EEF1A1; ATP13A2;	GO:1904714~regulation of chaperone-mediated autophagy	3	5	60	0.0450873737979566	0.511048040702223	1	1	0.999999976169535	0.999999976169535	1
up	PTPRC; PTPRJ; RAPGEF1;	GO:1905451~positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis	3	5	60	0.0450873737979566	0.511048040702223	1	1	0.999999976169535	0.999999976169535	1
up	LGALS9; CD55; TGFBR2;	GO:2000563~positive regulation of CD4-positive, alpha-beta T cell proliferation	3	5	60	0.0450873737979566	0.511048040702223	1	1	0.999999976169535	0.999999976169535	1
up	BST1; PRKD1; CD177;	GO:2001044~regulation of integrin-mediated signaling pathway	3	5	60	0.0450873737979566	0.511048040702223	1	1	0.999999976169535	0.999999976169535	1
up	ACTN2; SORL1; EHD1;	GO:2001137~positive regulation of endocytic recycling	3	5	60	0.0450873737979566	0.511048040702223	1	1	0.999999976169535	0.999999976169535	1
up	TNFSF11; TYROBP; GPR68;	GO:2001206~positive regulation of osteoclast development	3	5	60	0.0450873737979566	0.511048040702223	1	1	0.999999976169535	0.999999976169535	1
up	TRPA1; YBX3; GMPR; CDH8; CIRBP; CASP8; PCSK1N; UCP1; UCP2;	GO:0009409~response to cold	9	36	25	0.0457331817107576	0.5153945946524	1	1	0.999999976169535	0.999999976169535	1
up	FXYD1; DYSF; VCL; GLRA1; GJC1; UTRN; PXN; CHRND; SNTB1; KCNJ12; TAZ; SORBS1; MYOT; TLN1; TNNT3; TNNI1; LMOD2; TMOD1; MYOM1; LMOD3;	GO:0006936~muscle contraction	20	106	18.8679245283019	0.0459582847715465	0.516942997029571	1	1	0.999999976169535	0.999999976169535	1
down	APOD; AKR1A1; FABP5; TFAP2B;	GO:0006006~glucose metabolic process	4	56	7.14285714285714	0.0460405369520703	0.138388844486944	1	1	0.994494255819316	0.999480344286979	1
down	SLC28A2; TK1; SLC29A1;	GO:0006139~nucleobase-containing compound metabolic process	3	33	9.09090909090909	0.0467298051427086	0.139535044186424	1	1	0.994494255819316	0.999480344286979	1
down	ADCYAP1; FAM3B; ANXA1;	GO:0030073~insulin secretion	3	33	9.09090909090909	0.0467298051427086	0.139535044186424	1	1	0.994494255819316	0.999480344286979	1
down	HOXD9; CRABP2; TP63;	GO:0035115~embryonic forelimb morphogenesis	3	33	9.09090909090909	0.0467298051427086	0.139535044186424	1	1	0.994494255819316	0.999480344286979	1
down	SDC1; AQP1; AQP5;	GO:0042476~odontogenesis	3	33	9.09090909090909	0.0467298051427086	0.139535044186424	1	1	0.994494255819316	0.999480344286979	1
down	HSPA1B; ADCYAP1; BAD;	GO:0046034~ATP metabolic process	3	33	9.09090909090909	0.0467298051427086	0.139535044186424	1	1	0.994494255819316	0.999480344286979	1
down	HOXD8; HOXC8; HYAL2;	GO:0048705~skeletal system morphogenesis	3	33	9.09090909090909	0.0467298051427086	0.139535044186424	1	1	0.994494255819316	0.999480344286979	1
down	HES5; HEY2; HES2;	GO:0050767~regulation of neurogenesis	3	33	9.09090909090909	0.0467298051427086	0.139535044186424	1	1	0.994494255819316	0.999480344286979	1
down	BAD; BCL2L2; BOK;	GO:0097192~extrinsic apoptotic signaling pathway in absence of ligand	3	33	9.09090909090909	0.0467298051427086	0.139535044186424	1	1	0.994494255819316	0.999480344286979	1
down	ANXA1; GAS6; ELMO3; TYRO3;	GO:0006909~phagocytosis	4	57	7.01754385964912	0.048429078683088	0.144051690739988	1	1	0.996754470037087	0.999480344286979	1
down	GSN; NPR3; PLCD1; PIK3C2G;	GO:0048015~phosphatidylinositol-mediated signaling	4	57	7.01754385964912	0.048429078683088	0.144051690739988	1	1	0.996754470037087	0.999480344286979	1
up	TLR4; TLR2; SASH3; TNFSF4; CD40LG; FCER1G; TIGIT;	GO:0032733~positive regulation of interleukin-10 production	7	25	28	0.0484673149389894	0.534263779687991	1	1	0.999999976169535	0.999999976169535	1
up	RIOK3; SH2D1B; CCL5; CD1D; FPR2; ADAM8; GBP5;	GO:0045089~positive regulation of innate immune response	7	25	28	0.0484673149389894	0.534263779687991	1	1	0.999999976169535	0.999999976169535	1
down	FABP4; AKR1C1; PCSK9; LIPG; CYP39A1;	GO:0042632~cholesterol homeostasis	5	83	6.02409638554217	0.0485576077936762	0.144051690739988	1	1	0.996754470037087	0.999480344286979	1
down	FOXN1; HRAS; BMP2; ELN; PHLDA2; EGFLAM;	GO:0009887~animal organ morphogenesis	6	111	5.40540540540541	0.0490855727316453	0.144051690739988	1	1	0.996754470037087	0.999480344286979	1
